US20220020481A1 - Digital pass verification systems and methods - Google Patents
Digital pass verification systems and methods Download PDFInfo
- Publication number
- US20220020481A1 US20220020481A1 US17/068,601 US202017068601A US2022020481A1 US 20220020481 A1 US20220020481 A1 US 20220020481A1 US 202017068601 A US202017068601 A US 202017068601A US 2022020481 A1 US2022020481 A1 US 2022020481A1
- Authority
- US
- United States
- Prior art keywords
- user
- test
- digital pass
- examples
- code
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/26—Government or public services
- G06Q50/265—Personal security, identity or safety
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C9/00—Individual registration on entry or exit
- G07C9/20—Individual registration on entry or exit involving the use of a pass
- G07C9/22—Individual registration on entry or exit involving the use of a pass in combination with an identity check of the pass holder
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/06009—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code with optically detectable marking
- G06K19/06037—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code with optically detectable marking multi-dimensional coding
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K7/00—Methods or arrangements for sensing record carriers, e.g. for reading patterns
- G06K7/10—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation
- G06K7/14—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation using light without selection of wavelength, e.g. sensing reflected white light
- G06K7/1404—Methods for optical code recognition
- G06K7/1408—Methods for optical code recognition the method being specifically adapted for the type of code
- G06K7/1417—2D bar codes
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C9/00—Individual registration on entry or exit
- G07C9/20—Individual registration on entry or exit involving the use of a pass
- G07C9/22—Individual registration on entry or exit involving the use of a pass in combination with an identity check of the pass holder
- G07C9/25—Individual registration on entry or exit involving the use of a pass in combination with an identity check of the pass holder using biometric data, e.g. fingerprints, iris scans or voice recognition
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C9/00—Individual registration on entry or exit
- G07C9/20—Individual registration on entry or exit involving the use of a pass
- G07C9/27—Individual registration on entry or exit involving the use of a pass with central registration
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07C—TIME OR ATTENDANCE REGISTERS; REGISTERING OR INDICATING THE WORKING OF MACHINES; GENERATING RANDOM NUMBERS; VOTING OR LOTTERY APPARATUS; ARRANGEMENTS, SYSTEMS OR APPARATUS FOR CHECKING NOT PROVIDED FOR ELSEWHERE
- G07C9/00—Individual registration on entry or exit
- G07C9/20—Individual registration on entry or exit involving the use of a pass
- G07C9/29—Individual registration on entry or exit involving the use of a pass the pass containing active electronic elements, e.g. smartcards
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
- G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
Abstract
Digital pass verification systems and methods are disclosed herein. A server is to distribute instructions on a network. The instructions, when executed, are to cause a mobile device carried by a person to at least: access a user identification associated with the person; access a result of a diagnostic test performed on a sample gathered from the person; display the result on a display of the mobile device; generate an interface including the user identification and an indicator, the indicator generated in response to the result being negative and a number of days since the diagnostic test being below a threshold number of days; and display the interface on the display to enable the person to gain entry into a location.
Description
- This patent claims the benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 63/054,170, titled “ELECTRONIC HEALTH PASS VERIFICATION SYSTEMS AND METHODS,” filed Jul. 20, 2020, and to U.S. Provisional Application No. 63/080,391, titled “ELECTRONIC HEALTH PASS VERIFICATION SYSTEMS AND METHODS,” filed Sep. 18, 2020, both of which are incorporated herein by this reference in their entireties.
- This disclosure relates generally to health-based screening and, more particularly, to digital pass verification systems and methods.
- In recent years, there has been a rise in outbreaks of infectious diseases (e.g., viral diseases, bacterial diseases, etc.) such as the COVID-19 virus, Ebola virus, H1N1pdm09 virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome (SARS), to name a few. These infectious diseases are often contagious and easily transmitted from person-to-person in close proximity or through indirect contact via objects and surfaces. To curb the spread of infectious diseases, many entities (e.g., companies, schools, retailers, governments, facility managers, etc.) restrict people with symptoms of infectious diseases from accessing their locations or facilities.
-
FIG. 1 illustrates an example system or network of entities or persons with which the examples disclosed herein can be employed.FIG. 1 shows an example user, an example tester, an example verifier, and an example digital pass management system. -
FIG. 2 is a block diagram of an example user device associated with the example user ofFIG. 1 and used to execute an example user application. -
FIG. 3 is a block diagram of an example tester device associated with the example tester ofFIG. 1 and used to execute an example tester application. -
FIG. 4 is a block diagram of an example verifier device associated with the example verifier ofFIG. 1 and used to execute an example verifier application. -
FIG. 5 is a block diagram of the example digital pass management system ofFIG. 1 . -
FIGS. 6-13 are example user interface screens that may be displayed on the example user device ofFIG. 2 by the example user application. -
FIGS. 14-25 are example user interface screens that may be displayed on the example tester device ofFIG. 3 by the example tester application. -
FIGS. 26, 27A, 27B, 28A, and 28B are example user interface screens that may be displayed on the example user device ofFIG. 2 by the example user application. -
FIGS. 29-32 are example user interface screens that may be displayed on the example verifier device ofFIG. 4 by the example verification application. -
FIGS. 33-38 are example interface screens that may be displayed on the example user device ofFIG. 2 by the example user application. -
FIG. 39 is an example timeline or sequence of events as performed by and/or experienced by a user during an example digital pass verification process. -
FIG. 40A is an example timeline or sequence of events as performed by and/or experienced by a tester during an example digital pass verification process. -
FIG. 40B is another example timeline or sequence of events as performed by and/or experienced by a tester during an example digital pass verification process. -
FIG. 41 is an example timeline or sequence of events as performed by and/or experienced by a verifier during an example digital pass verification process. -
FIGS. 42A, 42B, and 42C are example timelines or sequences of events as performed and/or experienced by a user, a tester, and a verifier, respectively during an example digital pass verification process where an employer is the verifier and an employee is the user. -
FIG. 43 is example timeline or sequence of events as performed and/or experienced by a digital pass management system, a user, a tester, and a verifier during an example digital pass verification process where a school is the verifier and a student and/or the student's parent is the user. -
FIG. 44 is another example timeline or sequence of events as performed and/or experienced by a digital pass management system, a user, a tester, and a verifier during an example digital pass verification process where a school is the verifier and a student and/or the student's parent is the user and the user does not have an electronic mobile device. -
FIG. 45 is an example timeline or sequence of events as performed by and/or experience by a manufacturer and/or distributor of infectious disease test kits. -
FIGS. 46A and 46B are flowcharts representative of example machine readable instructions that may be executed to implement the example user application on the example user device ofFIG. 2 . -
FIG. 47 is a flowchart representative of example machine readable instructions that may be executed to implement the example tester application on the example tester device ofFIG. 3 . -
FIG. 48 is a flowchart representative of example machine readable instructions that may be executed to implement the example verifier application on the example verifier device ofFIG. 4 . -
FIG. 49 is a flowchart representative of machine readable instructions which may be executed to implement the example digital pass management system ofFIGS. 1 and 5 . -
FIG. 50 is a block diagram of an example processing platform structured to execute the instructions ofFIGS. 46A and 46B to implement the example user application. -
FIG. 51 is a block diagram of an example processing platform structured to execute the instructions ofFIG. 47 to implement the example tester application. -
FIG. 52 is a block diagram of an example processing platform structured to execute the instructions ofFIG. 48 to implement the example verifier application. -
FIG. 53 is a block diagram of an example processing platform structured to execute the instructions ofFIG. 49 to implement the digital pass management system. -
FIG. 54 is a block diagram of an example software distribution platform to distribute software (e.g., software corresponding to the example computer readable instructions ofFIGS. 46A, 46B, 47, 48, and 49 ) to client devices such as consumers (e.g., for license, sale and/or use), retailers (e.g., for sale, re-sale, license, and/or sub-license), and/or original equipment manufacturers (OEMs) (e.g., for inclusion in products to be distributed to, for example, retailers and/or to direct buy customers). - The figures are not to scale. In general, the same reference numbers will be used throughout the drawing(s) and accompanying written description to refer to the same or like parts.
- Unless specifically stated otherwise, descriptors such as “first,” “second,” “third,” etc. are used herein without imputing or otherwise indicating any meaning of priority, physical order, arrangement in a list, and/or ordering in any way, but are merely used as labels and/or arbitrary names to distinguish elements for ease of understanding the disclosed examples. In some examples, the descriptor “first” may be used to refer to an element in the detailed description, while the same element may be referred to in a claim with a different descriptor such as “second” or “third.” In such instances, it should be understood that such descriptors are used merely for identifying those elements distinctly that might, for example, otherwise share a same name.
- Disclosed herein are example apparatus, systems, methods, and articles of manufacture that enable entities or persons, referred to herein as verifiers, to verify whether a person has recently tested negative for an infectious disease (e.g., a pathogen, a virus, a bacteria, etc.) before granting the person access to a particular location or area. This enables a verifier to maintain a safe environment for the people in the particular area and reduce the likelihood of infection. Example verifiers may include airlines, offices, malls, libraries, sporting arenas, schools, theatres, retailers, utilities, employers, governments, facility managers, and/or any other entity or person that desires to control access to a particular location. Many examples disclosed herein are described in connection with testing for pathogens, viruses, and other infectious diseases. However, it is understood that any examples disclosed herein can be implemented in connection with testing for any analyte of interest.
- In examples disclosed herein, a person, referred to herein as a user, may be tested for a particular infectious disease. If the results are negative, a digital pass (which may also be referred to as an electronic pass, a digital health pass, an electronic health pass, a health pass, a digital health card, an electronic health card, or a health card) is generated that can be stored on the user's electronic device, such as, for example, his/her smartphone, smartwatch, etc. In some examples, the digital pass includes a code such as, for example, a Data Matrix Code, a Quick Response (QR) code, a bar code, and/or other machine-readable code. In some examples, the digital pass code includes a user identification (e.g., a user account ID) and a test kit identification associated with a test kit used to test the user. In other examples, the digital pass code can include other information. When the user arrives at a verifier location, a verifier can scan the digital pass code of the digital pass on the user's electronic device to confirm the user has been tested and the test was negative (i.e., the user is not infected with the pathogen subject to the test). In some examples, the verifier uses a verifier device, such as a smartphone, a handheld scanner, or a mounted scanner communicatively coupled to a computer to scan the digital pass code. In some examples, the scanner is a camera. In some examples, a record of the user's test result is stored in a digital pass management system. The verifier can check the identity of the user and their test result with the digital pass management system. The digital pass code enables the verifier to quickly and accurately obtain identifying information about the user that can be used to confirm whether the user has recently been tested and whether the test result was negative for the infectious disease. If the digital pass is valid, the verifier can allow the user to access the location. However, if the user does not have a digital pass, or the digital pass is invalid or expired, the verifier can deny the user access to the location, thereby reducing the risk of infection to others in the location.
- In some examples, the user is tested by a tester (e.g., medical professional such as a nurse, a doctor, etc.) at a testing facility (e.g., a doctor's office, hospital, medical clinic, etc.). In some examples, the user's electronic device generates a unique identity code to identify the user. The tester can scan the identity code (e.g., with a tester electronic device such as a tablet or smartphone) to create a record of the user and the test with the digital pass management system. The results of the test are stored with the user's record in the digital pass management system.
- In some examples, each user device, tester device, and verifier device operates an application that enables the persons and devices to interface with the digital pass management system. The digital pass management system stores account information, test results, and other information. The digital pass management system provides an interface between the various entities.
- In some examples, the verifier is a workplace that desires to keep their employees safe. The verifier may require that the employees have a valid digital pass every day the employees enter the workplace. In some examples, the digital pass expires after a certain period of time after being tested (e.g., 5 days, 7 days, 10 days, etc.). Therefore, the employees may need to be tested multiple times and/or on a regular basis.
- The examples disclosed herein benefit all parties, including the employees, the employers (the verifiers), and the testers. From an employee standpoint, for example, the examples disclosed herein enable the employee to safely return to work, which could be a more effective and productive environment than working remotely or could be the employee's only option to work if they cannot perform their duties remotely. This also encourages employees to be better citizens by maintaining awareness of their health and risk to others. From an employer standpoint, for example, the examples disclosed herein can be used to reinforce the importance of employee safety at the workplace, have confidence in the safety of the workplace, manage risk to employees at the workplace, understand who has access to a site, verify employee's pass ad-hoc, act locally based on high frequency data, and access data that may inform access policies to the workplace. From a tester standpoint, for example, the examples disclosed herein enable testers to administer tests and record results efficiently, manage throughput of employees in a reasonable fashion, and maintain the safety of employees awaiting testing and results. These and other benefits are similarly achieved in connection with other types of verifier organizations, such as schools, malls, airlines, sports arenas, etc.
-
FIG. 1 illustrates an example digitalpass management system 100 constructed in accordance with the teachings of this disclosure. The digitalpass management system 100 interfaces with multiple persons or entities and/or distributes software to such persons or entities to facilitate the example digital pass verification processes disclosed herein. For example, the example digitalpass management system 100 can be used to facilitate the generation of an digital pass for a user (e.g., a person) and enable a verifier to grant or deny access to the user based on the digital pass.FIG. 1 shows anexample user 102, anexample tester 104, and anexample verifier 106. In this example, theuser 102 has a firstelectronic device 108 referred to herein as auser device 108, thetester 104 has a secondelectronic device 110 referred to herein as atester device 110, and theverifier 106 has a thirdelectronic device 112 referred to herein as averifier device 112. While only one user, tester, and verifier are illustrated, it is understood that the example digitalpass management system 100 can support multiple (e.g., hundreds, thousands, millions, etc. of users) users, testers, and/or verifiers. - The
verifier 106 can represent any person or entity that desires to verify a health status of a person (e.g., the user 102) before granting access to a physical location. The health status includes information related to a person's health such as, for example, a positive or negative result from a diagnostic test for an infectious disease. Theverifier 106 may be an airline, an office, a school, a mall, a library, other businesses, a government, a park ranger, other facility managers, etc. For example, theverifier 106 may be an airline gate agent who checks tickets and digital passes of theuser 102 prior to boarding a plane. In another example, theverifier 106 may be a security agent or other person who checks the pass of theuser 102 prior to the user entering an office building. Theverifier 106 uses theverifier device 112 to check the health status of theuser 102, as disclosed in further detail herein. In some examples, theverifier device 112 is a mobile electronic device, such as a smartphone, a tablet, a laptop computer, a handheld code scanner, etc. In other examples, theverifier device 112 can be implemented as a non-mobile electronic device, such as a desktop computer, a kiosk, a non-mobile internet connected device capable of scanning a QR code, Data Matrix Code, and/or a barcode, etc. - The
user 102 can represent any person that desires to access the location regulated by theverifier 106. Theuser 102 can interact with theuser device 108 to create a digital pass account, receive and view results of a diagnostic test, and/or display a digital pass, as disclosed in further detail herein. Theuser device 108 is an electronic device that is carried by theuser 102. In this example, theuser device 108 is a smartphone. However, in other examples, theuser device 108 can be implemented by any type of mobile or non-mobile electronic device, such as a tablet, a smartwatch, a laptop computer, a desktop computer, etc. - The
tester 104 can represent any person or entity, such as a nurse, a doctor, a testing facility, a hospital, a clinic, etc. that tests a sample from a person/user to be tested for an infectious disease (e.g., a disease caused by a virus, a bacteria, etc.). Thetester 104 can interact with thetester device 110 to match theuser 102 with a testing kit, enter the test results, etc., as disclosed in further detail herein. In this example, thetester device 110 is a tablet. However, in other examples, thetester device 108 can be implemented by any type of mobile or non-mobile electronic device, such as a smartphone, a laptop computer, a desktop computer, etc. - The digital
pass management system 100, theuser device 108, thetester device 110, and theverifier device 112 communicate via anetwork 114, such as, for example, the Internet. In some examples, each of theuser device 108, thetester device 110, and theverifier device 112 downloads an application through which the digitalpass management system 100, theuser device 108, thetester device 110, and theverifier device 112 can communicate. The applications may be specific to the type of entity. For example, as shown inFIG. 1 , theuser device 108 includes auser application 116, thetester device 110 includes atester application 118, and theverifier device 112 includes averification application 120. In some examples the applications are downloaded onto the respective devices from the digitalpass management system 100 or another entity, such as, for example, the Apple App Store or the Google Play Store. Thus, the example application disclosed herein can utilize different operating systems. The digitalpass management system 100, theuser device 108, thetester device 110, and theverifier device 112 may communicate and view information provided in the applications. - While many of the example operations disclosed herein are described in connection with functions performed by the specific applications, these operations are not limited to functions performed by an application downloaded onto a device. Instead, the operations can be performed via a web browser or web-based applications. In some such examples, one or more of the operations can be performed remotely, such as by the digital
pass management system 100, and displayed on the respective devices. Also, in some examples, the operations of the applications disclosed herein are cloud based, partially cloud based, or edge based. -
FIG. 2 is a block diagram of theexample user device 108. As disclosed above, in some examples, theuser device 108 is implemented as a smartphone. However, in other examples, theuser device 108 can be implemented as any other type of mobile or non-mobile electronic device. In this example, theuser device 108 includes anexample processor 200, anexample memory 202, anexample transceiver 204, an example display 206 (e.g., a capacitive touchscreen), and anexample camera 207. Thetransceiver 204 can be any type of wired or wireless hardware, firmware, or software for enabling communication with other devices, such as via a wireless internet connection, Bluetooth®, Ethernet connection, etc. Theuser application 116 can be stored in thememory 202 and executed by theprocessor 200. Theuser application 116 includes anexample scheduler 208, anexample notifier 210, anexample code generator 212, anexample time comparator 214, anexample analyzer 216, and anexample output 218. Operation of theuser application 116 is disclosed in further detail below. -
FIG. 3 is a block diagram of theexample tester device 110. In some examples, thetester device 110 is implemented by a mobile electronic device such as a smartphone, a laptop computer, a tablet, etc. In other examples, thetester device 110 can be implemented by a non-mobile electronic device such as a desktop computer, a medical instrument, a server, etc. Thetester device 110 includes anexample processor 300, anexample memory 302, anexample transceiver 304, and anexample display 306. In this example, thetester device 110 also includes acamera 308. Thecamera 308 can be used to take pictures and/or scan codes, such as QR codes, as disclosed in further detail herein. Thecamera 308 can be part of the tester device 110 (e.g., a camera built into a smartphone) or communicatively coupled to the tester device 110 (e.g., a handheld scanner in wireless communication with the tester device 110). Thetester application 118 can be stored in thememory 302 and executed by theprocessor 300. Thetester application 118 includes anexample record generator 310, anexample test selector 312, anexample sample indicator 314, anexample comparator 316, and anexample reader 318. Operation of thetester application 118 is disclosed in further detail below. -
FIG. 4 is a block diagram of theexample verifier device 112. In some examples, theverifier device 112 is implemented by a mobile electronic device, such as a smartphone, a laptop computer, tablet, etc. In other examples, theverifier device 112 can be implemented by a scanner such as, for example, a handheld code scanner. In other examples, theuser device 108 can be implemented as any other type of mobile or non-mobile electronic device. Theverifier device 112 includes anexample processor 400, anexample memory 402, anexample transceiver 404, anexample display 406, and anexample camera 408. Thecamera 408 can be part of the verifier device 112 (e.g., a camera built into a smartphone) or communicatively coupled to the verifier device 112 (e.g., a mounted or a handheld scanner in wireless communication with the verifier device 112). Theverifier application 120 can be stored in thememory 402 and executed by theprocessor 404. Theverifier application 120 includes anexample detector 410, anexample certifier 412, and anexample notifier 414. Operation of theverifier application 120 is disclosed in further detail below. -
FIG. 5 is a block diagram of the example digitalpass management system 100. In some examples, the digitalpass management system 100 is an application server that supports the applications executed on the other devices. The digitalpass management system 100 includes anexample processor 500, anexample database 502, anexample record generator 504, anexample validator 506, and anexample transceiver 508. Thedatabase 502 can store information regarding users, tests, etc., and/or records generated by therecord generator 504 as disclosed in further detail herein. In some examples, the digitalpass management system 100 is owned, controlled, and/or otherwise operated by the verifier entity. For example, if the verifier entity is an airline, the digitalpass management system 100 can be controlled by the airline. As another example, if the verifier entity is an office, the digitalpass management system 100 can be controlled by the office. In other examples, the digitalpass management system 100 can be controlled or operated by the testing entity. For example, the digitalpass management system 100 can be provided by a hospital or medical facility. In other examples, the digitalpass management system 100 can be operated by a different entity not related to the verifier entity and/or the testing entity. For example, the digitalpass management system 100 could be owned by an entity or company that licenses the applications and/or data from the digitalpass management system 100 to different verifier organizations (e.g., airlines, schools, offices, etc.). In some such examples, the verifier organizations may have access and/or control to certain data and/or reporting (e.g., identity of the testers, test results, etc.), while the company owning the digitalpass management system 100 may be responsible for operating the backend datasets and environments in which the system(s) operate. - The verifier organizations may have separate accounts within the digital
pass management system 100. The verifier organizations may be able to access their account information (e.g., via an application on a device, such as a computer) to add, remove, edit, etc. users or user profiles as well as modify various parameters (e.g., digital pass expiration times, testing frequency, verification rules, approved testing sites, etc.) associated with the digital pass verification system for the respective verifier organization. The verifier organizations can also sync the digital passes with employment records so that digital passes of employees that have left employment can be deactivated. The verifier organizations may be operated by one or more designated persons from the verifier organization (e.g., a human resources (HR) personnel). - In some examples, the digital
pass management system 100 enables the verifier organization to view its list of users/participants and their associated information (e.g., ID, digital pass statuses, statuses of creating an account, statuses of getting tested, etc.) and generate reports (e.g., a report indicating people who are able to work). For example, the verifier organization can generate reports of the users that tested positive, negative, and/or invalid, and/or can be filtered by certain dates or ranges (e.g., all users that tested positive between two dates). In some examples, the verifier organization can send the reports to a local, state, or federal government agency (e.g., the Center for Disease Control (CDC)), another business, another verifier organization, and/or any other entity (e.g., a parent-teacher association). In some examples, the verifier organization manually generates and sends (e.g., via email) the reports. In other examples, the digitalpass management system 100 automatically generates and sends the reports (e.g., once a week, once a month, etc.). In some examples, the report generation and/or sending could be triggered by an event, such as a request by an outside entity (e.g., a request from the CDC). In some examples, the digitalpass management system 100 accesses results of diagnostic tests, receives sets of user identifications and test kit identifications from one or more second devices (e.g., tester devices), generates a report based on the results and receipt of the sets of user identifications and test kit identifications and transmits the report to a government agency. - In some examples, the digital
pass management system 100 may send out invites to the users to be added to the verifier organization. For example, a place of employment (a verifier organization) can create a verifier organization account and send out invites to all of its employees (users) to create user accounts via theuser application 116. Invitations may also be sent to new hires. The invites may be sent via email or text, for example. The invites may include a unique link or token code to link/associate the user's account with the verification organization account. Additionally or alternatively, a user may be able to search for certain verifier organizations via theuser application 116 and then associate his/her account with the verification organization's account. In some examples, one or more of the users may be granted administrative control to access and/or modify the verifier organization account information. In some examples, a verifier organization can assign different levels of access to different users based on various roles. The digitalpass management system 100 can be remote to thetester 104 and/or theverifier 106. One or more operations disclosed herein as being implemented by the applications can be partially or fully executed at the digitalpass management system 100. - An example of a digital pass verification process is described below in connection with the interface screens in
FIGS. 6-38 . The example process is described in connection with theuser 102 being tested for COVID-19. However, it is understood that the example process could be similarly performed in connection with assays for detection for any analyte of interest including analytes associated with the presence of an infectious disease and/or for multiple tests or assays for multiple analytes of interest or diseases. - As disclosed above, the
user 102 may download theuser application 116 on theuser device 108. In some examples, theuser 102 opens theuser application 116 on theuser device 108 and creates an account with the digitalpass management system 100, such as by agreeing to terms and conditions, agreeing to test consent and privacy conditions, entering identifying information (e.g., name, age, email, etc.), and creating a username and password. In some examples, theuser 102 creates an account in response to receiving an invite from a verifier organization and/or a tester. For example, the user's employer may send out invites (e.g., via email, via text, etc.) to all employees to create an account using theuser application 116. The unique link or token code may cause the application to open on theuser device 108, or if not installed, prompt theuser 102 to install theuser application 116 on theuser device 108. Additionally or alternatively, invite may include a unique link or token code to associate with the verifier organization. An example of this is shown inFIGS. 36-38 and disclosed in further detail below. In some examples, theuser 102 uses a username and password that the user already has established with theverifier 106. For example, if theverifier 106 is a place of business such as the user's employer, theuser 102 may use the username and password used to access their employer's computer network. -
FIGS. 6-11 show example interface screens presented by theuser application 116 on thedisplay 206 of theuser device 108 for creating an account with the digitalpass management system 100. Theuser 102 can enter his/her email address (and/or a username) and create a password to create an account. After creating an account, theuser 102 may use his/her email address (and/or username) and password to sign-in and access his/her information via theuser application 116. Theuser 102 can manually enter his/her identifying information (e.g., name, address, etc.) in to theuser device 108 to create an account. In some examples, in addition to or as an alternative to manually entering the user information, theuser 102 can scan (e.g., a barcode on the ID) or take a picture of his/her driver's license or other form of ID (e.g., an employee ID card) to enter his/her user information into theuser application 116 automatically. For example, theuser 102 can use the camera 207 (FIG. 2 ) of theuser device 108 to scan or take a picture of the ID. The information may include the user's full name, address including zip code, date of birth, gender, license number, etc. Additionally or alternatively, theuser 102 can manually enter his/her information, such as if theuser 102 does not have a phone. In some examples, additional information such as the user's race and/or ethnicity may be entered into theuser application 116. This information may be stored in thedatabase 502 with user's account. In some examples, this information is used to support state reporting (e.g., determining metrics of infected demographics). - The
user application 116 uses thetransceiver 204 to send the account information to the digital pass management system 100 (e.g., via the Internet). Therecord generator 504 of the digitalpass management system 100 creates an account for theuser 102 in thedatabase 502. An example record ordata entry 510 for the user account is shown inFIG. 5 . As shown, thedata entry 510 can include the user's name, date of birth (DOB), email address, and/or other identifying information. Therecord generator 504 of the digitalpass management system 100 also creates a unique user account ID (e.g., a serial number) for the user's account, as shown in thedata entry 510 inFIG. 5 . The user account ID can be used to identify theuser 102 during the digital pass verification process. The digitalpass management system 100 sends the user account ID to theuser device 108, which can then be stored in thememory 202. - The
user 102 then gets tested for the infectious disease or pathogen. In some examples, theuser 102 schedules an appointment with thetester 104. In some examples, theuser 102 uses thescheduler 208 in theuser application 116 on theuser device 108 to search for testing facility, to schedule an appointment with a testing facility, and/or schedule a telehealth session. Thescheduler 208 may provide an interface that allows the user to search for testing facilities within a certain geographical location. In some examples, thescheduler 208 automatically returns testing facilities within a certain radius (e.g., 20 miles) of the user's zip code or location, which was obtained during the account setup process. In some examples only certain testing facilities that are approved by theverifier 106 are displayed (e.g., partner testing facilities). In some examples, thescheduler 208 interfaces with the testing facilities' schedule applications or programs to enable theuser 102 to schedule an appointment through theuser application 116. Additionally or alternatively, thescheduler 208 may provide a link to access the testing facilities' sites for scheduling. Thescheduler 208 can provide a link to telehealth services to order tests and/or schedule a telehealth session. Thescheduler 208 may save the scheduled appointment with the user account in thememory 202 of theuser device 108 and/or in thedatabase 502 with the user's account. In some examples, thenotifier 210 in theuser application 116 provides reminders or alerts to the user when an appointment is approaching. In other examples, theuser 102 can use another application to schedule the test or schedules the test without an application such as, for example, by calling thetester 104 or testing facility. In still other examples, theuser 102 does not schedule an appointment, but merely arrives at the testing facility to be tested. In some examples, thetester application 118 provides thetester 102 with a schedule of all the scheduled tests. In some examples, thetester application 118 supports appointments from within the organization and/or from outside of the organization. - In some examples, to help identify the
user 102 and link the user's test to the user's account, thecode generator 212 of theuser application 116 generates an identity code, such as a machine-readable code. In some examples, the identity code may be a 1D code such as a bar code. In some examples, the identity code may be a 2D code such as a Data Matrix Code or a QR code. Other examples may use other types of codes or combinations of codes including, for example, other machine-readable codes. In some examples, the identity represented in the code contains the user account ID for theuser 102. In particular, thecode generator 212 of theuser application 116 converts the user account ID into the code format. The identity code is displayed on theuser device 108 so that theuser 102 can present the identity code to thetester 104.FIG. 12 shows anexample identity code 1200 presented on thedisplay 206 of theuser device 108. In this example, theidentity code 1200 is a QR code. However, in other examples, theidentity code 1200 can be another type of code. In some examples, theidentity code 1200 is presented in response to a user selection to present the identity code 1200 (e.g., selecting a “Display ID” button on the display 206).FIG. 13 shows another example interface on thedisplay 206 of theuser device 108 showing the profile of theuser 102. -
FIGS. 14-25 show example interface screens presented on thedisplay 306 of thetester device 110. Thetester 104 uses therecord generator 310 of thetester application 118 to create a test record for theuser 102.FIGS. 14 and 15 show example interface screens presented by thetester application 118 on thedisplay 306 of thetester device 110 for the creation of a new test record. In some examples, thetester 104 logs into thetester application 118 with a unique login name and/or password. In some examples, as shown inFIG. 15 , thetester 104 can ask theuser 102 if he/she has experienced any symptoms. Thetester 104 can enter the results into thetester application 118. Additionally or alternatively, theuser 102 could enter his/her results into thetester application 118 on thetester device 110 or into theuser application 116 on theuser device 108. In some examples, theuser 102 is prompted with targeted questions directed to particular physiological conditions, behaviors, and/or activities. In some examples, thetester application 118 provides a link to a list of symptoms provided by the Center for Disease Control and Prevention (CDC). In other examples, the symptoms are stored in thememory 302. In some examples, thetester application 118 prompts thetester 104 to gather information from theuser 102 regarding the user's travel history, health conditions and/or history, family health history, lifestyle, etc. - In some examples, details related to the user's symptoms, user's travel history, health conditions and/or history, family health history, lifestyle, etc. are presented to the
user 102 via theuser application 116 and stored in thememory 202 of theuser device 108. In some examples, some or all of this information may be shared between theuser application 116 and thetester application 118. In some examples, some or all of this information may be shared between theuser application 116 and digitalpass management system 100. - To identify the
user 102, thetester 104 uses thecamera 308 of thetester device 110 to scan theidentity code 1200 on theuser device 108. For example,FIG. 16 shows thedisplay 306 on thetester device 110, which is displaying the view from thecamera 308. Thetester 104 aligns theuser device 108 in the view of thecamera 308. Thetester application 118 detects and interprets theidentity code 1200 to obtain the user account ID. Thetester application 118 sends the user account ID to the digitalpass management system 100. The digitalpass management system 100 searches thedatabase 502 for the corresponding record (e.g., the data entry 510) and returns the name and/or other identifying information of theuser 102. For example,FIG. 17 shows the name of the user “Jane Doe” and user's birthday “Jan. 1, 2001” on thedisplay 306 of thetester device 110. In some examples, thetester 104 may ask theuser 102 for physical identification (e.g., a driver's license, a state ID, etc.) to confirm the user's identity. Theuser 102 may show his/her identification to thetester 104. If the ID matches the name and birthday on thetester device 110, thetester 104 can then select “Photo ID Verified” as shown inFIG. 18 . If not, thetester 104 can select “Unable to Verify.” In some examples, if theuser 102 does not have his/heruser device 108, theuser 102 can use his/her ID or other identifying means to confirm their identity with thetest 104. In some examples, theuser 102 may enter his/her username and/or password into thetester application 118 on thetester device 110. - In some examples, the
tester 104 uses thecamera 308 to scan the user's driver's license or other ID (e.g., take a picture of the ID, scan a code (e.g., a barcode) on the ID, etc.). Therecord generator 310 can create a record based on data obtained from the scanned ID and/or communicate with the digitalpass management system 100 to obtain a record based on data obtained from the scanned ID. Additionally or alternatively, in some examples, theuser 102 can scan his/her driver's license or other ID with the user device 108 (e.g., with thecamera 207 of the user device 108). In such an example, theuser application 116 can create a record with data obtained from the scanned ID and/or communicate data to thetester device 110 and/or digitalpass management system 100. - The test to be performed is a medical diagnostic test including, for example, a rapid diagnostic test (RDT). The diagnostic test detects a presence or an absence of an analyte of interest, such as an infectious disease, a pathogen, an antibody, etc. The test can be performed using any type of testing kit, device, and/or equipment. Different tests may require different types of samples from a user. A sample can include a nasal swab, an oral fluid swab, blood, urine, etc.
- The test or assay can be any test or assay able to detect an analyte of interest. The analyte can be monovalent (monoepitopic) or polyvalent (polyepitopic), synthetic or natural, antigenic or haptenic, and may be a single compound or plurality of compounds which share at least one common epitopic or determinant site. The analyte can be a nucleic acid, a protein, a nucleocapsid protein, an antibody or an antigen. The analyte can be a part of a cell such as bacteria or a cell bearing a blood group antigen such as A, B, D, etc., or an HLA antigen, plasma membrane receptors or a microorganism, e.g., bacterium, fungus, protozoan, or virus. The analyte can also be a chemical compound, such as a drug or a metabolite thereof. In some examples, the test is an assay to detect an analyte associated with an infectious disease.
- In some examples, the test is performed using a disposable test kit, such as a disposable lateral flow test kit. An example disposable lateral flow test kit that may be used is the BinaxNOW® test kit manufactured by Abbott Laboratories, having headquarters in Abbott Park, Ill., USA. In some examples, each test kit contains a unique test kit ID (e.g., a serial number), which may be generated by the manufacturer and/or distributer. The test kit ID may be displayed as a test kit code (e.g., a machine-readable code, such as a QR code) on the test kit. In other examples, the test may be performed using a laboratory analyzer device (e.g., a molecular or clinical chemistry analyzer device). In some examples, the test may be performed using apoint of care laboratory analyzer device such as the ID NOW′ analyzer manufactured by Abbott Laboratories. In some examples, test cartridges are used with the laboratory analyzer device. In some such examples, each cartridge contains a unique test kit ID generated by the manufacturer and/or distributer.
- In some examples, the
test selector 312 of thetester application 118 analyzes the information provided including, for example, user symptoms, travel history, health conditions and/or history, family health history, lifestyle, etc. to determine what diagnostic tests should be performed. For example, thetest selector 312 may determine what analyte of interest or infectious diseases a user may have been exposed to based on the data derived from the user's information. Thesample indicator 314 prompts thetester 104 as to what sample or samples to gather from theuser 102 based on the test determined by thetest selector 312. For example, if thetest selector 312 determine that theuser 102 should be tested for COVID-19, thesample indicator 314 prompts thetester 104 to gather a sample of nasal secretions using, for example, a nasopharyngeal swab. - When the
tester 104 is ready to perform the test, thetester 104 can scan a code on the test kit. In some examples, thetester 104 selects an option on the screen of thetester device 110 such as, for example, “Scan Test Kit” as shown inFIG. 19 . Thetester 104 uses thecamera 308 on thetester device 110 to scan atest kit code 2000 on atest kit 2002, as shown inFIG. 20 . Additionally or alternatively,tester 104 can use another device to obtain scan thetest kit code 2000, such as a mounted or a handheld scanner that is communicatively coupled to thetester device 110. In this example, thetest kit 2002 is a disposable lateral flow test kit. In other examples, such as when the test is to be performed using a laboratory analyzer device, thetester 104 can scan a test kit code on a test cartridge that is used to insert the sample into the laboratory analyzer device. In this example, thetest kit code 2000 is a Data Matrix Code. In other examples, thetest kit code 2000 can be another type of code, such as a bar code or a QR code. - The
test kit code 2000 contains the test kit ID (e.g., a serial ID, lot ID, and/or expiration date from the manufacturer) associated with thetest kit 2002. As disclosed herein, each test kit may include a unique test kit ID that is generated for every test kit. Therecord generator 310 of thetester application 118 detects and interprets thetest kit code 2000 to obtain the test kit ID. Thetester application 118 sends the test kit ID to the digitalpass management system 100, which stores the test kit ID with the user's account. For example, as shown inFIG. 5 , thedata entry 508 includes a test kit ID and date of the test. - In some examples, the
validator 506 of the digitalpass management system 100 verifies or authenticates the validity of the test kit by comparing the test kit ID with a list of valid test kit IDs from the manufacturer. Test kits with IDs that are not included in a list of valid test kit IDs may be counterfeit. In some examples, thevalidator 506 of the digitalpass management system 100 verifies the validity of the test kit by evaluating an expiration date of the test kit. In some examples, thevalidator 506 of the digitalpass management system 100 verifies the validity of the test kit by evaluating a recall status of the test kit. In some examples, thevalidator 506 of the digitalpass management system 100 verifies the validity of the test kit by evaluating if the test kit has already been used. If thevalidator 506 determines that a test kit is not a valid test kit, the digitalpass management system 100 notifies the tester 104 (e.g., by exchanging communications between thetransceiver 508 and the transceiver 304). After a test kit is used, therecord generator 504 records the test kit as being used. Any attempt to use the test kit again will result in thevalidator 506 indicating that the test kit is not valid. - In some examples, before or after scanning the
test kit code 2000, thetester application 118 displays instructions for how to obtain a sample from theuser 102 and/or use thetest kit 2000. The instructions are based on what sample type thesample indicator 314 selected for the test. For example,FIG. 21 shows an interface screen with a procedure for collecting the sample and performing the test with thetest kit 2000. In some examples, the instructions are specific to the type of test kit or test cartridge that has been scanned. - In some examples, the test is performed at the point of care. That is, the test is performed at the location where the sample was gathered from the user, such as for example, at the testing facility or a medical office or clinic. In some examples, a sample is gathered and a test is performed at the user's home. In other examples, the sample is shipped to a remote location, and the test is performed at the remote location. For example, the testing facility may obtain the sample from the
user 102 and ship the sample to the remote testing facility. As another example, theuser 102 may obtain his/her own sample (e.g., from an at-home sample kit) and ship the sample the remote testing facility. In some examples, such as with a disposable lateral flow test kit, the results are provided via a visual indication (e.g., one or more lines or colors) on the test kit. In other examples, such as with a laboratory analyzer device, the results are provided on a digital screen of the laboratory analyzer device. - When the test is complete, the
tester 104 interprets the test results. For example, via thetester application 118, thetester 104 can select “Interpret New Test” as shown inFIG. 22 to enter the results. In some examples, thetester 104 interpreting the results of the test is thesame tester 104 who gathered the samples (in this context “same tester” means the same facility though the individual obtaining the sample and the individual interpreting results are two different people). In some examples, thetester 104 interpreting the results of the test is different than thetester 104 who gathered the sample. For example, thetester 104 who gathered the sample may be a medical facility such as, for example, a doctor's office, and thetester 104 who interprets the results may be a lab technician at a diagnostic laboratory. - In some examples, when viewing and/or interpreting the results, the
tester 104 scans thetest kit code 2000 on thetest kit 2002 again, as shown inFIGS. 23 and 24 . In some examples, scanning thetest kit code 2000 after the test is complete confirms thesame test kit 2000 that was used to perform the test is the same test kit that is being interpreted. In some examples, thecomparator 316 of thetester application 118 compares the two test kit IDs. Additionally or alternatively, in some examples, the test kit IDs are sent to the digitalpass management system 100 for comparison by thevalidator 506. In other examples, a second scan of the test kit ID is not performed. - In some examples, the
tester application 118 provides a notification for the interpretation and entry of the result of the diagnostic test. For example, thetester application 118 can present thetester 104 with selectable options for the results of the test, as shown inFIG. 25 . In this example, the options include positive, negative, and invalid (or inconclusive). In some examples, as shown inFIG. 25 , the options include graphics that match the visual indicators on thetest kit 2002. Thetester 104 reviews the test results from thetest kit 2002 and selects the matching result. Thetester application 118, using thetransceiver 304, sends the results along with other identifying information to the digitalpass management system 100, where therecord generator 504 adds the results to the user's account in thedatabase 502, including the date of the test. - In other examples, the
camera 308 can be used to obtain an image of thetest kit 2002, and thereader 318 of thetester application 118 analyzes the image to automatically interpret the results. In such examples, thetester 104 does not need to enter the results into thetester device 110. In other examples, such as with a diagnostic test performed by a laboratory analyzer device, the laboratory analyzer device may automatically send the results to thetester application 118 and/or the digitalpass management system 100. - In some examples, the
tester 104 takes a picture of the used test kit 2002 (or at least a portion of the test kit 2002) as evidence of the results. In some such examples, the picture of the usedtest kit 2002 is saved in thedatabase 502 with the user's account (as shown inFIG. 5 ) and/or can be sent to theuser 102 as evidence and/or for record keeping. For example, thetransceiver 508 can transmit at least a portion of thetest kit 2002 to theuser device 108. - The
record generator 504 of the digitalpass management system 100 adds the results to the user account. For example, thedata entry 510 inFIG. 5 shows the result “Negative” saved with the user account. In some examples, other information can also be stored in the user account, such as, for example, the name and location of the testing facility that performed the test, the ID of thetester 104, an image of the test kit code, whether theuser 102 has any symptoms, an image of the test kit when reviewing the results (for records), etc. The digitalpass management system 100 sends the results and/or other information (e.g., the test kit ID) to theuser application 116 on theuser device 108 by, for example, exchanging communications between thetransceiver 508 and thetransceiver 204. - The
user application 116 can then access the test results. In some examples, the test results are sent to theuser device 108 via a text, an email, a URL link, etc. In other examples, the test results are pushed to theuser application 116. For example,FIG. 26 shows an example push notification on theuser device 108 indicating new results have been received. Theuser 102 may review the results via theuser application 116 or other means on theuser device 108, as shown inFIG. 27A . As shown inFIG. 27A , theuser application 116 displays information relating to the test, such as the date of the test, the name of theuser 102, and the result of the test. In some examples, the digitalpass management system 100 sends other information to theuser device 108 such as, for example, the test kit ID that was used to perform the test, the location of the test, the ID of thetester 104, etc. For example,FIG. 27B shows another example interface that may be displayed by theuser application 116. The interface shown inFIG. 27B includes the date of the test, the name of theuser 102, the result of the test, and the test kit ID (including the lot and serial number). This information may be stored in thememory 202 with the results on theuser device 108. - The
analyzer 216 of theuser application 116 determines what the test results are (e.g., positive, negative, or invalid/inconclusive). In some examples, in addition to displaying the results, thenotifier 210 of theuser application 116 on theuser device 108 can present instructions or guidelines (e.g., the CDC guidelines) relating to the infectious disease and/or the results. If the results are negative, for example, the post-testing instructions may be minimal. For example,FIG. 27A shows a list of guidelines for theuser 102 to follow. The guidelines may be updated as new guidelines are released. If the results are positive, for example, the post-testing instructions may include recommending a doctor's appointment, a follow-up exam, further testing, quarantine, and/or other actions. In some examples, prior to issuing a positive result, thetester 104 may call theuser 102 to alert theuser 102 immediately and personally about the positive result. - If the
analyzer 216 determines that the results are negative, thecode generator 212 of theuser application 116 on theuser device 108 generates adigital pass 2800, as shown inFIG. 28A . In other words, when theanalyzer 216 determines that a test result is negative, the generation of a digital pass is triggered. Thedigital pass 2800 is a record that theuser 102 tested negative for the infectious disease and/or analytes associated with the infectious disease. Thedigital pass 2800 can be used to confirm with a verifier that theuser 102 tested negative for the infectious disease, as disclosed in further detail herein. In some examples, theuser 102 can access the digital pass(es) by clicking “Go to My Pass” as shown in the interfaces inFIGS. 27A and 27B . - If the
analyzer 216 determines that the results are positive or invalid (inconclusive), no digital pass is generated. In some examples, thenotifier 210 may alert theuser 102 that no digital pass is to be generated because of the test results. In some examples, thenotifier 210 provides an indication within theuser application 116 that there is no valid digital pass. - If
analyzer 216 determines the results are negative, thecode generator 212 of theuser application 116 generates thedigital pass 2800 and saves thedigital pass 2800 on the user device 108 (e.g., in the memory 202). In some examples, thedigital pass 2800 is saved as part of a digital wallet on theuser device 108 that can be accessed with or without theuser application 116. In some examples, the digital wallet contains other digital passes (e.g., for the same infectious disease and/or other infectious diseases) and/or other types of passes (e.g., airline boarding passes, movie tickets, etc.). - In some examples, the
digital pass 2800 includes adigital pass code 2802. Thecode generator 212 of theuser application 116 generates thedigital pass code 2802. Thedigital pass code 2802 can be a machine-readable code. In this example, thedigital pass code 2802 is a QR code. In other examples, thedigital pass code 2802 can be another type of code, such as, for example, a bar code, a Data Matrix Code, and/or other types of machine-readable codes. In some examples, to generate thedigital pass 2800, thecode generator 212 communicates (via the transceiver 204) with thetester 104 and/or the digitalpass management system 100 to access data related to the test kit ID and an object ID. The object ID is the ID of the user account. In some examples, thedigital pass code 2802 includes the user account ID and the test kit ID associated with the diagnostic test. Thus, in some examples, thedigital pass code 2802 includes information to identify theuser 102. In other examples, thedigital pass code 2802 can include other identifying information in addition to or as an alternative to the user account ID and the test kit ID. Thedigital pass code 2802 enables theverifier 106 to quickly, accurately, and safely obtain information from theuser 102 that can be used to verify theuser 102. Thecode generator 212 embeds the QR code (or other type of machine-readable code) into thedigital pass 2800. In some examples, thecode generator 212 adds further details to thedigital pass 2800 including, for example, the user's name and an expiration date of thedigital pass 2800. Theoutput 218 sends thedigital pass 2800 to thedisplay 206 for presentation by theuser 102. - In some examples, the
digital pass 2800 has an expiration date or time, which represents a threshold number of days or time that thedigital pass 2800 is still valid. After the expiration date or time, thedigital pass 2800 is no longer valid. In some examples, theexample time comparator 214 monitors time to determine when an expiration date or time is approaching or has passed. The expiration date may be a predetermined number of days after the test, such as five days, seven days, ten days, etc., for example. In other examples, the expiration may be based on a certain time (e.g., 30 hours from the diagnostic test). In some examples, the expiration date or time is based on a pathogen incubation period or contagious period. In some examples, the expiration date or time is set by the organization or entity associated with theverifier 106. Thescheduler 208 monitors the dates and/or times of expiration of the digital passes. In some examples, as shown inFIG. 28A , theuser application 116 displays a calendar showing the current day and the number of days until thedigital pass 2800 expires. Additionally or alternatively, theuser application 116 may display a live ticker, such as a day and/or time counter that counts to the expiration date (e.g., by the day, by the hour, by the minute, but the second, etc.). This may enable theuser 102 to easily determine how much time is left until expiration and plan to retake a test before the currentdigital pass 2800 expires. In some examples, if thescheduler 208 determines that thedigital pass 2800 has expired, thenotifier 210 notifies theuser 102 that the pass has expired. In some examples, if thescheduler 208 determines that thedigital pass 2800 is about to expire, thenotifier 210 notifies theuser 102 of the upcoming expiration. Thus, thescheduler 208 determines a validity of the digital pass based on the expiration date. In some examples, thenotifier 210 notifies theuser 102 to schedule another test before and/or after the expiration of thedigital pass 2800. For example, if the number of days left before expiration drops below a threshold (e.g., one day), thescheduler 208 can display a notification or reminder to schedule a new diagnostic test. Therefore, thescheduler 208 can display a notification to theuser 102 to schedule a second diagnostic test based on the number of days since the first diagnostic test and the threshold number of days. In some examples, if theuser 102 is re-tested before a digital pass expires, a new digital pass is generated and the old digital pass is saved in a library that can be viewed for a certain amount of time. In some examples, thecode generator 212 can automatically deletes or otherwise removes expired digital passes from theuser application 116 when they expire. In other examples, if theuser 102 takes another test and passes, the samedigital pass 2800 can be updated and used again by extending the expiration date. In some examples, an expired digital pass can still be viewed for a threshold number of days or time after the expiration. For example, a digital pass may be viewable for up to seven days after expiration, after which thecode generator 212 deletes or otherwise removes the digital pass. However, the result of the test and other information relating to the test can still be viewed in a results history interface. As disclosed in further detail herein, if theuser 102 attempts to use an expired digital pass, theverifier device 112 can detect the expiration and deny theuser 102 access to the verifier location. - In some examples, after the
user application 116 receives the test result, and prior to generating thedigital pass 2800, thetime comparator 214 determines whether the expiration time or date has already passed. This may occur, for example, if there was a delay in testing or sending the results. In some examples, if the expiration has already passed, thecode generator 212 does not generate thedigital pass 2800. If the expiration date has not already passed, thecode generator 212 generates thedigital pass 2800 as disclosed herein. Therefore, in some examples, thecode generator 212 generates thedigital pass 2800 in response to the result being negative and the number of days (or time) since the diagnostic test being below a threshold number of days (or time). -
FIG. 28B shows another exampledigital pass 2804 with an exampledigital pass code 2806 that can be generated by thecode generator 212. Thedigital pass 2804 is substantially the same as thedigital pass 2800 ofFIG. 28A , but displays additional information, such as, for example, the result of the test, the date of the test, and the type of test that used. Therefore, thedigital pass code generator 212 of theuser application 116. In some examples, thedigital pass user 102 opens thedigital pass digital pass digital pass code FIGS. 28A and 28B . The indicator is generated in response to the result begin negative and the number of days (or time) since the diagnostic test being below a threshold number of numbers (or threshold time). Therefore, the indicator is indicative of the health status of theuser 102. - As disclosed above, in some examples, the
code generator 212 may create additional digital passes (e.g., for the same infectious disease and/or other infectious diseases). In some examples, a single digital pass may include information related to a number of tests infectious disease and/or other infectious diseases. - When the
user 102 decides to enter the location monitored by theverifier 106, theuser 102 displays thedigital pass 2800 on theuser device 108 to theverifier 106. For example, if theverifier 106 is an airline, theuser 102 may display thedigital pass 2800 to a gate agent before boarding the plane. As another example, if theverifier 106 is an office (e.g., the user's place of employment), theuser 102 can display thedigital pass 2800 to a person (e.g., a security officer or representative of the employer) in the lobby of the office. In some examples, theuser application 116 on theuser device 108 may send thedigital pass 2800 to another device to be displayed. For example, if the user has a smartwatch with a display screen, thetransceiver 204 may transmit thedigital pass 2800 to the user's smartwatch to be displayed. - The
verifier 106 uses thecamera 408 of theverifier device 112 to read or scan thedigital pass code 2802 on theuser device 108. For example,FIG. 29 shows thedisplay 406 on theverifier device 112, which is displaying the view from thecamera 408. Additionally or alternatively, theverifier 106 can use another device to scan the digital pass code 2082, such as a mounted or a handheld scanner (e.g., a QR code or barcode scanner) communicatively coupled to theverifier device 112. Thedetector 410 of theverifier application 120 detects thedigital pass code 2802. Thecertifier 412 interprets thedigital pass code 2802 and obtains the user account ID and the test kit ID (and/or other identifying information) embedded in thedigital pass code 2802. Thecertifier 312 sends (e.g., via the transceiver 404) the user account ID and test kit ID to the digitalpass management system 100. - The
validator 506 of the digitalpass management system 100 inspects the records to determine whether the user account ID and test kit ID match the user account and are still valid (e.g., not expired and still associated with the verifier organization). For example, thevalidator 506 may verify the result of the diagnostic test based on the user account ID and the test kit ID. In other words, thevalidator 506 may match user account ID and the test kit ID to the result of the diagnostic test. Thevalidator 506 may also determine the number of days since the diagnostic test and compare the number of days since the diagnostic test to a threshold number of days. Thevalidator 506 may transmit a verification outcome (indicating whether thedigital pass 2800 is valid, invalid, or not found) based on the verification of the result and the number of days. For example, if the diagnostic test result is negative and the number of days since the diagnostic test satisfies (e.g., is below) the threshold number of days, thevalidator 506 transmits a first notice, notification, or message indicating thedigital pass 2800 is valid. - If the number of days since the diagnostic since does not satisfy (e.g., is greater than) the threshold number of days, the
validator 506 transmits a second notice, notification, or message indicating thedigital pass 2800 is expired or not valid. In some examples, thevalidator 506 may also transmit the second notice, notification, or message if the user account ID has been inactivated or removed from a verifier organization associated with the verifier 106 (e.g., if an employee no longer works with the employer) or another reason. Additionally or alternatively, thevalidator 506 may transmit the second notice, notification, or message if the test result was positive or inconclusive. This helps prevent against fraudulent generation of a digital pass. Ifvalidator 506 could not find a diagnostic test associated/matched with the user account ID and/or the test kit ID, thevalidator 506 transmits a third notice, notification, or message indicating thedigital pass 2800 is not found. In some examples, if the result was inconclusive (e.g., the sample was contaminated or an insufficient amount of sample was gathered to effectively conduct the diagnostic test), thevalidator 506 transmits a fourth notice, notification, or message indicating the result was inconclusive. - In some examples, in addition to or as an alternative to using the number of days to determine if the
digital pass 2800 has expired, thevalidator 506 may use an amount of time (e.g., 30 hours). For example, thevalidator 506 may determine an amount of time between performance of the diagnostic test and receipt of the user account ID and test kit ID from theverifier device 112. When the amount of time satisfies (e.g., is below) a threshold amount of time, for example, thevalidator 506 may transmit the first notice, notification, or message disclosed above to indicate thedigital pass 2800 is still valid. When the amount of time does not satisfy (e.g., is greater) than the threshold amount of time, for example, thevalidator 506 may transmit the second notice, notification, or message disclosed above to indicate thedigital pass 2800 is expired or not valid. - In some examples, the threshold number of days and/or threshold amount of time is set by the verifier organization. Additionally or alternatively, the threshold number of days and/or the threshold amount of time may be based on a biological characteristic of the analyte of interest, such as an incubation period of the pathogen and/or a contagious period of the pathogen.
- If the
digital pass 2800 is valid, thenotifier 414 of theverifier application 120 displays a positive or an acceptance message (e.g., a first notice), such as, for example, the valid message shown inFIG. 30 . The acceptance message confirms that theuser 102 has recently tested negative for the infectious disease or analyte of interest and can be allowed access to the location. If thecertifier 412 determines that thedigital pass 2800 is expired or invalid, thenotifier 414 of theverifier application 120 can display a negative or denial message (e.g., a second notice), such as, for example, the message shown inFIG. 31 indicating that the pass is expired or not valid. As such, theverifier 106 can deny theuser 102 access to the location. In some examples, if the result of the test was inconclusive, thenotifier 414 can display the same interface as shown inFIG. 31 or another interface/display indicating the result was inconclusive. In such an instance, theverifier 106 can decide whether to allow or deny access to theuser 102. If a digital pass is not found, thenotifier 414 of theverifier application 120 can display another message (e.g., a third notice), such as, for example, the message shown inFIG. 32 indicating that a pass is not found. In such an instance, theverifier 106 can deny theuser 102 access. Therefore, theverifier application 120 can display the first notice (FIG. 30 ), the second notice (FIG. 31 ), the third notice (FIG. 32 ), and/or any other notices to grant or deny theuser 102 access to the location based on the verification outcome and a location of theverifier device 112. - In some examples, instead of or in addition to the
validator 506 checking whether the digital pass has expired, the digitalpass management system 100 confirms the result was negative and then sends the date of the diagnostic test to theverifier device 112. Then, theverifier application 120 compares the number of days or amount of time since the diagnostic test to a threshold number of days or amount of time. Depending on the outcome, theverification application 120 can present one of the interfaces shown inFIGS. 30-32 . In some examples, this enables theverifier 106 to set their own preferred expiration threshold through theverifier application 120 and without reliance on thevalidator 506 to maintain and/or verify expiration dates. - In some examples, different verifiers can have different expiration times or thresholds. For example, a first verifier may have a first expiration threshold of seven days and a second verifier may have a second expiration threshold of five days. These expiration thresholds can be saved with the digital
pass management system 100 and/or in their corresponding verification applications. When thedigital pass 2800 is scanned by the first verifier, the number of days or time since the diagnostic test is compared to the first expiration threshold, and when thedigital pass 2800 is scanned by the second verifier, the number of days or time since the diagnostic test is compared to the second expiration threshold. This enables verifier organizations to set their preferred expiration thresholds. - In addition to or as an alternative to displaying the verification outcome on the
verifier device 112, theverifier device 112 can automatically unlock at least one of a door, a gate, or a turnstile based on the verification outcome. For example, theuser 102 may present his/herdigital pass 2800 to the verification device 112 (e.g., a scanner at a gate) at a gate of a location managed by the verification organization. If thedigital pass 2800 is valid, theverification application 120 can unlock the gate to enable theuser 102 to access the location. If not, theverification application 120 enables the gate to remain locked to deny theuser 102 access to the location. - As disclosed above, the
user application 116 can be used to manage multiple digital passes for theuser 102. Each digital pass can be generated using the example digital pass verification process disclosed above. The digital passes can be associated with diagnostic tests for the same or different analyte of interest. Each diagnostic test may be used to detect a presence or an absence of a certain analyte of interest. For example, theuser application 116 may store a first digital pass with a first digital pass code associated with a first diagnostic test for a first analyte of interest (e.g., COVID-19) and a second digital pass with a second digital pass code associated with a second diagnostic test for a second analyte of interest (e.g., influenza), which may be the same or different than the first analyte of interest. - In some examples, when a digital pass expires, the
user 102 can get re-tested for the same analyte of interest to generate a new digital pass for that analyte of interest. In some examples, the second or subsequent diagnostic test may be a different type of test than the first diagnostic test. For example, the first diagnostic test may be an antigen test and the second diagnostic test may be an antibody test. In other examples, other types of tests may be used, such as polymerase chain reaction (PCR)/molecular tests, antigen tests, etc. In some examples, the first diagnostic test is performed with a first type of testing equipment (e.g., a disposable test kit) and the second diagnostic test is performed with a second type of testing equipment (e.g., a laboratory analyzer device) that is different than the first type of testing equipment. - The digital passes can be read by different verifier organizations. For example, a first digital pass can be read by a first verifier device of a first verifier (e.g., a school) when the
user 102 desires to enter a location managed by the first verifier, and a second digital pass can be read by a second verifier device of a second verifier (e.g., an employer) when theuser 102 desires to enter a location managed by the second verifier. - In some examples, the
user 102 can use theuser application 116 to manage digital passes associated with multiple verifier organizations or entities. For example, various organizations or entities may require a digital pass for access, such as the user's place of employment, the user's school, an airline, etc. Theuser 102 can use theuser application 116 to add organizations to and/or remove organizations from the user's account. Theuser application 116 may store (e.g., in a digital wallet) the digital passes for theuser 102 associated with the various organizations. - In some examples, the digital
pass management system 100 stores information associated with each scan of a digital pass such as the time/date, the person who scanned the pass, the location, the result of the scan (e.g., valid, invalid) etc. This may help prevent fraudulent use of the digital pass (e.g., if a second user attempts to use the same digital pass in a different location at the same time). - In some examples, in addition to the expiration date of the
digital pass 2800, other constraints can be placed on a valid digital pass. For example, the organization associated with theverifier 106 may desire to prevent or prohibit access to the verifier location on certain days and/or to allow or prevent access to specific buildings or areas of buildings controlled by the organization. In some examples, the organization may set limits such that thedigital pass 2800 is only valid on certain days, within certain time ranges, and/or to certain locations including, for example, specific turnstiles, elevators, doors, etc. For example, the user's employer may desire to only allow certain employees on the premises on certain days of the week to stagger the employees to reduce likelihood of virus transmission. In such an example, thedigital pass 2800 may be invalid on certain days of the week, which prevents theuser 102 from gaining access to the office on those days. These specific days and/or time ranges can be set by the verifier 106 (e.g., via the verification application 120) and saved with the user's account in thedatabase 502 and/or on theuser application 116 with thedigital pass 2800. Therefore, theverifier application 120 can display different notices including, for example, the first notice (FIG. 30 ), the second notice (FIG. 31 ), or the third notice (FIG. 32 ) to grant or deny theuser 102 access to the location based on the verification outcome and at least one of a time of day or a day of the week. - In some examples, a verifier organization, such as an employer, can deactivate a user's digital pass in the digital
pass management system 100 when the user leaves the company (e.g., is fired or voluntarily quits). Then, if thedigital pass code 2802 is scanned, thevalidator 506 invalidates thedigital pass code 2802 even when the number of days since the diagnostic test is below the threshold number of days. In such an instance, thevalidator 506 transmits an invalid message to theverifier device 112. Therefore, theverifier application 120 can display the first notice (FIG. 30 ), the second notice (FIG. 31 ), or the third notice (FIG. 32 ) based at least in part on an employment status of theuser 102. - In some examples, after the
user 102 has received a digital pass, theuser application 116 may require theuser 102 to answer a daily health questionnaire to ensure theuser 102 has not become sick. For example, theanalyzer 216 may cause theuser application 116 to display a list of health questions to check whether the user has had any recent symptoms (e.g., “Have you had a temperature over 103° F. in the last 24 hours?”, “Have you developed a cough in the last 24 hours?”, etc.). In some examples, based on theuser 102 answers to one or more of the questions, theanalyzer 216 deactivates the digital pass 2800 (e.g., prevents thedigital pass 2800 from being displayed), which prevents theuser 102 from gaining access to the verifier location. If later (e.g., the next day) theuser 102 answers the questions differently, theanalyzer 216 may re-activate the digital pass such as, for example, when theuser 102 no longer displays symptoms of an illness. In some examples, depending on the answers to the health questions, theanalyzer 216 may recommend that auser 102 take a test or, in some situations, that a user does not take a test. - In some examples, each time the
user 102 accesses (e.g., opens) theuser application 116, theuser 102 is required to log in with their account name and password. In some example, theuser application 116 may use one or more biometrics of theuser 102 to grant access (e.g., via facial recognition using thecamera 207, via a thumb print scan, etc.). In some examples, theuser application 116 requires multi-factor authentication (MFA). In some such examples, the MFA is associated with the user's phone number, which may be stored with the user's account in thedatabase 502. - In some examples, testers or testing facilities can create accounts with the digital
pass management system 100. This enables users to search for testers or testing facilities near the users. In some examples, certain ones of the tester or testing facilities may be registered or approved by certain verifier organizations. - In some examples, the
user application 116 can be used to manage one or more profile(s)/account(s) and/or digital pass(es) associated with other persons related to or associated with theuser 102. For example, theuser 102 may be able create and access user accounts(s) and/or digital pass(es) for younger dependents (e.g., people under the age of 18), such as the user's children, and/or older dependents, such as the user's parents or grandparents, via theuser application 116. Theuser application 116 may enable theuser 102 to add dependents, remove dependents, edit dependent account information, etc. The dependent's account ID may be linked to the user's account ID in the digitalpass management system 100. Theuser application 116 may also store all current and/or prior test results and digital passes associated with the dependents. Theuser 102 can view all prior tests and present digital passes associated with the dependents via theuser application 116, similar to the tests and digital passes associated with theuser 102 as disclosed herein. Theuser 102 can use theuser application 116 to present the dependent's digital passes to certain verifiers to enable access. For example, theuser 102 may use theuser application 116 to manage a digital pass associated with the user's child. In such an example, theuser 102 may use theuser application 116 to present a digital pass for the child to a certain verifier, such as a school when dropping the child off at school or to an airline when boarding an airplane. - For example,
FIG. 33 shows an example interface that may be presented by theuser application 116 on theuser device 108. The interface shows a list of all profiles or accounts stored and associated with the user's account. Theuser 102 can select to add an additional profile, such as a profile for a dependent (such as, for example, selecting the ‘+’ symbol shown inFIG. 33 ). After selecting to add a new profile, theuser application 116 presents the interface shown inFIG. 34 . Theuser 102 can select to create, for example, a dependent profile or an administrator profile, such as for example, a person who manages multiple user accounts. Theuser 102 can select to create a dependent profile.FIG. 35 shows an interface presented by theuser application 116 where theuser 102 can enter information (e.g., the dependent's name, birthday, address, etc.) to create a dependent account. Theuser application 116 transmits (e.g., via the transceiver 204) the dependent account information to the digitalpass management system 100, which is then stored in thedatabase 502 with the user's account (e.g., in the data entry 510). Theuser 102 can then have access to the dependent's account and utilize the dependent's account similar to the user's own account as disclosed herein. - As disclosed above, the
user 102 can connect or register himself/herself and/or one or more dependents to one or more verifier organization accounts in the digitalpass management system 100. This enables the verifier organizations to have access to the user's account information and/or dependent account information. The verifier organization can control certain parameters (e.g., expiration time) associated with the user's digital passes for the verifier organization. Theuser 102 can connect with an organization via theuser application 116. For example,FIG. 36 shows an interface presented by theuser application 116 on theuser device 108 where theuser 102 can enter a code or ID to connect with an organization. The code can be provided via an invite message (e.g., via email or text) from the verifier organization. Theuser application 116 obtains the identity of the organization from digitalpass management system 100 and presents the organization information to theuser 102 for confirmation, as shown inFIG. 37 . Theuser 102 can select to add the connection, as shown inFIG. 38 . In this example, the profile for a dependent is linked to the organization. The same process can be used to register the user's own account with the verifier organization. -
FIG. 39 shows an example timeline or sequence of events as performed and/or experienced by a user, such as theuser 102, during a digital pass verification process. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - At
step 3902, theuser 102 downloads theuser application 116 onto theuser device 108 and registers with the digitalpass management system 100. In some examples, theuser device 108 initially receives a communication (e.g., a text, an email, etc.) to download theuser application 116. For example, theverifier 106 may send communications to users (e.g., employees, future passengers, etc.) that intend to access the verifier location(s). Atstep 3904, theuser 102 schedules a test. In some examples, theuser 102 schedules the test via theuser application 116. In such an example, thescheduler 208 books an appointment with a testing facility. In some examples, thenotifier 210 provides alerts or reminders about the upcoming appointment. - At
step 3906, theuser 102 travels to the testing facility and notifies thetester 104. Atstep 3908, theuser 102 provides their identification and consent for the test. For example, thecode generator 212 may generate the identity code 1200 (as shown inFIG. 12 ) on theuser device 108, which is then scanned by thetester device 110. In some examples, theuser 102 also shows his/her physical ID (e.g., a driver's license) to thetester 104. Atstep 3910, a sample (e.g., a nasal swab, a urine sample, a blood sample, etc.) is taken from theuser 102 and given to thetester 104, and thetester 104 performs the test. - At
step 3912, theuser device 108 receives the results and theuser 102 can review the results on theuser device 108. In some examples, thenotifier 210 provides an indication (e.g., a push notification) that the results have been received. Atstep 3914, if the results are negative, thecode generator 212 generates thedigital pass 2800 and the digital pass code 2082 and saves thedigital pass 2800 to a digital wallet on theuser device 108. In some examples, thecode generator 212 creates an expiration date associated with thedigital pass 2800. Theuser 102 can then use thedigital pass 2800 until thedigital pass 2800 has expired. - At
step 3916, thetime comparator 214 andscheduler 208 determines whether thedigital pass 2800 has expired (e.g., by comparing the current date to the expiration date of the digital pass 2800). If thedigital pass 2800 has expired, thenotifier 210 may provide an alert to remind theuser 102 to get tested again, and the example cycle may be repeated. -
FIG. 40A shows an example timeline or sequence of events as performed and/or experienced by a tester, such as thetester 104, during a digital pass verification process. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - At
step 4002, thetester 104 downloads thetester application 118 onto thetester device 110 and registers with the digitalpass management system 100. In some examples, thetester device 110 initially receives a communication (e.g., a text, an email, etc.) to download thetester application 118. Atstep 4004, thetester 104 starts the test process by selecting the next patient. Atstep 4006, thetester 104 verifies the patient identity and creates a test record. For example, thereader 318 can detect and interpret theidentity code 1200 on theuser device 108. Therecord generator 310 creates a record for the test and may send the user information to the digitalpass management system 100 to store with the user account. - At
step 4008, thetester 104 selects a test kit or test cartridge to be used. In some examples, thetest kit selector 312 determines which test kit or test cartridge should be used. Thetester 104 can use thetester device 110 to scan a test kit code on the test kit. Thereader 318 detects and interprets the test kit code on the test kit to obtain the test kit ID. Thetester application 118 and/or the digitalpass management system 100 can verify the authenticity of the test kit (e.g., to ensure the test kit has not been used before, is manufactured by a list of approved manufacturers, has not expired, etc.). Therecord generator 310 can save the test kit code and/or send the test kit code to the digitalpass management system 100 to be saved with the user's account. - At
step 4010, thetester 104 collects a sample from theuser 102 and performs the test. Atstep 4012, thetester 104 captures the test results. In some examples, thetester 104 enters the results into the tester application 118 (e.g., by selecting one of a plurality of predefined options). In some examples, thetester 104 uses thetester device 110 to take a picture of at least a portion of the used test kit as evidence. Atstep 4014, therecord generator 310 saves and publishes the results (e.g., sends the results to the user device 108). In some examples, therecord generator 310 sends the results and/or the picture(s) to the digitalpass management system 100, which sends the results to theuser device 108. In some examples, in addition to viewing the results, theuser 102 can view the picture of the test kit via theuser application 116. In some examples, theuser application 116 saves and presents all historical pictures of the test kits associated with theuser 102. - If the results are negative, the example cycle can be repeated when the
user 102 comes back to get retested again (e.g., after expiration of the digital pass) or an additional test could be ordered and performed to determine a presence of another analyte of interest, confirm results of an initial test or determine possible immunity. If the results are positive, thetester 104 may recommend theuser 102 has a consultation with a licensed physician, atstep 4016. Atstep 4018, additional testing may be performed to verify the results. In some examples, a serology test is performed and the test results are sent to a lab. In some examples, theuser 102 is quarantined (e.g., via self-quarantining, quarantined in a medical facility, etc.) for a period of time, asstep 4020. -
FIG. 40B shows an example timeline or sequence of events as performed and/or experienced by a tester, such as thetester 104, during a digital pass verification process. In this example, a laboratory analyzer device, such as the Abbott Laboratories' ID NOW™ analyzer is used for testing. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - Similar to the timeline or sequence of events in
FIG. 40A , thetester device 110 receives a communication (e.g., an invite) to download the tester application 118 (step 4022), and thetester 104 downloads the tester application 118 (step 4024) and registers with the digital pass management system 100 (step 4026). - At
step 4028, thetester 104 verifies the patient identity and creates a test record. For example, thereader 318 can detect and interpret theidentity code 1200 on theuser device 108. Therecord generator 310 creates a record for the test and may send the user information to the digitalpass management system 100 to store with the user account. - At
step 4030, thetester 104 selects a test cartridge to be used in the ID NOW′ analyzer. Thetester 104 can use thetester device 110 to scan a test kit code on the test cartridge. Thereader 318 detects and interprets the test kit code on the test cartridge to obtain the test kit ID. Thetester application 118 and/or the digitalpass management system 100 can verify the authenticity of the test cartridge (e.g., to ensure the test cartridge has not been used before, is manufactured by a list of approved manufactures, has not expired, etc.). Therecord generator 310 can save the test kit code and/or send the test kit code to the digitalpass management system 100 to be saved with the user's account. - At
step 4032, thetester 104 collects a sample from theuser 102 and performs the test. Atstep 4034, thetester 104 for the test to be completed. In some examples, the ID NOWT analyzer has a digital screen that displays the results of the test. Atstep 4036, thetester 104 records and publishes the results. In some examples, thetester 104 enters the results into the tester application 118 (e.g., by selecting one of a plurality of predefined options). In some examples, thetester 104 uses thetester device 110 to take a picture of the digital screen as evidence. Therecord generator 310 saves and publishes the results (e.g., sends the results to the user device 108). In some examples, therecord generator 310 sends the results and/or the picture(s) to the digitalpass management system 100, which sends the results to theuser device 108. The example cycle can then be repeated with the next patient. -
FIG. 41 shows an example timeline or sequence of events as performed and/or experienced by a verifier, such as theverifier 106, during a digital pass verification process. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - At
step 4102, theverifier 106 downloads theverifier application 120 onto theverifier device 112 and registers with the digitalpass management system 100. In some examples, theverifier device 112 initially receives a communication (e.g., a text, an email, etc.) to download theverifier application 120. Atstep 4104, theverifier application 120 can display instructions on theverifier device 112 for how to use theverification application 120. - At
step 4106, theverifier 106 uses theverifier device 112 to scan thedigital pass code 2802 on theuser device 108. Thedetector 410 detects thedigital pass code 2802 and thecertifier 412 interprets thedigital pass code 2802 to obtain identifying information (e.g., the user account ID and test kit ID) embedded in thedigital pass code 2802. Theverifier application 120 records the digital pass details (e.g., date, time, location) and/or sends the details to the digitalpass management system 100 to be saved with the user account (step 4108). If the pass is valid, theverifier 106 can grant theuser 102 access to the location (step 4110). If not, theverifier 106 can deny theuser 102 access to the location. -
FIGS. 42A, 42B, and 42C show example timelines or sequences of events as performed and/or experienced by a user, a tester, and a verifier, respectively, in connection with a digital pass verification process implemented in connection with an employer as the verifier. The employer (verifier) can use the digital pass verification techniques disclosed herein to confirm the employees (users) have recently tested negative for an infectious disease before allowing the employees to enter the workplace facilities. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - The timeline in
FIG. 42A is similar to the timeline inFIG. 39 for theuser 102. However, in this example, when creating the user account, theuser 102 can add his/her employee ID information to verify association with a specific employer. The employee ID information can be saved with the user account in thedatabase 502. Theuser 102 may be prompted to enter additional information and/or answer questions related to the user's recent experiences including, for example, questions about travel, symptoms (e.g., current body temperature), proximity to infected or symptomatic people, etc. The information and/or answers to the questions may be analyzed to determine if theuser 102 qualifies to be tested or re-tested. Theuser 102 may be tested by an internal physician associated with the employer (e.g., an onsite testing department) or an external physician not associated with the employer. In some examples, the employer can authorize or validate requests for tests via external physicians. - The timeline in
FIG. 42B is similar to the timelines inFIGS. 40A and 40B for thetester 104. However, in this example, thetester 104 may be an internal physician associated with the employer. In other examples, as shown inFIG. 42B , theuser 102 can be tested by an external physician. In some examples the results are communicated to the employer. For example, thetester application 118 and/or the digitalpass management system 100 can transmit the test results to the employer (the verifier). In some examples, the results are submitted to the state or other government agency. - The timeline in
FIG. 42C is similar to the timeline inFIG. 41 for theverifier 106. In this example, the employer (the verifier) can set the number of days until a digital pass expires. In some examples, theverifier application 120 records the date, time, and location when digital passes are scanned. In some examples, theverifier 106 may be an automated machine. For example, theuser 102 may scan his/her digital pass code at a security gate. If the digital pass is valid, the gate automatically opens to allow entry. Thus, in some examples, no human interaction is needed. -
FIG. 43 shows an example timeline or sequence of events as performed and/or experienced by a digital pass management system, a user, a tester, and a verifier in connection with a digital pass verification process implemented in connection with a school as the verifier. The example timeline or sequence is described in connection with the digitalpass management system 100, the user 102 (e.g., a parent or guardian), thetester 104, and the verifier 106 (e.g., a school). The school can use the digital pass verification techniques disclosed herein to confirm the staff and/or students have recently tested negative for an infectious disease before allowing the staff and/or students to enter the school. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - At
step 4302, the verifier 106 (e.g., the school) performs an onboarding process. The verifier 106 (e.g., the school) creates a school organization account with the digitalpass management system 100. The verifier 106 (e.g., the school) can create the account using via theverifier application 120 on theverifier device 112 and/or another electronic device (e.g., a computer). The verifier 106 (e.g., the school) can log into the digitalpass management system 100 to access and modify information associated with the school organization account. This may be referred to as a school portal. The verifier 106 (e.g., the school) can create administrative controls and privileges for certain people (e.g., human resources (HR) personnel). - At
step 4304, the verifier 106 (e.g., the school) can load a school roster into the digitalpass management system 100. The school roster may include the names and other identifying information (e.g., parent's names, email addresses, phone numbers, etc.) associated with each of the students. Atstep 4306, the digitalpass management system 100 generates a unique invitation ID for each student. The unique invitation ID can be used to link the student's account or his/her parent's account to the school organization account. Atstep 4308, the digitalpass management system 100 sends the invitation IDs to the parents (e.g., via email, via text message, via regular mail, etc.). - At steps 4310-4314, the user 102 (e.g., a parent) can create a user account for himself/herself and/or a dependent account/profile for the student via the
user application 116 and connect their account(s) to the school organization account. Examples of this process are disclosed above in connection withFIGS. 6-11 and 33-38 , for example. - At
step 4316, the user 102 (e.g., a parent) can use theuser application 116 to find a testing location and schedule a test (e.g., via the scheduler 208) to have the child tested. In some examples, only testing center approved by the verifier 106 (e.g., the school) are to be used. Atstep 4318, the child is tested. An example of the testing process is disclosed in connection withFIGS. 40A and 40B . The results of the tests are sent to the digitalpass management system 100 and stored with the user's account. - At
step 4320, the digitalpass management system 100 releases the results of the tests to the verifier 106 (e.g., the school) and the associated users 102 (e.g., the parents). Atstep 4322, the verifier 106 (e.g., the school) can log into their account with the digitalpass management system 100 to review the results of the students connected to the school organization account. Atstep 4324, the user 102 (e.g., a parent) can access the result of the test for his/her child in theuser application 116. If the user's child tested negative, theuser application 116 can generate a digital pass for the child, as disclosed in connection withFIGS. 26, 27A, 27B, 28A, and 28B . The user 102 (e.g., a parent) can use theuser application 116 with the digital pass to enable the student to gain entry into the school. The verifier 106 (e.g., the school) may scan the digital pass on theuser device 108 each time the student arrives at the school, for example. - If the
user 102 does not have an electronic mobile device (e.g., a phone) to display a digital pass or does not have an electronic mobile device capable of displaying a digital pass, a similar digital pass verification process can be implemented in which certain information is mailed or emailed to theuser 102. For example,FIG. 44 shows an example timeline or sequence of events that is similar toFIG. 43 except theuser 102 does not have an electronic mobile device. In this example, atstep 4402, the verifier 106 (e.g., the school) and/or the digitalpass management system 100 physically mails the instructions and invitation ID (which may be referred to as a Connect-ID) to theuser 102. In other examples, the instructions and invitation ID can be emailed to theuser 102 who can print the instructions and invitation ID at home. During testing, atstep 4404, theuser 102 can present the invitation ID to thetester 104. Thetester 104 can input the invitation ID into thetester application 118 to link the user 102 (and/or the dependent) to the test. Atstep 4406, the digitalpass management system 100 and/or the verifier 106 (e.g., the school) can physically mail the results to theuser 102 or email the results to theuser 102, effectively providing theuser 102 with the results in an analog manner rather than digitally. In some examples, the digitalpass management system 100 and/or the verifier can physically mail theuser 102 the digital pass and/or digital pass code on a piece of paper or email the digital pass to theuser 102 to print out at home. Theuser 102 can then present the piece of paper to theverifier 106 as a pass. - While in some of the examples disclosed herein the
tester 104 performs the test, in other examples, theuser 102 can perform the test themselves. For example, the test may be performed via an at-home disposable test kit (e.g., a lateral flow test strip). In some examples, theuser application 116 presents instructions to inform theuser 102 on how to collect the sample for the diagnostic test. In some examples, after the test, theuser 102 can then enter the results of the test into theuser application 116. For example, theuser application 116 can provide a notification similar toFIG. 25 for interpretation and entry of the result of the diagnostic test. Additionally or alternatively, theuser application 116 can use thecamera 207 to scan the test kit, and theanalyzer 216 can analyze the image and automatically determine the result of the diagnostic test (e.g., by analyzing the lines and colors on the test kit). In such examples, theuser application 116 communicates with the digitalpass management system 100 to exchange the information disclosed above to be used in the generation of thedigital pass 2800. The at-home test kit may be provided by theverifier 106 or may be paid for individually by theuser 102. For example, a user planning to attend a concert may be responsible for obtaining his/her own test. In such an example, the user may order an at-home test kit (e.g., from the concert organization or a third-party organization). The user may conduct the at-home test, upload the results, and receive the digital pass prior to attending the concert. Theuser 102 can perform the test anywhere, such as at the user's home, a work place, a public facility, a school, etc. - As disclosed above, in some examples, rather than going to a testing facility to get tested, the
user 102 may perform the diagnostic test himself/herself. In some examples, theuser 102 may perform the test while being virtually monitored by the tester 104 (which may be referred to, in this example, as telehealth, telemed, telemedicine, electronic medicine, and/or virtual testing) to ensure the fidelity of the testing process. For example, theuser application 116 can electronically connect theuser device 108 with a telehealth service provide prior to collection of the sample. In some examples, theuser device 108 and thetester device 110 connect via a video conference session. In such an example, thetester 104 can monitor and watch theuser 102 while theuser 102 collects his/her sample and performs the diagnostic. In some examples, theuser 102 can use theuser device 108 to can scan the test kit code on the test kit to obtain the test kit ID. Theuser application 116 transmits the test kit ID to the digitalpass management system 100 to be stored with the user's account. When the test is completed, theuser 102 can show the test kit with the result to thetester 104 via the video call. For example, the test kit may include a visual indication (e.g., lines) that indicate the result of the test. Thetester 104 can then enter the results into thetester application 118 and transmit the results to the digitalpass management system 100. -
FIG. 45 shows an example timeline or sequence of events as performed and/or experienced by a manufacturer of the test kits. The example events can be performed in any other order and any of the events can be removed, replaced, and/or repeated. - At
step 4502, the manufacturer of the test kits creates serial numbers, lot IDs and expiration dates for the test kits. Atstep 4504, the manufacture updates a test kit lot manifest. The manufacturing prints and labels the test kits the test kit codes (e.g., QR codes) (step 4506) and distributes the test kits (step 4508). In some examples, the test kit codes include the serial IDs, the lot IDs, and/or the expiration dates. - In some examples, the lot manifest is encrypted and the data is encoded (step 4510) and a secure registry is created (step 4512). In some examples, this secure registry is saved with the digital
pass management system 100 and/or otherwise accessible for checking by the digitalpass management system 100. - At
step 4514, a new test kit is scanned by thetester application 118, which may correspond tosteps FIGS. 40A and 40B . Thetester application 118 sends the test kit ID (e.g., the serial ID, the lot ID, the expiration, etc.) that was embedded in the test kit code (step 4516). The digitalpass management system 100 or another system verifies the test kit ID by matching the test kit ID with the test kit information in the secured registry (step 4518). The digitalpass management system 100 or another system can log the verification event (step 4520) and update the kit inventory (step 4522). The digitalpass management system 100 or another system sends the results back to the tester application 118 (step 4524).Steps pass management system 100 and/or another system, such as a cloud-based server managed by the manufacturer. - While an example manner of implementing the
example user application 116 and theexample user device 108, theexample tester application 118 and theexample tester device 110, theexample verifier application 120 and theexample verifier device 112, and the example digitalpass management system 100 are illustrated inFIGS. 1-5 , one or more of the elements, processes and/or devices illustrated inFIGS. 1-5 may be combined, divided, re-arranged, omitted, eliminated and/or implemented in any other way. Further, theexample user application 116, theexample processor 200, theexample memory 202, theexample transceiver 204, theexample display 206, theexample camera 207, theexample scheduler 208, theexample notifier 210, theexample code generator 212, theexample time comparator 214, theexample analyzer 216, theexample tester application 118, theexample processor 300, theexample memory 302, theexample transceiver 304, theexample display 306, theexample camera 308, theexample record generator 310, theexample test selector 312, theexample sample indicator 314, theexample comparator 316, theexample reader 318, theexample verifier application 120, theexample processor 400 theexample memory 402, theexample transceiver 404, theexample display 406, theexample camera 408, theexample detector 410, theexample certifier 412, theexample notifier 414, the example digitalpass management system 100, theexample processor 500, theexample database 502, theexample record generator 504, theexample validator 506, and/or theexample transceiver 508 ofFIGS. 1-5 may be implemented by hardware, software, firmware and/or any combination of hardware, software and/or firmware. Thus, for example, any of the example user application 116, the example processor 200, the example memory 202, the example transceiver 204, the example display 206, the example camera 207, the example scheduler 208, the example notifier 210, the example code generator 212, the example time comparator 214, the example analyzer 216, the example tester application 118, the example processor 300, the example memory 302, the example transceiver 304, the example display 306, the example camera 308, the example record generator 310, the example test selector 312, the example sample indicator 314, the example comparator 316, the example reader 318, the example verifier application 120, the example processor 400 the example memory 402, the example transceiver 404, the example display 406, the example camera 408, the example detector 410, the example certifier 412, the example notifier 414, the example digital pass management system 100, the example processor 500, the example database 502, the example record generator 504, the example validator 506, and/or the example transceiver 508 could be implemented by one or more analog or digital circuit(s), logic circuits, programmable processor(s), programmable controller(s), graphics processing unit(s) (GPU(s)), digital signal processor(s) (DSP(s)), application specific integrated circuit(s) (ASIC(s)), programmable logic device(s) (PLD(s)) and/or field programmable logic device(s) (FPLD(s)). When reading any of the apparatus or system claims of this patent to cover a purely software and/or firmware implementation, at least one of the example user application 116, the example processor 200, the example memory 202, the example transceiver 204, the example display 206, the example camera 207, the example scheduler 208, the example notifier 210, the example code generator 212, the example time comparator 214, the example analyzer 216, the example tester application 118, the example processor 300, the example memory 302, the example transceiver 304, the example display 306, the example camera 308, the example record generator 310, the example test selector 312, the example sample indicator 314, the example comparator 316, the example reader 318, the example verifier application 120, the example processor 400 the example memory 402, the example transceiver 404, the example display 406, the example camera 408, the example detector 410, the example certifier 412, the example notifier 414, the example digital pass management system 100, the example processor 500, the example database 502, the example record generator 504, the example validator 506, and/or the example transceiver 508 is/are hereby expressly defined to include a non-transitory computer readable storage device or storage disk such as a memory, a digital versatile disk (DVD), a compact disk (CD), a Blu-ray disk, etc. including the software and/or firmware. Further still, the example user application 116, the example processor 200, the example memory 202, the example transceiver 204, the example display 206, the example camera 207, the example scheduler 208, the example notifier 210, the example code generator 212, the example time comparator 214, the example analyzer 216, the example tester application 118, the example processor 300, the example memory 302, the example transceiver 304, the example display 306, the example camera 308, the example record generator 310, the example test selector 312, the example sample indicator 314, the example comparator 316, the example reader 318, the example verifier application 120, the example processor 400 the example memory 402, the example transceiver 404, the example display 406, the example camera 408, the example detector 410, the example certifier 412, the example notifier 414, the example digital pass management system 100, the example processor 500, the example database 502, the example record generator 504, the example validator 506, and/or the example transceiver 508 ofFIGS. 1-5 may include one or more elements, processes and/or devices in addition to, or instead of, those illustrated inFIGS. 1-5 , and/or may include more than one of any or all of the illustrated elements, processes and devices. As used herein, the phrase “in communication,” including variations thereof, encompasses direct communication and/or indirect communication through one or more intermediary components, and does not require direct physical (e.g., wired) communication and/or constant communication, but rather additionally includes selective communication at periodic intervals, scheduled intervals, aperiodic intervals, and/or one-time events. - In the illustrated example of
FIG. 2 , theanalyzer 216 includes means for determining a result of a diagnostic test. In this example, the determining means is implemented by any processor structured to perform the corresponding operation by executing software or firmware, or hardware circuit (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, a PLD, a FPLD, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware, but other structures are likewise appropriate. In some examples, theanalyzer 216 implements the determining means. - In the illustrated example of
FIG. 2 , thecode generator 212 includes means for accessing a test identification based on the result, accessing a user identification based on the result, constructing a machine-readable code based on the test identification and the user identification; and incorporating the code into a digital pass. In this example, the generating means is implemented by any processor structured to perform the corresponding operation by executing software or firmware, or hardware circuit (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, a PLD, a FPLD, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware, but other structures are likewise appropriate. In some examples, thecode generator 212 implements the determining means. - In the illustrated example of
FIG. 2 , theoutput 218 includes means for displaying or outputting for display the digital pass. In this example, the outputting means is implemented by any processor structured to perform the corresponding operation by executing software or firmware, or hardware circuit (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, a PLD, a FPLD, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware, but other structures are likewise appropriate. In some examples, theoutput 218 implements the outputting means. - In the illustrated example of
FIG. 2 , thescheduler 208 includes means for determining a validity of the digital pass based on an expiration date. In this example, the means for determining validity is implemented by any processor structured to perform the corresponding operation by executing software or firmware, or hardware circuit (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, a PLD, a FPLD, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware, but other structures are likewise appropriate. In some examples, thescheduler 208 implements the means for determining validity. - In the illustrated example of
FIG. 2 , thenotifier 210 includes means for prompting scheduling of a test when the time comparator determines the digital pass is not valid In this example, the prompting means is implemented by any processor structured to perform the corresponding operation by executing software or firmware, or hardware circuit (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, a PLD, a FPLD, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware, but other structures are likewise appropriate. In some examples, thenotifier 210 implements the prompting means. - A flowchart representative of example hardware logic, machine readable instructions, hardware implemented state machines, and/or any combination thereof for implementing the
user application 116 ofFIGS. 1 and 2 is shown inFIGS. 46A and 46B . The machine readable instructions may be one or more executable programs or portion(s) of an executable program for execution by a computer processor and/or processor circuitry, such as the processor 5012 shown in theexample processor platform 5000 discussed below in connection withFIG. 50 . The program may be embodied in software stored on a non-transitory computer readable storage medium such as a CD-ROM, a floppy disk, a hard drive, a DVD, a Blu-ray disk, or a memory associated with the processor 5012, but the entire program and/or parts thereof could alternatively be executed by a device other than the processor 5012 and/or embfodied in firmware or dedicated hardware. Further, although the example program is described with reference to the flowchart illustrated inFIGS. 46A and 46B , many other methods of implementing theexample user application 116 may alternatively be used. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. Additionally or alternatively, any or all of the blocks may be implemented by one or more hardware circuits (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware. The processor circuitry may be distributed in different network locations and/or local to one or more devices (e.g., a multi-core processor in a single machine, multiple processors distributed across a server rack, etc.). - A flowchart representative of example hardware logic, machine readable instructions, hardware implemented state machines, and/or any combination thereof for implementing the
tester application 118 ofFIGS. 1 and 3 is shown inFIG. 47 . The machine readable instructions may be one or more executable programs or portion(s) of an executable program for execution by a computer processor and/or processor circuitry, such as the processor 5112 shown in theexample processor platform 5100 discussed below in connection withFIG. 51 . The program may be embodied in software stored on a non-transitory computer readable storage medium such as a CD-ROM, a floppy disk, a hard drive, a DVD, a Blu-ray disk, or a memory associated with the processor 5112, but the entire program and/or parts thereof could alternatively be executed by a device other than the processor 5112 and/or embodied in firmware or dedicated hardware. Further, although the example program is described with reference to the flowchart illustrated inFIG. 47 , many other methods of implementing theexample tester application 118 may alternatively be used. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. Additionally or alternatively, any or all of the blocks may be implemented by one or more hardware circuits (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware. The processor circuitry may be distributed in different network locations and/or local to one or more devices (e.g., a multi-core processor in a single machine, multiple processors distributed across a server rack, etc.). - A flowchart representative of example hardware logic, machine readable instructions, hardware implemented state machines, and/or any combination thereof for implementing the
verifier application 120 ofFIGS. 1 and 4 is shown inFIG. 48 . The machine readable instructions may be one or more executable programs or portion(s) of an executable program for execution by a computer processor and/or processor circuitry, such as the processor 5212 shown in theexample processor platform 5200 discussed below in connection withFIG. 52 . The program may be embodied in software stored on a non-transitory computer readable storage medium such as a CD-ROM, a floppy disk, a hard drive, a DVD, a Blu-ray disk, or a memory associated with the processor 5212, but the entire program and/or parts thereof could alternatively be executed by a device other than the processor 5212 and/or embodied in firmware or dedicated hardware. Further, although the example program is described with reference to the flowchart illustrated inFIG. 48 , many other methods of implementing theexample verifier application 118 may alternatively be used. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. Additionally or alternatively, any or all of the blocks may be implemented by one or more hardware circuits (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware. The processor circuitry may be distributed in different network locations and/or local to one or more devices (e.g., a multi-core processor in a single machine, multiple processors distributed across a server rack, etc.). - A flowchart representative of example hardware logic, machine readable instructions, hardware implemented state machines, and/or any combination thereof for implementing the digital
pass management system 100 ofFIGS. 1 and 5 is shown inFIG. 49 . The machine readable instructions may be one or more executable programs or portion(s) of an executable program for execution by a computer processor and/or processor circuitry, such as theprocessor 5312 shown in theexample processor platform 5300 discussed below in connection withFIG. 53 . The program may be embodied in software stored on a non-transitory computer readable storage medium such as a CD-ROM, a floppy disk, a hard drive, a DVD, a Blu-ray disk, or a memory associated with theprocessor 5312, but the entire program and/or parts thereof could alternatively be executed by a device other than theprocessor 5312 and/or embodied in firmware or dedicated hardware. Further, although the example program is described with reference to the flowchart illustrated inFIG. 49 , many other methods of implementing the example digitalpass management system 100 may alternatively be used. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. Additionally or alternatively, any or all of the blocks may be implemented by one or more hardware circuits (e.g., discrete and/or integrated analog and/or digital circuitry, an FPGA, an ASIC, a comparator, an operational-amplifier (op-amp), a logic circuit, etc.) structured to perform the corresponding operation without executing software or firmware. The processor circuitry may be distributed in different network locations and/or local to one or more devices (e.g., a multi-core processor in a single machine, multiple processors distributed across a server rack, etc.). - The machine readable instructions described herein may be stored in one or more of a compressed format, an encrypted format, a fragmented format, a compiled format, an executable format, a packaged format, etc. Machine readable instructions as described herein may be stored as data or a data structure (e.g., portions of instructions, code, representations of code, etc.) that may be utilized to create, manufacture, and/or produce machine executable instructions. For example, the machine readable instructions may be fragmented and stored on one or more storage devices and/or computing devices (e.g., servers) located at the same or different locations of a network or collection of networks (e.g., in the cloud, in edge devices, etc.). The machine readable instructions may require one or more of installation, modification, adaptation, updating, combining, supplementing, configuring, decryption, decompression, unpacking, distribution, reassignment, compilation, etc. in order to make them directly readable, interpretable, and/or executable by a computing device and/or other machine. For example, the machine readable instructions may be stored in multiple parts, which are individually compressed, encrypted, and stored on separate computing devices, wherein the parts when decrypted, decompressed, and combined form a set of executable instructions that implement one or more functions that may together form a program such as that described herein.
- In another example, the machine readable instructions may be stored in a state in which they may be read by processor circuitry, but require addition of a library (e.g., a dynamic link library (DLL)), a software development kit (SDK), an application programming interface (API), etc. in order to execute the instructions on a particular computing device or other device. In another example, the machine readable instructions may need to be configured (e.g., settings stored, data input, network addresses recorded, etc.) before the machine readable instructions and/or the corresponding program(s) can be executed in whole or in part. Thus, machine readable media, as used herein, may include machine readable instructions and/or program(s) regardless of the particular format or state of the machine readable instructions and/or program(s) when stored or otherwise at rest or in transit.
- The machine readable instructions described herein can be represented by any past, present, or future instruction language, scripting language, programming language, etc. For example, the machine readable instructions may be represented using any of the following languages: C, C++, Java, C#, Perl, Python, JavaScript, HyperText Markup Language (HTML), Structured Query Language (SQL), Swift, etc.
- As mentioned above, the example processes of
FIGS. 46A, 46B, 47, 48, and 49 may be implemented using executable instructions (e.g., computer and/or machine readable instructions) stored on a non-transitory computer and/or machine readable medium such as a hard disk drive, a flash memory, a read-only memory, a compact disk, a digital versatile disk, a cache, a random-access memory and/or any other storage device or storage disk in which information is stored for any duration (e.g., for extended time periods, permanently, for brief instances, for temporarily buffering, and/or for caching of the information). As used herein, the term non-transitory computer readable medium is expressly defined to include any type of computer readable storage device and/or storage disk and to exclude propagating signals and to exclude transmission media. - “Including” and “comprising” (and all forms and tenses thereof) are used herein to be open ended terms. Thus, whenever a claim employs any form of “include” or “comprise” (e.g., comprises, includes, comprising, including, having, etc.) as a preamble or within a claim recitation of any kind, it is to be understood that additional elements, terms, etc. may be present without falling outside the scope of the corresponding claim or recitation. As used herein, when the phrase “at least” is used as the transition term in, for example, a preamble of a claim, it is open-ended in the same manner as the term “comprising” and “including” are open ended. The term “and/or” when used, for example, in a form such as A, B, and/or C refers to any combination or subset of A, B, C such as (1) A alone, (2) B alone, (3) C alone, (4) A with B, (5) A with C, (6) B with C, and (7) A with B and with C. As used herein in the context of describing structures, components, items, objects and/or things, the phrase “at least one of A and B” is intended to refer to implementations including any of (1) at least one A, (2) at least one B, and (3) at least one A and at least one B. Similarly, as used herein in the context of describing structures, components, items, objects and/or things, the phrase “at least one of A or B” is intended to refer to implementations including any of (1) at least one A, (2) at least one B, and (3) at least one A and at least one B. As used herein in the context of describing the performance or execution of processes, instructions, actions, activities and/or steps, the phrase “at least one of A and B” is intended to refer to implementations including any of (1) at least one A, (2) at least one B, and (3) at least one A and at least one B. Similarly, as used herein in the context of describing the performance or execution of processes, instructions, actions, activities and/or steps, the phrase “at least one of A or B” is intended to refer to implementations including any of (1) at least one A, (2) at least one B, and (3) at least one A and at least one B.
- As used herein, singular references (e.g., “a”, “an”, “first”, “second”, etc.) do not exclude a plurality. The term “a” or “an” entity, as used herein, refers to one or more of that entity. The terms “a” (or “an”), “one or more”, and “at least one” can be used interchangeably herein. Furthermore, although individually listed, a plurality of means, elements or method actions may be implemented by, e.g., a single unit or processor. Additionally, although individual features may be included in different examples or claims, these may possibly be combined, and the inclusion in different examples or claims does not imply that a combination of features is not feasible and/or advantageous.
-
FIGS. 46A and 46B are flowcharts representative of instructions executed by the user device 108 (e.g., by theprocessor 200 of the user device 108) to implement theuser application 116 and/or otherwise implement operations performed on theuser device 108. In some examples, theuser 102 downloads theuser application 116 onto the user device 108 (e.g., from the digitalpass management system 100, the Apple App Store, and/or the Google Play Store). In other examples, theuser application 116 can be pre-installed on theuser device 108. Theuser 102 can open theuser application 116 and create an account (e.g., by entering his/her name, birthday, etc.). Example interfaces screens for creating an account are shown inFIGS. 6-11 . Atblock 4602, theuser application 116 receives and stores (e.g., in the memory 202) the account information entered by theuser 102. - At
block 4604, theuser application 116 transmits (e.g., communicates with thetransceiver 204 via the internet) the user account information to the digitalpass management system 100 for registration. Therecord generator 504 of the digitalpass management system 100 creates and stores a record of the user account in thedatabase 502. Therecord generator 504 of the digitalpass management system 100 creates a user account ID for the user account. The digitalpass management system 100 transmits (e.g., communicates with the transceiver 508) the user account ID to theuser device 102. Atblock 4606, thetransceiver 204 receives the user account ID, and theuser application 116 stores the user account ID (e.g., in the memory 202). - At
block 4608, thecode generator 212 of theuser application 116 generates the identity code 1200 (e.g., a QR code, a Data Matrix Code, other machine-readable codes) with the user account ID. Theidentity code 1200 can be used to confirm the identity of theuser 102 when theuser 102 is tested. Theuser application 116 stores the identity code 1200 (e.g., in the memory 202). - In some examples, to get tested for an infectious disease, the
user 102 can schedule an appointment. For example, atblock 4610, theuser 102 uses thescheduler 208 of theuser application 116 to schedule a test with a testing facility. In other examples, theuser 102 can proceed to the testing facility without an appointment. - The
user 102 shows theidentity code 1200 to thetester 104. For example, atblock 4612, theuser application 116 presents theidentity code 1200 on thedisplay 206 of the user device 108 (e.g.,FIG. 12 ). Thetester 104 scans theidentity code 104 with thetester device 110. Thetester 104 also performs the test as disclosed herein. - In some examples, the
user 102 may perform the test themselves. In some such examples, theuser application 116 may present instructions to inform theuser device 108 how to collect the sample and/or perform the test. In some examples, theuser 102 may enter his/her results into theuser application 116. For example, theuser application 116 can provide a notification similar toFIG. 25 for interpretation and entry of the result of the diagnostic test. Theuser 102 can then select the appropriate result. Additionally or alternatively, theuser application 116 can use thecamera 207 to scan the test kit, and theanalyzer 216 can analyze the image and automatically determine the result of the diagnostic test (e.g., by analyzing the lines and colors on the test kit). In such examples, theuser application 116 communicates with the digitalpass management system 100 to exchange the information disclosed above to be used in the generation of thedigital pass 2800. In other examples, a remote tester may monitor the user during the testing process. In such examples, theuser application 116 can electronically connect with a telehealth service provider prior to collection of the sample. Also, in this example, the remote tester enters the results via a tester device. - Referring to
FIG. 46B , atblock 4614, theuser application 116 accesses and displays the result on theuser device 108. In particular, after the test, the result is transmitted to theuser device 108 by thetester 104 and/or the digitalpass management system 100 as disclosed herein. In some examples, the digitalpass management system 100 may automatically transmit the test result to theuser application 116 when the digitalpass management system 100 receives the result from thetester 104. In other examples, theuser application 116 may request the result from the digitalpass management system 100. In some examples, the test kit ID and other information is/are also transmitted to theuser device 108. Thetransceiver 204 receives the results, and thenotifier 210 displays the results. Examples of these displays are shown inFIGS. 26, 27A, and 27B . Thenotifier 210 of theuser application 116 may display different information depending on the result of the diagnostic test. For example, if the result was positive for the infectious disease, thenotifier 210 of theuser application 116 may display certain guidelines or suggestions. If the result was negative for the infectious disease, thenotifier 210 of theuser application 116 may display other guidelines or suggestions. If the result was invalid (e.g., inconclusive), thenotifier 210 of theuser application 116 may present a suggestion to take the test again. - At
block 4616, theanalyzer 216 of theuser application 116 determines if the result was negative for the infectious disease. In some examples, if the result was not negative (i.e., the result was positive or invalid), the example process may end, and a digital pass is not generated. In other examples, if theanalyzer 216 of theuser application 116 determines that the result was not negative, the example process may continue with theuser 102 scheduling another test (block 4610). If the result was negative, atblock 4618, thecode generator 212 of theuser application 116 generates thedigital pass 2800 including the digital pass code 2802 (e.g., a QR code, a Data Matrix Code, and/or other types of machine-readable codes). In some examples, thedigital pass code 2802 includes the account ID associated with the user's account and the test kit ID of the test kit used to perform the test. Therefore, theuser application 116 accesses the user account ID (e.g., stored in the memory 202) and the test kit ID (e.g., stored in the memory 202) and generates thedigital pass code 2802 based on the user account ID and the test kit ID. Exampledigital passes digital pass codes FIGS. 28A and 28B . Atblock 4620, theuser application 116 saves the digital pass, such as the digital pass 2800 (e.g., in the memory 202). In some examples, thedigital pass 2800 is saved in a digital wallet on theuser device 108, which can be accessed without theuser application 116. - The
user 102 can then present thedigital pass 2800 to one or more verifiers as needed. Atblock 4622, theuser application 116 presents or displays the digital pass 2800 (including the digital pass code 2802) on thedisplay 206 of theuser device 108. Thedigital pass 2800 can be used to enable theuser 102 to gain entry into a location. Thedigital pass 2800 can be used multiple times with the same verifier or different verifiers. - At
block 4624, thetime comparator 214 of theuser application 116 determines whether thedigital pass 2800 has expired. If thedigital pass 2800 has not expired, thedigital pass 2800 is still valid and can continue to be used. If thedigital pass 2800 has expired, theuser 102 can get re-tested (e.g., proceeding to block 3810) and the example process continues from there. - The example process shown in
FIGS. 46A and 46B can be repeated each time the user 102 (and/or a dependent associated with the user 102) is tested. Theuser application 116 can manage multiple digital passes for theuser 102. The example process can be used in connection with the same type of test (e.g., for a same analyte of interest) or different types of tests (e.g., for different analytes of interest). -
FIG. 47 is a flowchart representative of instructions executed by the tester device 110 (e.g., by theprocessor 300 of the tester device 110) to implement thetester application 118 and/or otherwise implement operations performed on thetester device 110. In some examples, thetester 104 downloads thetester application 118 onto the tester device 110 (e.g., from the digitalpass management system 100, the Apple App Store, and/or the Google Play Store). In other examples, thetester application 118 can be pre-installed on thetester device 110. - In some examples, before testing the
user 102, thetester 104 creates a new test record by identifying theuser 102. As disclosed above, theuser 102 can present theidentity code 1200 on theuser device 108 to thetester 104. Thetester 104 uses thetester device 110 to scan theidentity code 1200. For example, thetester device 110 may include thecamera 308, which can be used to scan theidentity code 1200. In some examples, thetester application 118 displays the video feed from thecamera 308 to enable thetester 104 to align theidentity code 1200 in view of thecamera 308. An example of this interface is shown inFIG. 16 . Atblock 4702, therecord generator 310 of thetester application 118 detects and interprets theidentity code 1200 to obtain the user account ID (and/or other identifying information associated with the user 102) embedded in theidentity code 1200. - At
block 4704, thetester application 118 transmits the user account ID to the digitalpass management system 100 using, for example, thetransceiver 304. In some examples, the digitalpass management system 100 returns the name and/or other identifying information associated with theuser 102 so that thetester 104 can confirm the identity of theuser 102. Atblock 4706, thetester application 118 receives (e.g. via the transceiver 304) and presents the user identification information on thetester device 110. An example user interface showing the user identification information on thetester device 110 is shown inFIG. 17 . In some examples, thetester 104 confirms the user's identity via a driver's license or other form of identification. If the user's identity matches, thetester 104 proceeds to perform the test. As disclosed herein, various types of tests can be used. - Depending on the type of test, the test kit or test cartridge contains a test kit code with a unique test kit ID. The
tester 104 uses thetester device 110 to scan the test kit code on the test kit or test cartridge. In some examples, thetester application 118 displays the video feed from thecamera 308 to enable thetester 104 to align the test kit code in view of thecamera 308. An example of this interface is shown inFIG. 20 . Atblock 4708, therecord generator 310 of thetester application 118 detects and interprets the test kit code to obtain the test kit ID embedded in the test kit code. - In some examples, at
block 4710, thetester application 118 presents instructions on how to perform the test. An example of this interface is shown inFIG. 21 . After performing the test, the tester 104 (or another tester) can rescan the test kit code on the test kit. Atblock 4712, the tester application scans and interprets the test kit code to receive the test kit ID. An example of this interface is shown inFIG. 24 . In some examples, this second scan is used to prevent an accidental mix-up of test kits. In other examples, a second scan is not performed. - At
block 4714, thetester application 118 presents a user interface with selectable options for the results of the test. An example of this user interface is shown inFIG. 25 . Thetester 104 can select the appropriate test result. Therefore, thetester application 118 provides a notification for the interpretation and entry of the result of the diagnostic test. Atblock 4716, thetester application 118 receives input (e.g., from thetester 104 selecting the option on the display 306) indicative of the result of the diagnostic test. - At
block 4718, thetester application 118 transmits the user account ID, the test kit ID (from one or both scans), and the test results to the digital pass management system 100 (using, for example, the transceiver 304). The results are saved in thedatabase 502 with the user account and sent to theuser device 108. In some examples, thetester application 118 transmits an image of the test kit used in the diagnostic device to be saved in thedatabase 502. In addition to or as an alternative to sending the information to the digitalpass management system 100, thetester application 118 can also send the information directly to theuser device 108. -
FIG. 48 is a flowchart representative of instructions executed by the verifier device 112 (e.g., by theprocessor 400 of the verifier device 112) to implement theverifier application 120 and/or otherwise implement operations performed on theverifier device 112. In some examples, theverifier 106 downloads theverifier application 120 onto the verifier device 112 (e.g., from the digitalpass management system 100, the Apple App Store, and/or the Google Play Store). In other examples, theverifier application 120 can be pre-installed on theverifier device 112. - When the
user 102 intends to gain access to the location monitored by theverifier 106, theuser 102 can present thedigital pass 2800 on theuser device 108. Theverifier 106 uses theverifier device 112 to scan thedigital pass code 2802. For example, theverifier device 112 may include thecamera 408, which can be used to scan thedigital pass code 2802. In some examples, theverifier application 120 displays the video feed from thecamera 408 to enable theverifier 106 to align thedigital pass code 2802 in view of thecamera 408. An example of this interface is shown inFIG. 29 . Atblock 4802, thedetector 410 of theverification application 120 detects thedigital pass code 2802 displayed on theuser device 108, and thecertifier 412 interprets thedigital pass code 2802 to obtain the user account ID and the test kit ID. Thus, theverifier application 120 can determine the user account ID and test kit ID based on thedigital pass code 2802. In other examples, thedigital pass code 2802 can contain other identifying information that can be retrieved by theverifier application 120 when scanning thedigital pass code 2802. - At
block 4804, theverifier application 120 transmits the user account ID and test kit ID to the digital pass management system 100 (e.g., using the transceiver 404). In some examples, thevalidator 506 of the digitalpass management system 100 determines whether the user account ID and the test kit ID match in the user account. Thevalidator 506 of the digitalpass management system 100 also confirms that the result of the test was negative. In some examples, thevalidator 506 of the digitalpass management system 100 also confirms that the expiration date has not passed. The digitalpass management system 100 transmits a verification outcome based on whether thedigital pass 2800 is determined to be valid, invalid (e.g., expired), or not found to the verifier device 112 (e.g., using the transceiver 508). Atblock 4806, theverifier application 120 receives (e.g., via the transceiver 404) the verification outcome from the digitalpass management system 100. Thenotifier 414 of theverifier application 120, atblock 4808, presents the results. If thedigital pass 2800 is valid and not expired, thecertifier 412 of theverifier application 120 indicates that thedigital pass 2800 is valid. An example of this interface is shown inFIG. 30 . Theverifier 106 may then allow theuser 102 to enter the location. - If the
digital pass 2800 is expired or not valid (e.g., because theuser 102 has been removed from the verifier organization), thecertifier 412 of theverifier application 120 may indicate thedigital pass 2800 is expired or not valid. An example of this interface is shown inFIG. 31 . In such an instance, theverifier 106 can deny theuser 102 access to the location (e.g., an airplane, an office, a mall, a controlled outdoor space, etc.). In some examples, theuser 102 has to get tested again to obtain a new, valid digital pass. - If the digital pass is not found, such as if no user account is found, the
certifier 412 of theverifier application 120 may indicate the pass is not found. An example of this interface is shown inFIG. 33 . In some examples, in addition to or as an alternative to displaying the verification outcome, theverification application 120 can automatically unlock at least one of a door, a gate, or a turnstile based on the verification outcome to enable or deny access to theuser 102. -
FIG. 49 is a flowchart representative of instructions executed (e.g., by the processor 500) to implement the digitalpass management system 100. As disclosed above, theuser 102 can create an account by entering user information in theuser application 116 on theuser device 108. Atblock 4902, the digitalpass management system 100 receives the user information from theuser application 116 and therecord generator 504 creates a user account. The user account can be saved in thedatabase 502. Anexample data entry 510 for the user account is shown inFIG. 5 . Atblock 4104, therecord generator 504 of the digitalpass management system 100 creates a unique user account ID for the user account. Atblock 4906, the digitalpass management system 100 transmits the user account ID to the user device 108 (e.g., using the transceiver 508). The user account ID can be used to generate theidentity code 1200, thedigital pass 2800, and thedigital pass code 2802, as disclosed in connection withFIGS. 46A and 46B . - As disclosed above, when the
user 102 is at the testing facility, thetester 104 scans theidentity code 1200 on theuser device 108 to obtain the user account ID. Thetester application 118 sends the user account ID to the digitalpass management system 100. Atblock 4908, the digitalpass management system 100 receives the user account ID from the tester device 110 (e.g., via the tester application 118) and thevalidator 506 identifies the associated user account. Atblock 4910, the digitalpass management system 100 transmits the user name (and/or other identifying information) to the tester device 110 (e.g., using the transceiver 508). Thetester 104 can use the user name to confirm the identity of theuser 102 before or after performing the test. - As disclosed above, after the test is performed, the test kit ID and result information is/are sent to the digital
pass management system 100. Atblock 4912, the digitalpass management system 100 receives and stores the test kit ID and result of the test associated with the user account. In particular, when the digitalpass management system 100 receives the test kit ID and the result, theprocessor 500 associates the test kit ID and result of the diagnostic test with the user account ID and saves this information in thedatabase 502 with the user account (e.g., in the data entry 510). Thereafter, theprocessor 500 can access the result of the diagnostic test associated with the test kit ID. Atblock 4914, the digitalpass management system 100 transmits the result of the test to the user device 108 (e.g., using the transceiver 508). In some examples, in addition to the result, the digitalpass management system 100 transmits the test kit ID to theuser device 108. The test kit ID may be used in thedigital pass code 2802, as disclosed herein. In some examples, the digitalpass management system 100 verifies at least one of an expiration date of the test kit or a recall status of the test kit based on the test kit prior to transmitting the result of the diagnostic test and the test kit ID. In some examples, the digitalpass management system 100 verifies an authenticity of the test kit based on the test kit ID prior to transmitting the result of the diagnostic test and the test kit ID to theuser device 108. Additionally or alternatively, the digitalpass management system 100 can transmit other information to theuser device 108, such as the date of the diagnostic test, the type of test, etc. As disclosed above, the result can be used to create a digital pass on theuser device 108. - As disclosed above, the
verifier 106 can scan thedigital pass code 2802 on theuser device 108 to obtain the user account ID and test kit ID. Theverifier application 120 sends the user account ID and test kit ID to the digitalpass management system 100. Atblock 4916, the digitalpass management system 100 receives the user account ID and the test kit ID from the verifier device 112 (e.g., via the verifier application 120). Atblock 4918, thevalidator 506 of the digitalpass management system 100 determines whether thedigital pass 2800 for the user account is still valid. In some examples, thevalidator 506 of the digitalpass management system 100 confirms that the test kit ID matches the test kit ID associated with the user account. Thevalidator 506 verifies the result of the test based on the user account ID and the test kit ID. In other words, the validator 506 matches the user account ID and the test kit ID with the test result of the diagnostic test. For example, thevalidator 506 of the digitalpass management system 100 determines whether the result of the test associated with the user account for that test kit ID is negative. In some examples, thevalidator 506 of the digitalpass management system 100 confirms whether thedigital pass 2800 has not expired. For example, thevalidator 506 can determine a number of days since the diagnostic test and compare the number of days to a threshold number of days. If the number of days satisfies the threshold (e.g., is at or below the threshold), thevalidator 506 determines thedigital pass 2800 is still valid. If the number of days does not satisfy the threshold (e.g., is above the threshold), thevalidator 506 determines thedigital pass 2800 is not valid. In some examples, even if the number of days satisfies the threshold, thevalidator 506 can invalidate thedigital pass 2800, such as if theuser 102 is no longer employed at the verifier organization and the verifier organization has deactivated the user's passes. - At
block 4920, the digitalpass management system 100 transmits a verification outcome (e.g., valid, invalid (expired), or not found), indicating the validity of thedigital pass 2800, to the verifier device 112 (e.g., using the transceiver 508). The verification outcome can include a first notice when the result of the diagnostic test is negative and the number of days since the diagnostic test is below the threshold number of days, a second notice when the number of days since the diagnostic test is greater than the threshold, or a third notice when the digital pass is not found. Theverifier application 120 displays a message associated with the verification outcome, as shown inFIGS. 30-32 . -
FIG. 50 is a block diagram of anexample processor platform 5000 structured to execute the instructions ofFIGS. 46A and 46B to implement theuser application 116 ofFIGS. 1 and 2 . Theprocessor platform 5000 can be incorporated into theuser device 108. Theprocessor platform 5000 can be, for example, a server, a personal computer, a workstation, a self-learning machine (e.g., a neural network), a mobile device (e.g., a cell phone, a smart phone, a tablet such as an iPad™), a personal digital assistant (PDA), an Internet appliance, a DVD player, a CD player, a digital video recorder, a Blu-ray player, a personal video recorder, a headset or other wearable device, or any other type of computing device. - The
processor platform 5000 of the illustrated example includes a processor 5012. The processor 5012 of the illustrated example is hardware. For example, the processor 5012 can be implemented by one or more integrated circuits, logic circuits, microprocessors, GPUs, DSPs, or controllers from any desired family or manufacturer. The hardware processor may be a semiconductor based (e.g., silicon based) device. In this example, the processor 5012 can represent theprocessor 200 and implements theexample user application 116. - The processor 5012 of the illustrated example includes a local memory 5013 (e.g., a cache). The processor 5012 of the illustrated example is in communication with a main memory including a
volatile memory 5014 and anon-volatile memory 5016 via a bus 5018. Thevolatile memory 5014 may be implemented by Synchronous Dynamic Random Access Memory (SDRAM), Dynamic Random Access Memory (DRAM), RAMBUS® Dynamic Random Access Memory (RDRAM®) and/or any other type of random access memory device. Thenon-volatile memory 5016 may be implemented by flash memory and/or any other desired type of memory device. Access to themain memory - The
processor platform 5000 of the illustrated example also includes aninterface circuit 5020. Theinterface circuit 5020 may be implemented by any type of interface standard, such as an Ethernet interface, a universal serial bus (USB), a Bluetooth® interface, a near field communication (NFC) interface, and/or a PCI express interface. - In the illustrated example, one or
more input devices 5022 are connected to theinterface circuit 5020. The input device(s) 5022 permit(s) a user to enter data and/or commands into the processor 5012. In some examples, the input device(s) 5022 can include thedisplay 206, which may be a touchscreen, and/or thecamera 207. Additionally or alternatively, the input device(s) can be implemented by, for example, an audio sensor, a microphone, a keyboard, a button, a mouse, a touchscreen, a track-pad, a trackball, isopoint and/or a voice recognition system. - One or
more output devices 5024 are also connected to theinterface circuit 5020 of the illustrated example. Theoutput devices 5024 can include thedisplay 206 and can be implemented, for example, by display devices (e.g., a light emitting diode (LED), an organic light emitting diode (OLED), a liquid crystal display (LCD), a cathode ray tube display (CRT), an in-place switching (IPS) display, a touchscreen, etc.), a tactile output device, a printer and/or speaker. Theinterface circuit 5020 of the illustrated example, thus, typically includes a graphics driver card, a graphics driver chip and/or a graphics driver processor. - The
interface circuit 5020 of the illustrated example also includes a communication device such as a transmitter, a receiver, a transceiver (e.g., the transceiver 204), a modem, a residential gateway, a wireless access point, and/or a network interface to facilitate exchange of data with external machines (e.g., computing devices of any kind) via a network 5026 (e.g., thenetwork 114, such as the internet). The communication can be via, for example, an Ethernet connection, a digital subscriber line (DSL) connection, a telephone line connection, a coaxial cable system, a satellite system, a line-of-site wireless system, a cellular telephone system, etc. - The
processor platform 5000 of the illustrated example also includes one or moremass storage devices 5028 for storing software and/or data. Examples of suchmass storage devices 5028 include floppy disk drives, hard drive disks, compact disk drives, Blu-ray disk drives, redundant array of independent disks (RAID) systems, and digital versatile disk (DVD) drives. - The machine
executable instructions 5032 ofFIGS. 46A and 46B may be stored in themass storage device 5028, in thevolatile memory 5014, in thenon-volatile memory 5016, and/or on a removable non-transitory computer readable storage medium such as a CD or DVD. Thememory 202 can be implemented by any of the aforementioned. -
FIG. 51 is a block diagram of anexample processor platform 5100 structured to execute the instructions ofFIG. 47 to implement thetester application 118 ofFIGS. 1 and 3 . Theprocessor platform 5100 can be incorporated into thetester device 118. Theprocessor platform 5100 can be, for example, a medical instrument (e.g., a laboratory analyzer device) a server, a personal computer, a workstation, a self-learning machine (e.g., a neural network), a mobile device (e.g., a cell phone, a smart phone, a tablet such as an iPad™), a PDA, an Internet appliance, a DVD player, a CD player, a digital video recorder, a Blu-ray player, a personal video recorder, a headset or other wearable device, or any other type of computing device. - The
processor platform 5100 of the illustrated example includes a processor 5112. The processor 5112 of the illustrated example is hardware. For example, the processor 5112 can be implemented by one or more integrated circuits, logic circuits, microprocessors, GPUs, DSPs, or controllers from any desired family or manufacturer. The hardware processor may be a semiconductor based (e.g., silicon based) device. In this example, the processor 5112 can represent theprocessor 300 and implements theexample tester application 118. - The processor 5112 of the illustrated example includes a local memory 5113 (e.g., a cache). The processor 5112 of the illustrated example is in communication with a main memory including a
volatile memory 5114 and anon-volatile memory 5116 via a bus 5118. Thevolatile memory 5114 may be implemented by SDRAM, DRAM, RDRAM® and/or any other type of random access memory device. Thenon-volatile memory 5116 may be implemented by flash memory and/or any other desired type of memory device. Access to themain memory - The
processor platform 5100 of the illustrated example also includes aninterface circuit 5120. Theinterface circuit 5120 may be implemented by any type of interface standard, such as an Ethernet interface, a USB, a Bluetooth® interface, an NFC interface, and/or a PCI express interface. - In the illustrated example, one or
more input devices 5122 are connected to theinterface circuit 5120. The input device(s) 5122 permit(s) a user to enter data and/or commands into the processor 5112. In some examples, the input device(s) 5122 can include thedisplay 306, which may be a touchscreen, and/or thecamera 308. Additionally or alternatively, the input device(s) can be implemented by, for example, an audio sensor, a microphone, a keyboard, a button, a mouse, a track-pad, a trackball, isopoint and/or a voice recognition system. - One or
more output devices 5124 are also connected to theinterface circuit 5120 of the illustrated example. Theoutput devices 5124 can include thedisplay 306 and can be implemented, for example, by display devices (e.g., an LED, an OLED, an LCD display, a CRT display, an IPS display, a touchscreen, etc.), a tactile output device, a printer and/or speaker. Theinterface circuit 5120 of the illustrated example, thus, typically includes a graphics driver card, a graphics driver chip and/or a graphics driver processor. - The
interface circuit 5120 of the illustrated example also includes a communication device such as a transmitter, a receiver, a transceiver (e.g., the transceiver 304), a modem, a residential gateway, a wireless access point, and/or a network interface to facilitate exchange of data with external machines (e.g., computing devices of any kind) via a network 5126 (e.g., thenetwork 114, such as the internet). The communication can be via, for example, an Ethernet connection, a DSL connection, a telephone line connection, a coaxial cable system, a satellite system, a line-of-site wireless system, a cellular telephone system, etc. - The
processor platform 5100 of the illustrated example also includes one or more mass storage devices 5128 for storing software and/or data. Examples of such mass storage devices 5128 include floppy disk drives, hard drive disks, compact disk drives, Blu-ray disk drives, RAID systems, and DVD drives. - The machine
executable instructions 5132 ofFIG. 47 may be stored in the mass storage device 5128, in thevolatile memory 5114, in thenon-volatile memory 5116, and/or on a removable non-transitory computer readable storage medium such as a CD or DVD. Thememory 302 can be implemented by any of the aforementioned. -
FIG. 52 is a block diagram of anexample processor platform 5200 structured to execute the instructions ofFIG. 48 to implement theverifier application 120 ofFIGS. 1 and 4 . Theprocessor platform 5200 incorporated into theverifier device 112. Theprocessor platform 5200 can be can be, for example, a server, a handheld code scanner, a personal computer, a workstation, a self-learning machine (e.g., a neural network), a mobile device (e.g., a cell phone, a smart phone, a tablet such as an iPad™), a PDA, an Internet appliance, a DVD player, a CD player, a digital video recorder, a Blu-ray player, a personal video recorder, a headset or other wearable device, or any other type of computing device. - The
processor platform 5200 of the illustrated example includes a processor 5212. The processor 5212 of the illustrated example is hardware. For example, the processor 5212 can be implemented by one or more integrated circuits, logic circuits, microprocessors, GPUs, DSPs, or controllers from any desired family or manufacturer. The hardware processor may be a semiconductor based (e.g., silicon based) device. In this example, the processor 5212 can represent theprocessor 400 and implements theexample verifier application 120. - The processor 5212 of the illustrated example includes a local memory 4413 (e.g., a cache). The processor 5212 of the illustrated example is in communication with a main memory including a
volatile memory 5214 and anon-volatile memory 5216 via a bus 5218. Thevolatile memory 5214 may be implemented by SDRAM, DRAM, RDRAM® and/or any other type of random access memory device. Thenon-volatile memory 5216 may be implemented by flash memory and/or any other desired type of memory device. Access to themain memory - The
processor platform 5200 of the illustrated example also includes aninterface circuit 5220. Theinterface circuit 5220 may be implemented by any type of interface standard, such as an Ethernet interface, a USB, a Bluetooth® interface, an NFC interface, and/or a PCI express interface. - In the illustrated example, one or
more input devices 5222 are connected to theinterface circuit 5220. The input device(s) 5222 permit(s) a user to enter data and/or commands into the processor 5212. In some examples, the input device(s) 5222 can include thedisplay 406, which may be a touchscreen, and/or thecamera 408. Additionally or alternatively, the input device(s) can be implemented by, for example, an audio sensor, a microphone, a keyboard, a button, a mouse, a track-pad, a trackball, isopoint and/or a voice recognition system. - One or
more output devices 5224 are also connected to theinterface circuit 5220 of the illustrated example. Theoutput devices 5224 can include thedisplay 406 and can be implemented, for example, by display devices (e.g., an LED, an OLED, an LCD display, a CRT display, an IPS display, a touchscreen, etc.), a tactile output device, a printer and/or speaker. Theinterface circuit 5220 of the illustrated example, thus, typically includes a graphics driver card, a graphics driver chip and/or a graphics driver processor. - The
interface circuit 5220 of the illustrated example also includes a communication device such as a transmitter, a receiver, a transceiver (e.g., the transceiver 404), a modem, a residential gateway, a wireless access point, and/or a network interface to facilitate exchange of data with external machines (e.g., computing devices of any kind) via a network 5226 (e.g., thenetwork 114, such as the internet). The communication can be via, for example, an Ethernet connection, a DSL connection, a telephone line connection, a coaxial cable system, a satellite system, a line-of-site wireless system, a cellular telephone system, etc. - The
processor platform 5200 of the illustrated example also includes one or moremass storage devices 5228 for storing software and/or data. Examples of suchmass storage devices 5228 include floppy disk drives, hard drive disks, compact disk drives, Blu-ray disk drives, RAID systems, and DVD drives. - The machine
executable instructions 5232 ofFIG. 48 may be stored in themass storage device 5228, in thevolatile memory 5214, in thenon-volatile memory 5216, and/or on a removable non-transitory computer readable storage medium such as a CD or DVD. Thememory 402 can be implemented by any of the aforementioned. -
FIG. 53 is a block diagram of anexample processor platform 5300 structured to execute the instructions ofFIG. 49 to implement the digitalpass management system 100 ofFIGS. 1 and 5 . Theprocessor platform 5300 can be, for example, a server, a personal computer, a workstation, a self-learning machine (e.g., a neural network), a mobile device (e.g., a cell phone, a smart phone, a tablet such as an iPad™), a PDA, an Internet appliance, a DVD player, a CD player, a digital video recorder, a Blu-ray player, a personal video recorder, a headset or other wearable device, or any other type of computing device. - The
processor platform 5300 of the illustrated example includes aprocessor 5312. Theprocessor 5312 of the illustrated example is hardware. For example, theprocessor 5312 can be implemented by one or more integrated circuits, logic circuits, microprocessors, GPUs, DSPs, or controllers from any desired family or manufacturer. The hardware processor may be a semiconductor based (e.g., silicon based) device. In this example, theprocessor 5312 can implement theexample record generator 504 and theexample validator 506. - The
processor 5312 of the illustrated example includes a local memory 5313 (e.g., a cache). Theprocessor 5312 of the illustrated example is in communication with a main memory including avolatile memory 5314 and anon-volatile memory 5316 via abus 5318. Thevolatile memory 5314 may be implemented by SDRAM, DRAM, RDRAM® and/or any other type of random access memory device. Thenon-volatile memory 5316 may be implemented by flash memory and/or any other desired type of memory device. Access to themain memory - The
processor platform 5300 of the illustrated example also includes aninterface circuit 5320. Theinterface circuit 5320 may be implemented by any type of interface standard, such as an Ethernet interface, a USB, a Bluetooth® interface, an NFC interface, and/or a PCI express interface. - In the illustrated example, one or
more input devices 5322 are connected to theinterface circuit 5320. The input device(s) 5322 permit(s) a user to enter data and/or commands into theprocessor 5312. The input device(s) can be implemented by, for example, an audio sensor, a microphone, a camera (still or video), a keyboard, a button, a mouse, a touchscreen, a track-pad, a trackball, isopoint and/or a voice recognition system. - One or
more output devices 5324 are also connected to theinterface circuit 5320 of the illustrated example. Theoutput devices 5324 can be implemented, for example, by display devices (e.g., an LED, an OLED, an LCD display, a CRT display, an IPS display, a touchscreen, etc.), a tactile output device, a printer and/or speaker. Theinterface circuit 5320 of the illustrated example, thus, typically includes a graphics driver card, a graphics driver chip and/or a graphics driver processor. - The
interface circuit 5320 of the illustrated example also includes a communication device such as a transmitter, a receiver, a transceiver, a modem, a residential gateway, a wireless access point, and/or a network interface to facilitate exchange of data with external machines (e.g., computing devices of any kind) via a network 5326 (e.g., thenetwork 114, such as the internet). The communication can be via, for example, an Ethernet connection, a DSL connection, a telephone line connection, a coaxial cable system, a satellite system, a line-of-site wireless system, a cellular telephone system, etc. - The
processor platform 5300 of the illustrated example also includes one or moremass storage devices 5328 for storing software and/or data. Examples of suchmass storage devices 5328 include floppy disk drives, hard drive disks, compact disk drives, Blu-ray disk drives, RAID systems, and DVD drives. - The machine
executable instructions 5332 ofFIG. 49 may be stored in themass storage device 5328, in thevolatile memory 5314, in thenon-volatile memory 5316, and/or on a removable non-transitory computer readable storage medium such as a CD or DVD. Thedatabase 502 can be implemented by any of the aforementioned. - A block diagram illustrating an example
software distribution platform 5400 to distribute software such as the example computerreadable instructions FIGS. 50-53 to third parties is illustrated inFIG. 54 . The examplesoftware distribution platform 5400 may be implemented by any computer server, data facility, cloud service, etc., capable of storing and transmitting software to other computing devices. The third parties may be customers, employees, patients, clients of the entity owning and/or operating the software distribution platform. For example, the entity that owns and/or operates the software distribution platform may be a developer, a seller, and/or a licensor of software such as the example computerreadable instructions FIGS. 50-53 . The third parties may be consumers, users, retailers, OEMs, etc., who purchase and/or license the software for use and/or re-sale and/or sub-licensing. - In the illustrated example, the
software distribution platform 5400 includes (or is implemented by) one or more servers to distribute the example computerreadable instructions corresponding processor platforms FIGS. 50-53 . The one or more servers include one ormore storage devices 5402. Thestorage devices 5402 can be one or more non-transitory computer readable medium. Thestorage devices 5402 store the computer readable instructions, which may correspond to the example computerreadable instructions FIGS. 50-53 , as described above. The one or more servers of the examplesoftware distribution platform 5400 are in communication with anetwork 5404, which may correspond to any one or more of the Internet and/or any of the example networks described above. The one or more servers also include at least oneprocessor 5406. Thestorage device 5402stores instructions 5408 that, when executed by the at least oneprocessor 5406, cause the at least one orprocessor 5406 to transmit and/or otherwise distribute the example computerreadable instructions FIGS. 50-53 over thenetwork 5404. In some examples, the one or more servers are responsive to requests to transmit the software to a requesting party as part of a commercial transaction. Payment for the delivery, sale and/or license of the software may be handled by the one or more servers of the software distribution platform and/or via a third party payment entity. The servers enable purchasers and/or licensors to download the computerreadable instructions software distribution platform 5400. For example, the software, which may correspond to the example computerreadable instructions FIGS. 50-53 , may be downloaded to the examplerespective processor platforms readable instructions user application 116, thetester application 118, theverifier application 120, and/or the digitalpass management system 100. In some example, one or more servers of the software distribution platform 5405 periodically offer, transmit, and/or force updates to the software (e.g., the example computerreadable instructions FIGS. 50-53 ) to ensure improvements, patches, updates, etc. are distributed and applied to the software at the end user devices. - From the foregoing, it will be appreciated that example methods, apparatus, systems, and articles of manufacture have been disclosed that enable verifiers to quickly, easily, and accurately verify whether a user (e.g., an employee, a passenger, a spectator, a patient, or other person) has recently tested negative for an infectious diseases before allowing the person access to a particular area or location. As such, the examples, disclosed herein can help reduce the risk of spreading an infectious disease and, thus, improve safety.
- The examples disclosed herein also increase communication bandwidth among the
user application 116, thetester application 118, theverifier application 120, and the digitalpass management system 100 because the digital passes are produced on theuser device 108 and do not have to be transmitted over the Internet or computed in the cloud. Furthermore, theuser application 116 constructs the digital pass based on a negative result. Therefore, user devices do not expend operating resources to construct a digital pass for every test that is performed. - In some examples, the
verifier application 120 communicates directly with the digitalpass management system 100. In such examples, theverifier 106 may receive test results without communication with a user. For example, an employer may receive an employee's test result before an employee arrives at work. In this example, the employer may preemptively contact the employee and notify them that they have been restricted from attendance at work. - In some examples, the
tester 104 and/or the digitalpass management system 100 develop a sequence of tests to recommend to a user. For example, the sequence of tests may be based on a pathogen life cycle and/immune response. In such examples, a first type of test may be recommended at a first time period. Based on an incubation period, the pathogen life cycle, and/or immune response, a second instance of the first type of test and/or a second type of test may be recommended at a second time period. Thetester 104 and/or the digitalpass management system 100 can transmit a notification of the sequence of diagnostic tests to theuser device 108. Thescheduler 208 of theuser application 116 causes theuser device 108 to display the notification of the recommended testing sequence. - In some examples, the
tester 104 and/or the digitalpass management system 100 may publish test results. In some examples, geographic data regarding where digital pass codes have been scanned is gathered. In some examples, geographic data regarding where positive tests have occurred (e.g., user residential and work data is gathered. Theuser application 116, thetester application 118, theverifier application 120, and the digitalpass management system 100 may work in concert to aggregate geographic data related to positive tests, negative tests, user travel history, and user movement. The aggregated data may be used to create heat maps that identify regions or smaller geographic locations (e.g., a particular school or business) that are areas of relatively higher positivity rates. - Example digital pass verification systems, methods, apparatus, devices, and articles of manufacture are disclosed herein. Further examples and combinations thereof include the following:
- Example 1 includes one or more servers to distribute first instructions, second instructions, third instructions, and fourth instructions, on a network. The one or more servers include at least one storage device including fifth instructions and at least one processor to execute the fifth instructions to transmit the first instructions, the second instructions, the third instructions, and the fourth instructions over the network. The first instructions, when executed, cause a first device carried by a person to at least: access a result of a diagnostic test performed on the person, the result provided by a second device; generate a machine-readable code in response to the result being negative; and display the machine-readable code on a display of the first device to enable the person to gain access to a location. The second instructions, when executed, cause the second device to at least: receive input indicative of the result of the diagnostic test; and transmit the result to a third device. The third instructions, when executed, cause a fourth device to at least: detect the machine-readable code from the first device; determine a user identification associated with the person based on the machine-readable code; determine a test identification associated with the diagnostic test based on the machine-readable code; transmit the user identification and the test identification to the third device, the third device remote from the fourth device; and receive a verification outcome from the third device. The fourth instructions, when executed, cause the third device to at least: transmit the result of the diagnostic test to the first device; receive the user identification and the test identification from the fourth device; verify the result of the diagnostic test based on the user identification and the test identification; determine a number of days since the diagnostic test; and transmit the verification outcome to the fourth device. The verification outcome includes a first notice when the result of the diagnostic test is negative and the number of days since the diagnostic test is below a threshold number of days, and the verification outcome includes a second notice when the number of days since the diagnostic test is greater than the threshold.
- Example 2 includes the one or more servers of Example 1, wherein the result is a first result, the diagnostic test is a first diagnostic test, and the machine-readable code is a first machine-readable code. The first instructions, when executed, cause the first device to: access a second result of a second diagnostic test performed on the person; and generate a second machine-readable code in response to the second result being negative.
- Example 3 includes the one or more servers of Example 2, wherein the first diagnostic test is to detect a presence or an absence of a first analyte of interest, and the second diagnostic test is to detect a presence or an absence of a second analyte of interest. The second analyte of interest is different than the first analyte of interest.
- Example 4 includes the one or more servers of Example 2, wherein the first diagnostic test is to detect a presence or an absence of an analyte of interest, and the second diagnostic test is to detect a presence or an absence of the analyte of interest. The second diagnostic test performed is subsequent to the first diagnostic test.
- Example 5 includes the one or more servers of any of Examples 2-4, wherein the second diagnostic test is a different type of diagnostic test than the first diagnostic test.
- Example 6 includes the one or more servers of Example 5, wherein the first diagnostic test is an antigen test and the second diagnostic test is an antibody test.
- Example 7 includes the one or more servers of an of Examples 2-6, wherein the first diagnostic test is to be performed with a first type of testing equipment and the second diagnostic test is to be performed with a second type of testing equipment. The second type is different than the first type.
- Example 8 includes the one or more servers of any of Examples 2-7, wherein the second machine-readable code is to be read by a fifth device. The fifth device is remote from the third device.
- Example 9 includes the one or more servers of any of Examples 1-8, wherein the fourth instructions, when executed, enable the third device to invalidate the machine-readable code when the number of days since the diagnostic test is below the threshold number of days.
- Example 10 includes the one or more servers of any of Examples 1-9, wherein the diagnostic test is to detect a presence or an absence of a pathogen and the threshold is based on an incubation period of the pathogen.
- Example 11 includes the one or more servers of any of Examples 1-10, wherein the diagnostic test is a first diagnostic test, and the first instructions, when executed, cause the first device to display a notification to the person to schedule a second diagnostic test based on the number of days since the first diagnostic test and the threshold number of days.
- Example 12 includes the one or more servers of any of Examples 1-11, wherein the third instructions, when executed, cause the fourth device to display the first notice or the second notice to grant or deny the person access to the location based on the verification outcome and a location of the fourth device.
- Example 13 includes the one or more servers of any of Examples 1-12, wherein the third instructions, when executed, cause the fourth device to display the first notice or the second notice to grant or deny the person access to the location based on the verification outcome and at least one of a time of day or a day of the week.
- Example 14 includes the one or more servers of any of Examples 1-13, wherein the third instructions, when executed, cause the fourth device to automatically unlock at least one of a door, a gate, or a turnstile based on the verification outcome.
- Example 15 includes the one or more servers of any of Examples 1-14, wherein the fourth instructions, when executed, cause the third device to: develop a sequence of diagnostic tests based on at least one of a pathogen incubation period, a pathogen life cycle, or an immune response; and transmit a notification of the sequence of diagnostic tests to the first device. The first instructions, when executed, cause the first device to display the notification of the sequence of diagnostic tests to the person on the first device.
- Example 16 includes one or more non-transitory computer readable medium including instructions that, when executed, cause one or more processors in a first device carried by a person to at least: access a result of a diagnostic test performed on the person; generate a machine-readable code in response to the result being negative; and display the machine-readable code on a display of the first device to enable the person to gain access to a location. The instructions, when executed, cause one or more processors in a second device to at least: detect the machine-readable code from the first device; determine a user identification associated with the person based on the machine-readable code; determine a test identification associated with the diagnostic test based on the machine-readable code; transmit the user identification and the test identification to a third device, the third device remote from the second device; and receive a verification outcome from the third device. The instructions, when executed, cause one or more processors in the third device to at least: transmit the result of the diagnostic test to the first device; receive the user identification and the test identification from the second device; verify the result of the diagnostic test based on the user identification and the test identification; determine a number of days since the diagnostic test; and transmit the verification outcome to the second device. The verification outcome includes a first notice when the result of the diagnostic test is negative and the number of days since the diagnostic test is below a threshold number of days, and the verification outcome includes a second notice when the number of days since the diagnostic test is greater than the threshold.
- Example 17 includes the one or more non-transitory computer readable medium of Example 16, wherein the instructions, when executed, cause one or more processors in a fourth device to at least: automatically determine the result of the diagnostic test; and transmit the result of the diagnostic test to the third device.
- Example 18 includes the one or more non-transitory computer readable medium of Examples 16 or 17, wherein the instructions, when executed, cause one or more processors in a fourth device to at least: provide a notification for the interpretation and entry of the result of the diagnostic test; and transmit the result of the diagnostic test to the third device.
- Example 19 includes the one or more non-transitory computer readable medium of an of Examples 16-18, wherein the instructions, when executed, cause one or more processors in a fourth device to transmit an image of at least a portion of a test kit used in the diagnostic test to the first device.
- Example 20 includes the one or more non-transitory computer readable medium of any of Examples 16-19, wherein the instructions cause the one or more processors of the second device to display the first notice or the second notice to grant or deny the person access to the location based on the verification outcome and at least one of: a location of the second device, a time of day, a day of the week, or an employment status.
- Example 21 includes a server to distribute first instructions on a network. The server includes at least one storage device including second instructions and at least one processor to execute the second instructions to transmit the first instructions over the network. The first instructions, when executed, are to cause a mobile device carried by a person to at least: access a user identification associated with the person; access a result of a diagnostic test performed on a sample gathered from the person; display the result on a display of the mobile device; and generate an interface including the user identification and an indicator. The indicator is generated in response to the result being negative and a number of days since the diagnostic test being below a threshold number of days. The first instructions, when executed, are also to cause the mobile device to display the interface on the display to enable the person to gain entry into a location.
- Example 22 includes the server of Example 21, wherein the result is a first result, the diagnostic test is a first diagnostic test, the interface is a first interface, and the indicator is a first indicator. The first instructions, when executed, cause the mobile device to: access a second result of a second diagnostic test; display the second result on the display of the mobile device; and generate a second interface including a second indicator. The second indicator is generated in response to the second result being negative and a number of days since the second diagnostic test being below the threshold number of days.
- Example 23 includes the server of Example 22, wherein the person is a first person and the second diagnostic test is performed on a second person.
- Example 24 includes the server of any of Examples 21-23, wherein the diagnostic test is to detect a presence or an absence of a pathogen and the threshold number of days is based on an incubation period of the pathogen.
- Example 25 includes the server of any of Examples 21-24, wherein the diagnostic test is a first diagnostic test, and the first instructions, when executed, cause the mobile device to display a notification to the person to schedule a second diagnostic test based on the number of days since the diagnostic test and the threshold number of days.
- Example 26 includes the server of any of Examples 21-25, wherein the first instructions, when executed, cause the mobile device to inform the person how to collect the sample for the diagnostic test.
- Example 27 includes the server of any of Examples 21-26, wherein the first instructions, when executed, cause the mobile device to detect and interpret a test kit code on a test kit to obtain a test kit identification associated with the test kit.
- Example 28 includes the server of any of Examples 21-27, wherein the first instructions, when executed, cause the mobile device to provide a notification for interpretation and entry of the result of the diagnostic test.
- Example 29 includes the server of any of Examples 21-28, wherein the first instructions, when executed, enable the person to schedule an appointment to provide the sample for the diagnostic test.
- Example 30 includes the server of any of Examples 21-29, wherein the first instructions, when executed, cause the mobile device to electronically connect with a telehealth service provider prior to collection of the sample.
- Example 31 includes at least one non-transitory computer readable medium including instructions that, when downloaded to a mobile device and executed, cause a processor of the mobile device to at least: access a result of a diagnostic test performed on a sample gathered from a person; generate a machine-readable code in response to the result being negative; and display the machine-readable code on a display of the mobile device to enable the person to gain entry into a location.
- Example 32 includes the at least one non-transitory computer readable medium of Example 31, wherein the machine-readable code includes a user identification and a test kit identification associated with a test kit used to perform the diagnostic test.
- Example 33 includes the at least one non-transitory computer readable medium of Examples 31 or 32, wherein the result is a first result, the diagnostic test is a first diagnostic test, the sample is a first sample, and the machine-readable code is a first machine-readable code. The instructions, when executed, cause the processor of the mobile device to: access a second result of a second diagnostic test performed on a second sample gathered from the person; and generate a second machine-readable code in response to the second result being negative.
- Example 34 includes the at least one non-transitory computer readable medium of Example 33, wherein the first diagnostic test is to detect a presence or an absence of a first analyte of interest, and the second diagnostic test is to detect a presence or an absence of a second analyte of interest. The second analyte of interest is different than the first analyte of interest.
- Example 35 includes the at least one non-transitory computer readable medium of Example 33, wherein the first diagnostic test is to detect a presence or an absence of an analyte of interest, and the second diagnostic test is to detect a presence or an absence of the analyte of interest. The second diagnostic test is performed subsequent to the first diagnostic test.
- Example 36 includes the at least one non-transitory computer readable medium of Example 36, wherein the first diagnostic test is an antigen test and the second diagnostic test is an antibody test.
- Example 37 includes the at least one non-transitory computer readable medium of any of Examples 31-36, wherein the instructions, when executed, cause the processor of the mobile device to: receive a notification of a sequence of diagnostic tests based on at least one of a pathogen incubation period, a pathogen life cycle, or an immune response; and display the notification of the sequence of diagnostic tests to the person on the display of the mobile device.
- Example 38 includes the at least one non-transitory computer readable medium of any of Examples 31-37, wherein the instructions, when executed, cause the processor of the mobile device to electronically connect with a telehealth service provider prior to collection of the sample.
- Example 39 includes the at least one non-transitory storage medium of any of Examples 31-38, wherein the instructions, when executed, cause the processor of the mobile device to: inform the person how to collect the sample for the diagnostic test; and automatically determine the result of the diagnostic test.
- Example 40 includes the at least one non-transitory computer readable medium of any of Examples 31-39, wherein the instructions, when executed, cause the processor of the mobile device to: inform the person how to collect the sample for the diagnostic test; and provide a notification for interpretation and entry of the result of the diagnostic test into the mobile device.
- Example 41 includes an apparatus including processor circuitry and memory including instructions which, when executed, cause the processor circuitry to: access a result of a diagnostic test associated with a test kit identification; associate the result of the diagnostic test with a user identification; transmit the result of the diagnostic test and the test kit identification to a first device to cause the first device to generate a machine-readable pass on a display of the first device; receive the user identification and the test kit identification from a second device that is communicatively coupled to a scanner of the second device when the scanner reads the machine-readable pass, and, when the test kit identification and the user identification match the result of the diagnostic test: transmit a first notification to the second device when a number of days since the diagnostic test is less than a threshold number of days to cause the second device to present a first display; and transmit a second notification to the second device when the number of days since the diagnostic test is greater than the threshold number of days to cause the second device to present a second display, the second display different from the first display.
- Example 42 includes the apparatus of Example 41, wherein the instructions, when executed, cause the processor circuitry to transmit the second notification to the second device when the user identification has been inactivated from a verifier organization associated with the second device.
- Example 43 includes the apparatus of Examples 41 or 42, wherein the instructions, when executed, cause the processor circuitry to transmit a third notification to the second device when at least one of the user identification or the test kit identification is not matched to the result to cause the second device to present a third display. The third display is different from the first display and the second display.
- Example 44 includes the apparatus of any of Examples 41-43, wherein the instructions, when executed, cause the processor circuitry to receive the result of the diagnostic test from the first device.
- Example 45 includes the apparatus of any of Examples 41-44, wherein the instructions, when executed, cause the processor circuitry to receive the result of the diagnostic test from a third device, the third device remote from the first device and the second device.
- Example 46 includes the apparatus of any of Examples 41-45, wherein the threshold number of days is set by a verifier organization associated with the second device.
- Example 47 includes the apparatus of any of Examples 41-46, wherein the threshold number of days is based on a biological characteristic of an analyte of interest to be tested in the diagnostic test.
- Example 48 includes the apparatus of any of Examples 41-47, wherein the instructions, when executed, cause the processor circuitry to: access results of diagnostic tests; receive sets of user identifications and test kit identifications from one or more second devices; generate a report based on the results and receipt of the sets of user identifications and test kit identifications; and transmit the report to a government agency.
- Example 49 includes the apparatus of any of Examples 41-48, wherein the instructions, when executed, cause the processor circuitry to verify at least one of an expiration date of a test kit or a recall status of the test kit based on the test kit identification prior to transmitting the result of the diagnostic test and the test kit identification to the first device.
- Example 50 includes the apparatus of any of Examples 41-49, wherein the instructions, when executed, cause the processor circuitry to verify an authenticity of a test kit based on the test kit identification prior to transmitting the result of the diagnostic test and the test kit identification to the first device.
- Example 51 includes at least one non-transitory storage medium including instructions that, when executed, cause a machine to: access a result of a diagnostic test associated with a test kit identification; associate the result of the diagnostic test with a user identification; transmit the result of the diagnostic test and the test kit identification to a first device to cause the first device to generate a digital pass code on a display of the first device; receive the user identification and the test kit identification from a second device that is communicatively coupled to a scanner of the second device when the scanner reads the digital pass code; and, when the test kit identification and the user identification match the result of the diagnostic test: transmit a first notification to the second device when an amount of time since the diagnostic test is below a threshold amount of time to cause the second device to present a first display; and transmit a second notification to the second device when the amount of time since the diagnostic test is greater than the threshold amount of time to cause the second device to present a second display, the second display different from the first display.
- Example 52 includes the storage medium of Example 51, wherein the instructions, when executed, cause the machine to transmit the second notification to the second device when the user identification has been removed from a verifier organization associated with the second device.
- Example 53 includes the storage medium of Examples 51 or 52, wherein the instructions, when executed, cause the machine to transmit a third notification to the second device when at least one of the user identification or the test kit identification is not matched to the result to cause the second device to present a third display. The third display is different from the first display and the second display.
- Example 54 includes the storage medium of any of Examples 51-53, wherein the instructions, when executed, cause the machine to receive the result of the diagnostic test from the first device.
- Example 55 includes the storage medium of any of Examples 51-54, wherein the instructions, when executed, cause the machine to receive the result of the diagnostic test from a third device, the third device remote from the first device and the second device.
- Example 56 includes the storage medium of any of Examples 51-55, wherein the threshold amount of time is set by a verifier organization associated with the second device.
- Example 57 includes the storage medium of any of Examples 51-56, wherein the threshold amount of time is based on a biological characteristic of an analyte of interest to be tested in the diagnostic test.
- Example 58 includes the storage medium of any of Examples 51-57, wherein the instructions, when executed, cause the machine to: access results of diagnostic tests; receive sets of user identifications and test kit identifications from one or more second devices; generate a report based on the results and receipt of the sets of user identifications and test kit identifications; and transmit the report to a government agency.
- Example 59 includes the storage medium of any of Examples 51-58, wherein the instructions, when executed, cause the machine to verify at least one of an expiration date of a test kit or a recall status of the test kit based on the test kit identification prior to transmitting the result of the diagnostic test and the test kit identification to the first device.
- Example 60 includes the storage medium of any of Examples 51-59, wherein the instructions, when executed, cause the machine to verify an authenticity of a test kit based on the test kit identification prior to transmitting the result of the diagnostic test and the test kit identification to the first device.
- Example 61 is a device to generate a digital pass. The device includes an analyzer to determine a result of a diagnostic test and a code generator to: access a test identification based on the result, access a user identification based on the result, construct a machine-readable code based on the test identification and the user identification, and incorporate the code into a digital pass. The device further includes an output to display the digital pass.
- Example 62 includes the device of Example 61, wherein the code generator is to incorporate an expiration date into the digital pass. The device further includes a scheduler to determine a validity of the digital pass based on the expiration date, and a notifier to prompt scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 63 is a device to generate a digital pass. The device includes means for determining a result of a diagnostic test, means for generating a code, the generating means to: access a test identification based on the result, access a user identification based on the result, construct a machine-readable code based on the test identification and the user identification, and incorporate the code into a digital pass, and means for displaying the digital pass.
- Example 64 includes the device of Example 63, wherein the generating means is to incorporate an expiration date into the digital pass. The device further includes means for determining a validity of the digital pass based on the expiration date, and means for prompting scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 65 is an apparatus to generate a digital pass. The apparatus includes processor circuitry and a memory including instructions which, when executed, cause the processor circuitry to: determine a result of a diagnostic test, generate a code, the generating means to: access a test identification based on the result, access a user identification based on the result, construct a machine-readable code based on the test identification and the user identification, and incorporate the code into a digital pass, and display the digital pass.
- Example 66 includes the apparatus of Example 65, wherein the instructions, when executed, cause the processor circuitry to: incorporate an expiration date into the digital pass, determine a validity of the digital pass based on the expiration date, and prompt scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 67 includes a non-transitory computer readable storage medium including instructions which, when executed, cause one or more processors to at least: determine a result of a diagnostic test, generate a code, the generating means to: access a test identification based on the result, access a user identification based on the result, construct a machine-readable code based on the test identification and the user identification, incorporate the code into a digital pass, and display the digital pass.
- Example 68 includes the computer readable storage medium of Example 67, wherein the instructions, when executed, cause the one or more processors to: incorporate an expiration date into the digital pass; determine a validity of the digital pass based on the expiration date, and prompt scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 69 includes a method to create a digital pass. The method includes determining, by executing instructions with a processor, a result of a diagnostic test, generating, by executing instructions with the processor, a code, the generating means to: accessing, by executing instructions with the processor, a test identification based on the result, accessing, by executing instructions with the processor, a user identification based on the result, constructing, by executing instructions with the processor, a machine-readable code based on the test identification and the user identification, incorporating, by executing instructions with the processor, the code into a digital pass, and displaying, by executing instructions with the processor, the digital pass.
- Example 70 includes the method of Example 69, further including: incorporating, by executing instructions with the processor, an expiration date into the digital pass, determining, by executing instructions with the processor, a validity of the digital pass based on the expiration date, and prompting, by executing instructions with the processor, scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 71 is a server to distribute first instructions on a network. The server includes at least one storage device including second instructions, and at least one processor to execute the second instructions to transmit the first instructions over the network. The first instructions, when executed, to cause at least one device to at least: determine a result of a diagnostic test, generate a code, the generating means to: access a test identification based on the result, access a user identification based on the result, construct a machine-readable code based on the test identification and the user identification, incorporate the code into a digital pass, and display the digital pass.
- Example 72 includes the server of Example 71, wherein the first instructions, when executed, to cause at least one device to further: incorporate an expiration date into the digital pass, determine a validity of the digital pass based on the expiration date, and prompt scheduling of a test when the time comparator determines the digital pass is not valid.
- Example 73 includes a system that includes a first non-transitory computer readable storage medium including a first set of instructions which, when executed, cause at least a first processor to at least: generate a record of a test result of a medical diagnostic test of a biological sample from a user, and transmit the test result to a second processor. The system also includes a second non-transitory computer readable storage medium including a second set of instructions which, when executed, cause at least the second processor to at least: generate a machine-readable code based on the test result and user identification, incorporate the code into a digital pass, and display the digital pass. The system further includes a third non-transitory computer readable storage medium including a third set of instructions which, when executed, cause at least a third processor to at least: scan the digital pass, and verify the test result.
- Example 74 includes the system of Example 73, wherein the machine-readable code is a first machine readable code, the second instructions, when executed, cause the second device to: generate a second machine-readable code based on the user identification, and display the second machine-readable code; and the first instructions, when executed, cause a fourth device to: scan the second-machine readable code, and associate the user identification is a test kit and the biological sample.
- Example 75 is a server to distribute first, second, and third instructions over a network. The server includes at least one storage device including fourth instructions, and at least one processor to execute the fourth instructions to: transmit the first instructions over the network to a first device, transmit the second instructions over the network to a second device, and transmit the third instructions over the network to a third device. The first instructions, when executed, to cause the first device to: generate a record of a test result of a medical diagnostic test of a biological sample from a user, and transmit the test result to the second device. The second instructions, when executed, to cause the second device to: generate a machine-readable code based on the test result and user identification, incorporate the code into a digital pass, and display the digital pass. The third instructions, when executed, to cause the third device to: scan the digital pass, and verify the test result.
- Example 76 includes the server of Example 75, wherein the wherein the machine-readable code is a first machine readable code, the second instructions, when executed, cause the second device to: generate a second machine-readable code based on the user identification, and display the second machine-readable code; and the first instructions, when executed, cause a fourth device to: scan the second-machine readable code, and associate the user identification is a test kit and the biological sample.
- Example 77 is device including any feature described, either individually or in combination with any feature, in any configuration.
- Example 78 is a system including any feature described, either individually or in combination with any feature, in any configuration.
- Example 79 is a server to transmit instructions to perform any method disclosed herein.
- Example 80 is a method to operate any device, system, processor, or server disclosed herein.
- Example 71 is a non-transitory computer readable storage medium including instructions which, when executed, cause at least one or more processors to perform any method or function disclosed herein.
- Although certain example methods, apparatus, systems, and articles of manufacture have been disclosed herein, the scope of coverage of this patent is not limited thereto. On the contrary, this patent covers all methods, apparatus, systems, and articles of manufacture fairly falling within the scope of the claims of this patent.
- The following claims are hereby incorporated into this Detailed Description by this reference, with each claim standing on its own as a separate embodiment of the present disclosure.
Claims (25)
1. A server to distribute first instructions on a network, the server comprising:
at least one storage device including second instructions; and
at least one processor to execute the second instructions to transmit the first instructions over the network, the first instructions, when executed, to cause a mobile device carried by a person to at least:
access a user identification associated with the person;
access, via input on a display of the mobile device from the person, a result of a diagnostic test performed on a sample gathered from the person using a test kit, the test kit to test for an infectious disease;
access one or more images from a camera of the mobile device while the person aligns a test kit code on the test kit in view of the camera, the test kit code being a machine-readable code;
detect and interpret the test kit code from the one or more images to obtain a test kit identification associated with the test kit;
display the result on the display of the mobile device;
generate an interface including the user identification, the test kit identification, and an indicator, the indicator generated in response to the result for the infectious disease being negative;
store the interface in a memory of the mobile device;
determine, at a first time, a first number of days since the diagnostic test;
compare the first number of days to a threshold number of days;
display the interface on the display in response to the first number of days being less than the threshold number of days to enable the person to gain entry into a location;
determine, at a second time, a second number of days since the diagnostic test;
compare the second number of days to the threshold number of days; and
delete the interface in response to the second number of days being greater than the threshold number of days.
2. The server of claim 1 , wherein the result is a first result, the diagnostic test is a first diagnostic test, the interface is a first interface, and the indicator is a first indicator, the first instructions, when executed, cause the mobile device to:
access a second result of a second diagnostic test;
display the second result on the display of the mobile device; and
generate a second interface including a second indicator, the second indicator generated in response to the second result being negative and a number of days since the second diagnostic test being below the threshold number of days.
3. The server of claim 2 , wherein the person is a first person and the second diagnostic test is performed on a second person.
4. The server of claim 1 , wherein the diagnostic test is to detect a presence or an absence of a pathogen and the threshold number of days is based on an incubation period of the pathogen.
5. The server of claim 1 , wherein the diagnostic test is a first diagnostic test, and the first instructions, when executed, cause the mobile device to display a notification to the person to schedule a second diagnostic test based on a current number of days since the diagnostic test and the threshold number of days.
6. The server of claim 1 , wherein the first instructions, when executed, cause the mobile device to inform the person how to collect the sample for the diagnostic test.
7. (canceled)
8. The server of claim 1 , wherein the first instructions, when executed, cause the mobile device to provide a notification for interpretation and entry of the result of the diagnostic test.
9. The server of claim 1 , wherein the first instructions, when executed, enable the person to schedule an appointment to provide the sample for the diagnostic test.
10. The server of claim 1 , wherein the first instructions, when executed, cause the mobile device to electronically connect with a telehealth service provider prior to collection of the sample.
11. At least one non-transitory computer readable medium comprising instructions that, when downloaded to a mobile device and executed, cause a processor of the mobile device to at least:
access, based on input on a display of the mobile device from a person, a result of a diagnostic test performed on a sample gathered from the person using a test kit, the test kit to test for an infectious disease;
access one or more images from a camera of the mobile device while the person aligns a test kit code on the test kit in view of the camera, the test kit code being machine-readable;
detect and interpret the test kit code from the one or more images to obtain a test kit identification (ID) associated with the test kit;
generate a machine-readable code in response to the result being negative, the machine-readable code including at least one of a one-dimensional (1D) machine-readable code or a two-dimensional (2D) machine-readable code, the machine-readable code including a user identification (ID) associated with the person and the test kit (ID); and
display the machine-readable code on a display of the mobile device for communication of the user ID and the test kit ID to an electronic device when the electronic device reads the machine-readable code to enable the person to gain entry into a location.
12. (canceled)
13. The at least one non-transitory computer readable medium of claim 11 , wherein the result is a first result, the diagnostic test is a first diagnostic test, the sample is a first sample, and the machine-readable code is a first machine-readable code, the instructions, when executed, cause the processor of the mobile device to:
access a second result of a second diagnostic test performed on a second sample gathered from the person; and
generate a second machine-readable code in response to the second result being negative.
14. The at least one non-transitory computer readable medium of claim 13 , wherein the first diagnostic test is to detect a presence or an absence of a first analyte of interest, and the second diagnostic test is to detect a presence or an absence of a second analyte of interest, the second analyte of interest different than the first analyte of interest.
15. The at least one non-transitory computer readable medium of claim 13 , wherein the first diagnostic test is to detect a presence or an absence of an analyte of interest, and the second diagnostic test is to detect a presence or an absence of the analyte of interest, the second diagnostic test performed subsequent to the first diagnostic test.
16. The at least one non-transitory computer readable medium of claim 15 , wherein the first diagnostic test is an antigen test and the second diagnostic test is an antibody test.
17. The at least one non-transitory computer readable medium of claim 11 , wherein the instructions, when executed, cause the processor of the mobile device to:
receive a notification of a sequence of diagnostic tests based on at least one of a pathogen incubation period, a pathogen life cycle, or an immune response; and
display the notification of the sequence of diagnostic tests to the person on the display of the mobile device.
18. The at least one non-transitory computer readable medium of claim 11 , wherein the instructions, when executed, cause the processor of the mobile device to electronically connect with a telehealth service provider prior to collection of the sample.
19. The at least one non-transitory computer readable medium of claim 11 , wherein the instructions, when executed, cause the processor of the mobile device to:
inform the person how to collect the sample for the diagnostic test; and
automatically determine the result of the diagnostic test.
20. The at least one non-transitory computer readable medium of claim 11 , wherein the instructions, when executed, cause the processor of the mobile device to:
inform the person how to collect the sample for the diagnostic test; and
provide a notification for interpretation and entry of the result of the diagnostic test into the mobile device.
21. The server of claim 1 , wherein the indicator includes at least one of a one-dimensional (1D) machine-readable code or a two-dimensional (2D) machine-readable code.
22. The server of claim 21 , wherein the at least one of the 1D machine-readable code or the 2D machine-readable code includes a user account identification associated with a user account of the person and the test kit identification.
23. (canceled)
24. The at least one non-transitory computer readable medium of claim 11 , wherein the at least one of the 1D machine-readable code or the 2D machine-readable code is a barcode, a quick response (QR) code, or a data matrix code.
25. The at least one non-transitory computer readable medium of claim 11 , wherein the test kit ID is a unique serial number associated with the test kit.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/068,601 US20220020481A1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
EP21719354.9A EP4183155A1 (en) | 2020-07-20 | 2021-03-22 | Digital pass verification systems and methods |
US18/006,093 US20230298416A1 (en) | 2020-07-20 | 2021-03-22 | Digital pass verification systems and methods |
PCT/US2021/023488 WO2022019963A1 (en) | 2020-07-20 | 2021-03-22 | Digital pass verification systems and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063054170P | 2020-07-20 | 2020-07-20 | |
US202063080391P | 2020-09-18 | 2020-09-18 | |
US17/068,601 US20220020481A1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/068,608 Continuation US10991190B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/068,599 Continuation US10991185B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220020481A1 true US20220020481A1 (en) | 2022-01-20 |
Family
ID=75587430
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/068,608 Active US10991190B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
US17/068,601 Abandoned US20220020481A1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
US17/068,599 Active US10991185B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
US17/208,754 Active US11514737B2 (en) | 2020-07-20 | 2021-03-22 | Digital pass verification systems and methods |
US17/240,644 Active US11514738B2 (en) | 2020-07-20 | 2021-04-26 | Digital pass verification systems and methods |
US17/476,223 Active US11574514B2 (en) | 2020-07-20 | 2021-09-15 | Digital pass verification systems and methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/068,608 Active US10991190B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/068,599 Active US10991185B1 (en) | 2020-07-20 | 2020-10-12 | Digital pass verification systems and methods |
US17/208,754 Active US11514737B2 (en) | 2020-07-20 | 2021-03-22 | Digital pass verification systems and methods |
US17/240,644 Active US11514738B2 (en) | 2020-07-20 | 2021-04-26 | Digital pass verification systems and methods |
US17/476,223 Active US11574514B2 (en) | 2020-07-20 | 2021-09-15 | Digital pass verification systems and methods |
Country Status (1)
Country | Link |
---|---|
US (6) | US10991190B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220176970A1 (en) * | 2020-12-08 | 2022-06-09 | Endera Corporation | Vehicle-based wellness diagnostic platform |
US11514737B2 (en) | 2020-07-20 | 2022-11-29 | Abbott Laboratories | Digital pass verification systems and methods |
US20230057531A1 (en) * | 2021-08-17 | 2023-02-23 | Emed Labs, Llc | Mobile device stands for at-home diagnostics and healthcare |
US11894137B2 (en) | 2021-01-12 | 2024-02-06 | Emed Labs, Llc | Health testing and diagnostics platform |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11423755B2 (en) * | 2017-05-17 | 2022-08-23 | Blue Storm Media, Inc. | System and method for a digital proof of vaccine |
GB201809558D0 (en) * | 2018-06-09 | 2018-07-25 | Smiths Medical International Ltd | Spirometer apparatus |
US20200324998A1 (en) * | 2019-04-11 | 2020-10-15 | Otis Elevator Company | Management of elevator service |
WO2021222908A1 (en) * | 2020-05-01 | 2021-11-04 | Koska Family Limited | Medical injectors and systems and methods for an injection management platform |
DE102020113311A1 (en) * | 2020-05-15 | 2021-11-18 | Bundesdruckerei Gmbh | Method for generating a security document and using the security document and security system |
US20210365445A1 (en) * | 2020-05-25 | 2021-11-25 | Fortior Solutions, Llc | Technologies for collecting, managing, and providing contact tracing information for infectious disease response and mitigation |
USD958819S1 (en) | 2020-07-28 | 2022-07-26 | Abbott Laboratories | Display screen with a graphical user interface |
USD976949S1 (en) | 2020-08-14 | 2023-01-31 | Abbott Laboratories | Display screen with graphical user interface |
US11443856B2 (en) * | 2021-01-03 | 2022-09-13 | Hawaikiki Telehealth, LLC | Health service system |
US11615888B2 (en) | 2021-03-23 | 2023-03-28 | Emed Labs, Llc | Remote diagnostic testing and treatment |
US11929168B2 (en) | 2021-05-24 | 2024-03-12 | Emed Labs, Llc | Systems, devices, and methods for diagnostic aid kit apparatus |
US20220375594A1 (en) * | 2021-05-24 | 2022-11-24 | Emed Labs, Llc | Systems, devices, and methods for diagnostic aid kit apparatus |
US20220375595A1 (en) * | 2021-05-24 | 2022-11-24 | Emed Labs, Llc | Systems, devices, and methods for diagnostic aid kit apparatus |
US11373756B1 (en) | 2021-05-24 | 2022-06-28 | Emed Labs, Llc | Systems, devices, and methods for diagnostic aid kit apparatus |
DE202021103055U1 (en) | 2021-06-07 | 2022-09-08 | Ion Cristea | Test device and test system for performing a self-test and computer program product therefor |
WO2022271668A1 (en) | 2021-06-22 | 2022-12-29 | Emed Labs, Llc | Systems, methods, and devices for non-human readable diagnostic tests |
JP2023021657A (en) * | 2021-08-02 | 2023-02-14 | 東芝テック株式会社 | Security management device |
CN113689601B (en) * | 2021-08-04 | 2023-10-24 | 支付宝(杭州)信息技术有限公司 | Block chain-based pass verification method and device, electronic equipment and storage medium |
US11973639B2 (en) * | 2021-12-27 | 2024-04-30 | Ricoh Company, Ltd. | Information processing system, information processing method, and recording medium |
US11610673B1 (en) | 2022-01-25 | 2023-03-21 | Raul Esteban Rojer Ruiz | Rojer gathering biological index (ROGBIX) system and CyberGath device |
Family Cites Families (826)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3873974A (en) | 1973-10-12 | 1975-03-25 | Geometric Data Corp | Scanning system for location and classification of patterns |
US4380695A (en) | 1976-07-06 | 1983-04-19 | Crutcher Resources Corporation | Control of torch position and travel in automatic welding |
JPS5928332B2 (en) | 1977-02-14 | 1984-07-12 | 三井化学株式会社 | Production method of α-olefin polymer |
US4347568A (en) | 1978-12-07 | 1982-08-31 | Diamond Shamrock Corporation | Occupational health/environmental surveillance |
JPS57189958A (en) | 1981-05-15 | 1982-11-22 | Matsushita Electric Works Ltd | Pushing plate transportation device |
US4835372A (en) | 1985-07-19 | 1989-05-30 | Clincom Incorporated | Patient care system |
US4838275A (en) | 1985-11-29 | 1989-06-13 | Lee Arnold St J | Home medical surveillance system |
US4803625A (en) | 1986-06-30 | 1989-02-07 | Buddy Systems, Inc. | Personal health monitor |
JPS6313738A (en) | 1986-07-04 | 1988-01-21 | 日本鋼管ライトスチール株式会社 | Vibration-damping sound-insulating sheet |
FR2636594B1 (en) | 1988-09-16 | 1990-12-21 | Aerospatiale | MONOCYCLIC STEP CONTROL DEVICE IN FIXED MARK AND MULTICYCLIC STEP IN ROTARY MARK, FOR ROTOR BLADES OF GIRAVIONS |
US5171977A (en) | 1990-05-14 | 1992-12-15 | Sunquest Information Systems, Inc. | Portable medical specimen data collection system |
US5301105A (en) | 1991-04-08 | 1994-04-05 | Desmond D. Cummings | All care health management system |
US5502636A (en) | 1992-01-31 | 1996-03-26 | R.R. Donnelley & Sons Company | Personalized coupon generating and processing system |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
JPH06329627A (en) | 1993-05-03 | 1994-11-29 | Bristol Myers Squibb Co | Guanidyl- or amdinyl-substituted heterocyclic thrombin inhibitor |
EP0684575A4 (en) | 1993-12-14 | 1997-05-14 | Mochida Pharm Co Ltd | Medical measuring apparatus. |
US5660176A (en) | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US5827180A (en) | 1994-11-07 | 1998-10-27 | Lifemasters Supported Selfcare | Method and apparatus for a personal health network |
US5619991A (en) | 1995-04-26 | 1997-04-15 | Lucent Technologies Inc. | Delivery of medical services using electronic data communications |
JPH0947436A (en) | 1995-08-09 | 1997-02-18 | Noboru Akasaka | Home medical system |
AU4407697A (en) | 1996-09-19 | 1998-04-14 | Ortivus Aktiebolag | Portable telemedicin device |
US5841975A (en) | 1996-12-10 | 1998-11-24 | The Regents Of The University Of California | Method and apparatus for globally-accessible automated testing |
US8734339B2 (en) | 1996-12-16 | 2014-05-27 | Ip Holdings, Inc. | Electronic skin patch for real time monitoring of cardiac activity and personal health management |
WO1998029790A2 (en) | 1996-12-30 | 1998-07-09 | Imd Soft Ltd. | Medical information system |
US6032119A (en) | 1997-01-16 | 2000-02-29 | Health Hero Network, Inc. | Personalized display of health information |
US6514461B1 (en) | 1997-02-14 | 2003-02-04 | Escreen, Inc. | System for automatically testing a fluid specimen |
JP2001515620A (en) | 1997-03-07 | 2001-09-18 | インフォメディックス・インコーポレーテッド | Method, apparatus and operating system for real-time monitoring and management of patient health and medical treatment regimen |
US20040157612A1 (en) | 1997-04-25 | 2004-08-12 | Minerva Industries, Inc. | Mobile communication and stethoscope system |
JP2002511965A (en) | 1997-07-14 | 2002-04-16 | アボツト・ラボラトリーズ | Telemedicine |
US6057758A (en) | 1998-05-20 | 2000-05-02 | Hewlett-Packard Company | Handheld clinical terminal |
US7860725B2 (en) | 1998-05-26 | 2010-12-28 | Ineedmd.Com, Inc. | Method for remote medical consultation and care |
TW377046U (en) | 1998-09-09 | 1999-12-11 | Inventec Corp | Electronic device with removable battery support seat for the coin type batteries |
US6602469B1 (en) | 1998-11-09 | 2003-08-05 | Lifestream Technologies, Inc. | Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
US8239627B2 (en) | 2008-05-08 | 2012-08-07 | Lifenexus, Inc. | Smartcard accessed dual server electronic data storage system |
US20110004488A1 (en) | 1998-11-13 | 2011-01-06 | Anuthep Benja-Athon | Server-guidance of health-care I |
IL127373A0 (en) | 1998-12-02 | 1999-10-28 | Lavi Natan | System for attendance registration of service-workers in movement and a personal attendance registration device for use therein |
GB2347503A (en) | 1999-03-05 | 2000-09-06 | Peter Oliver | Intelligent remote sensor for veterinary applications |
TW537880B (en) | 1999-03-11 | 2003-06-21 | Remote Medical Corp | Method for improving patient compliance with a medical program |
US6702988B1 (en) | 1999-04-21 | 2004-03-09 | Peter J. Sagona | Automatic on-site drug testing system and method |
US7315825B2 (en) | 1999-06-23 | 2008-01-01 | Visicu, Inc. | Rules-based patient care system for use in healthcare locations |
US7256708B2 (en) | 1999-06-23 | 2007-08-14 | Visicu, Inc. | Telecommunications network for remote patient monitoring |
KR20020064298A (en) | 1999-10-13 | 2002-08-07 | 시쿼넘, 인코포레이티드 | Methods for generating databases and databases for identifying polymorphic genetic markers |
US7156809B2 (en) | 1999-12-17 | 2007-01-02 | Q-Tec Systems Llc | Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity |
US20010041991A1 (en) | 2000-02-09 | 2001-11-15 | Segal Elliot A. | Method and system for managing patient medical records |
US8577697B2 (en) | 2000-02-28 | 2013-11-05 | Gregory A. Demopulos | Use of internet site as a registry for results of medical tests |
CA2439396A1 (en) | 2000-02-28 | 2001-09-07 | Gregory Demopulos | Use of internet site as a registry for results of medical tests |
FR2806561B1 (en) | 2000-03-16 | 2002-08-09 | France Telecom | HOME TELE ASSISTANCE SYSTEM |
KR100342073B1 (en) | 2000-03-29 | 2002-07-02 | 조중열 | Method of Fabricating Semiconductor Device |
US20020026331A1 (en) | 2000-03-31 | 2002-02-28 | Robert Case | System and method for providing a server-based wireless communication of medical test requests and results |
US20030036683A1 (en) | 2000-05-01 | 2003-02-20 | Kehr Bruce A. | Method, system and computer program product for internet-enabled, patient monitoring system |
US7599847B2 (en) | 2000-06-09 | 2009-10-06 | Airport America | Automated internet based interactive travel planning and management system |
US20020013519A1 (en) | 2000-06-14 | 2002-01-31 | Scott Adams | Secure test and test result delivery system |
US6944767B1 (en) | 2000-07-07 | 2005-09-13 | Genaissance Pharmaceuticals, Inc. | Methods and apparatus for ensuring the privacy and security of personal medical information |
US8043224B2 (en) | 2000-07-12 | 2011-10-25 | Dimicine Research It, Llc | Telemedicine system |
WO2002007064A2 (en) | 2000-07-17 | 2002-01-24 | Labnetics, Inc. | Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities |
AU2001273373A1 (en) | 2000-07-18 | 2002-01-30 | Centralized Laboratory Services, Inc. | Personal health card cd |
US7783500B2 (en) | 2000-07-19 | 2010-08-24 | Ijet International, Inc. | Personnel risk management system and methods |
US6454709B1 (en) | 2000-08-29 | 2002-09-24 | Peter Kleinschmidt | Tele-evaluation system, especially for medicine |
US20020099572A1 (en) | 2000-09-26 | 2002-07-25 | Dyckman John D. | Communication system for delivering sterilization test results to customers |
US10776804B2 (en) | 2001-04-06 | 2020-09-15 | Cuesol, Inc. | Methods and systems for providing personalized information to users in a commercial establishment |
CA2342977A1 (en) | 2001-04-09 | 2002-10-09 | Jaswinder Gill | Internet based medical data handling, processing, securing and providing controlled access |
US20030196097A1 (en) * | 2001-09-19 | 2003-10-16 | Korosec Jason A. | System and method for airport security employing identity validation |
CA2465531A1 (en) | 2001-11-02 | 2003-05-15 | R. Bharat Rao | Patient data mining for clinical trials |
US20040225527A1 (en) | 2001-11-05 | 2004-11-11 | Holz Siegfried K. | Prescription fulfillment system and method |
US8234222B2 (en) | 2001-12-20 | 2012-07-31 | Benefit Resource, Inc. | Benefit management system and method |
US20030217037A1 (en) | 2002-01-22 | 2003-11-20 | Uwe Bicker | Method and system for anonymous test administration and user-enabled personal health risk assessment |
US20040010425A1 (en) | 2002-01-29 | 2004-01-15 | Wilkes Gordon J. | System and method for integrating clinical documentation with the point of care treatment of a patient |
JP4355124B2 (en) | 2002-01-31 | 2009-10-28 | インターナショナル・ビジネス・マシーンズ・コーポレーション | Entrance / exit management system, entrance / exit management method, program for executing entrance / exit management, and recording medium recording the program |
CA2480202A1 (en) | 2002-04-10 | 2003-10-23 | Transtech Pharma, Inc. | System and method for data analysis, manipulation, and visualization |
US7908155B2 (en) | 2002-04-12 | 2011-03-15 | Becton, Dickinson And Company | System for collecting, storing, presenting and analyzing immunization data having remote stations in communication with a vaccine and disease database over a network |
DE60321826D1 (en) | 2002-04-22 | 2008-08-07 | Medtronic Inc | SEAMLESS COMMUNICATION BETWEEN AN IMPLANTABLE MEDICAL DEVICE AND A REMOTE SYSTEM |
US7993266B2 (en) | 2002-04-26 | 2011-08-09 | Lawrence Livermore National Security, Llc | Early detection of contagious diseases |
EP1512102A4 (en) | 2002-05-15 | 2010-03-17 | Us Gov Sec Army | System and method for handling medical information |
AU2002315871A1 (en) | 2002-06-24 | 2004-01-06 | Moss Institute Co., Ltd. | Test result management system, test processor, test result management method, and program |
JP4076386B2 (en) | 2002-07-18 | 2008-04-16 | 帝人株式会社 | Medical remote information system, information processing method, computer program, recording medium for computer program, telemedicine system |
US10607732B2 (en) | 2002-10-01 | 2020-03-31 | Zhou Tian Xing | Wearable digital device for personal health use for saliva, urine, and blood testing and mobile wrist watch powered by user body |
US9811818B1 (en) | 2002-10-01 | 2017-11-07 | World Award Academy, World Award Foundation, Amobilepay, Inc. | Wearable personal digital device for facilitating mobile device payments and personal use |
DE10248682A1 (en) | 2002-10-18 | 2004-05-13 | T-Mobile Deutschland Gmbh | Portable diagnostic device and associated method for transferring the diagnostic data |
WO2004042596A1 (en) | 2002-11-07 | 2004-05-21 | Alcidion Corporation Pty Ltd | Clinical risk management system and method |
US20040100376A1 (en) | 2002-11-26 | 2004-05-27 | Kimberly-Clark Worldwide, Inc. | Healthcare monitoring system |
US20040166550A1 (en) | 2003-02-25 | 2004-08-26 | Sullivan Brian M. | Bio-gateway |
TW560437U (en) | 2003-02-27 | 2003-11-01 | Chandleada Technology Co Ltd | Improved conveying roller structure for screen printing machine |
US20060288253A1 (en) | 2003-06-18 | 2006-12-21 | Tatsurou Kawamura | Biological information utilization system, biological information utilization method, program and recording medium |
US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US20050060174A1 (en) | 2003-09-15 | 2005-03-17 | Heyward Salome M. | Absence management systems and methods |
US20050075543A1 (en) | 2003-10-03 | 2005-04-07 | Calabrese Charles A. | Method of anonymous medical testing and providing the patient with the test results |
GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
KR100514036B1 (en) | 2003-12-31 | 2005-09-08 | (주)프로톤소프트 | An electronic medical treatment card and a medical service method using the card |
US8147426B2 (en) | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
CA2597224C (en) | 2004-02-11 | 2013-12-24 | Cstar Technologies Inc. | Method and apparatus for cataloguing and poling movement in an environment for purposes of tracking and/or containment of infectious diseases |
US20060154642A1 (en) | 2004-02-20 | 2006-07-13 | Scannell Robert F Jr | Medication & health, environmental, and security monitoring, alert, intervention, information and network system with associated and supporting apparatuses |
CN1667418B (en) | 2004-03-10 | 2010-10-06 | 马杰 | Multifunctional portable unit for measurement, analysis and diagnosis |
EP1575010A1 (en) | 2004-03-12 | 2005-09-14 | Eugenio Ruiz-Morales Fadrique | Detector and people-monitoring device for the provision of tele-assistance |
US8128871B2 (en) | 2005-04-22 | 2012-03-06 | Alverix, Inc. | Lateral flow assay systems and methods |
WO2005104933A1 (en) | 2004-04-28 | 2005-11-10 | Arkray, Inc. | Data processing device, measurement device, and data collection method |
JP2005315802A (en) | 2004-04-30 | 2005-11-10 | Olympus Corp | User support device |
US20050277872A1 (en) | 2004-05-24 | 2005-12-15 | Colby John E Jr | Apparatus and method for mobile medical services |
CA2468483A1 (en) | 2004-05-28 | 2005-11-28 | Gaston Sylvain | Mobile level i to iii laboratory intended for the identification of biochemical agents |
US20060031101A1 (en) | 2004-06-30 | 2006-02-09 | Ross S M | Bi-directional messaging in health care |
US20060036619A1 (en) | 2004-08-09 | 2006-02-16 | Oren Fuerst | Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs |
KR100700219B1 (en) | 2004-08-13 | 2007-03-27 | 주식회사 메디컬익스프레스 | Method For Managing A Consultation Schedule Of A Dialysis Patient |
CA2584466A1 (en) | 2004-10-18 | 2006-04-27 | Bioveris Corporation | Systems and methods for obtaining, storing, processing and utilizing immunologic information of an individual or population |
US7097108B2 (en) | 2004-10-28 | 2006-08-29 | Bellsouth Intellectual Property Corporation | Multiple function electronic cards |
US20060094028A1 (en) | 2004-11-04 | 2006-05-04 | Welch Allyn, Inc. | Rapid diagnostic assay |
US7278579B2 (en) | 2004-11-12 | 2007-10-09 | Siemens Medical Solutions Usa, Inc. | Patient information management system |
US20060106646A1 (en) | 2004-11-18 | 2006-05-18 | Eastman Kodak Company | Medical kiosk with multiple input sources |
US20060165040A1 (en) | 2004-11-30 | 2006-07-27 | Rathod Yogesh C | System, method, computer program products, standards, SOA infrastructure, search algorithm and a business method thereof for AI enabled information communication and computation (ICC) framework (NetAlter) operated by NetAlter Operating System (NOS) in terms of NetAlter Service Browser (NSB) to device alternative to internet and enterprise & social communication framework engrossing universally distributed grid supercomputing and peer to peer framework |
US8255238B2 (en) | 2005-01-03 | 2012-08-28 | Airstrip Ip Holdings, Llc | System and method for real time viewing of critical patient data on mobile devices |
US8306831B2 (en) | 2005-01-10 | 2012-11-06 | International Business Machines Corporation | Systems with message integration for data exchange, collection, monitoring and/or alerting |
CN100361133C (en) | 2005-01-19 | 2008-01-09 | 陈燕 | Automatic recognition system for blood center |
DE102005006024A1 (en) | 2005-02-08 | 2006-10-05 | Deutsche Telekom Ag | Device for monitoring vital signs frail |
DE102005010094A1 (en) | 2005-03-04 | 2006-09-07 | Siemens Ag | Medical plant e.g. for examinations measurements with mobile medical instruments, has medical instrument mobile execution of medical measurement between mobile medical instrument receiving station data is electronically exchanged |
US20060252999A1 (en) | 2005-05-03 | 2006-11-09 | Devaul Richard W | Method and system for wearable vital signs and physiology, activity, and environmental monitoring |
WO2006123253A2 (en) | 2005-03-29 | 2006-11-23 | Inverness Medical Switzerland Gmbh | Device and method of monitoring a patient |
PL3026874T3 (en) | 2005-04-01 | 2020-05-18 | Polymer Technology Systems, Inc. | Body fluid testing component for analyte detection |
US20070004969A1 (en) | 2005-06-29 | 2007-01-04 | Microsoft Corporation | Health monitor |
US20070002791A1 (en) | 2005-07-01 | 2007-01-04 | Kasprzyk Marlon Z | Medical monitoring data collection and remote control module and method |
US9390458B2 (en) * | 2005-08-12 | 2016-07-12 | Pharma-Smart International, Inc. | Network for health management and mobile device controlled access |
US7565132B2 (en) | 2005-08-17 | 2009-07-21 | Mourad Ben Ayed | Portable health monitoring system |
US20070078682A1 (en) | 2005-09-30 | 2007-04-05 | John Zubak | Electronic healthcare identification and reconciliation |
US7733224B2 (en) | 2006-06-30 | 2010-06-08 | Bao Tran | Mesh network personal emergency response appliance |
US20070092871A1 (en) | 2005-10-20 | 2007-04-26 | Combimatrix Corporation | Microarray for pathogen identification |
SG180041A1 (en) | 2005-10-24 | 2012-05-30 | Manawatu Biotech Invest Ltd | Ovulation cycle monitoring and management |
US20160321480A1 (en) | 2005-12-09 | 2016-11-03 | Tego, Inc. | Methods and systems for rf communications in blood-extraction procedures |
US8852916B2 (en) | 2010-01-22 | 2014-10-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with microorganisms |
US7520419B2 (en) | 2005-12-21 | 2009-04-21 | Bml Medrecordsalert Llc | Method for transmitting medical information identified by a unique identifier |
US7324918B1 (en) | 2005-12-30 | 2008-01-29 | At&T Corp | Forecasting outcomes based on analysis of text strings |
US20070156456A1 (en) | 2006-01-04 | 2007-07-05 | Siemens Medical Solutions Health Services Corporation | System for Monitoring Healthcare Related Activity In A Healthcare Enterprise |
US20070179810A1 (en) | 2006-01-05 | 2007-08-02 | Goodman Edward L | Controls for antimicrobial use and infection |
CN100444788C (en) | 2006-01-17 | 2008-12-24 | 山东优加利信息科技有限公司 | Remote mobile electrophysiological data monitoring method and apparatus based on WAN |
JP2007200107A (en) | 2006-01-27 | 2007-08-09 | Shigeo Nishifuji | Infectious disease information disclosure system |
CA2571904A1 (en) | 2006-02-15 | 2007-08-15 | Fio Corporation | System and method of detecting pathogens |
US20070211965A1 (en) | 2006-03-07 | 2007-09-13 | Helbing Rene P | Hand-held diagnostic systems and methods of use thereof |
US7705723B2 (en) | 2006-03-15 | 2010-04-27 | Dp Technologies, Inc. | Method and apparatus to provide outbreak notifications based on historical location data |
US7811824B2 (en) | 2006-03-30 | 2010-10-12 | Randox Laboratories Limited | Method and apparatus for monitoring the properties of a biological or chemical sample |
US20070239487A1 (en) | 2006-03-30 | 2007-10-11 | Klaus Abraham-Fuchs | Electronic health card and method of promoting the use of the electronic health card |
US20120035439A1 (en) | 2006-04-12 | 2012-02-09 | Bran Ferren | Map-based navigation of a body tube tree by a lumen traveling device |
WO2007120904A2 (en) | 2006-04-14 | 2007-10-25 | Fuzzmed, Inc. | System, method, and device for personal medical care, intelligent analysis, and diagnosis |
US7977103B2 (en) | 2006-04-20 | 2011-07-12 | Kimberly-Clark Worldwide, Inc. | Method for detecting the onset of ovulation |
US9060683B2 (en) | 2006-05-12 | 2015-06-23 | Bao Tran | Mobile wireless appliance |
US20070276702A1 (en) | 2006-05-25 | 2007-11-29 | Sandeep Dani | System and Method for Collaboration and Communication in Health Management |
WO2008001348A2 (en) | 2006-06-26 | 2008-01-03 | Ben-Gurion University Of The Negev Research And Development Authority | Method for estimating the strength of bodies and structures |
WO2008013553A2 (en) | 2006-07-25 | 2008-01-31 | Northrop Grumman Corporation | Global disease surveillance platform, and corresponding system and method |
CN101129257A (en) | 2006-08-23 | 2008-02-27 | 沈渊瑶 | Application system for remote medical diagnosis by using mobile communication equipment |
US7625763B2 (en) | 2006-09-11 | 2009-12-01 | Alverix, Inc. | Rapid diagnostic test systems and methods |
US7809816B2 (en) | 2006-09-19 | 2010-10-05 | At&T Intellectual Property I, L.P. | Imaging viewer systems and methods |
WO2008147382A1 (en) | 2006-09-27 | 2008-12-04 | Micronics, Inc. | Integrated microfluidic assay devices and methods |
US8684923B2 (en) | 2006-10-17 | 2014-04-01 | At&T Intellectual Property I, Lp | Methods systems, and computer program products for aggregating medical information |
CN101578520B (en) | 2006-10-18 | 2015-09-16 | 哈佛学院院长等 | Based on formed pattern porous medium cross flow and through biometric apparatus, and preparation method thereof and using method |
ITRM20060672A1 (en) | 2006-12-13 | 2008-06-14 | Biochemical Systems Internat S R L | TELEMATIC SYSTEM FOR THE USE OF REACTIVE DIAGNOSTIC STRIPS AND METHOD OF ACQUISITION CALIBRATION DATA. |
US7908153B2 (en) | 2006-12-15 | 2011-03-15 | Siemens Medical Solutions Usa, Inc. | Infection control management and workflow system |
US8930178B2 (en) | 2007-01-04 | 2015-01-06 | Children's Hospital Medical Center | Processing text with domain-specific spreading activation methods |
WO2008101732A1 (en) | 2007-02-23 | 2008-08-28 | Ese Embedded System Engineering Gmbh | Optical measuring instrument |
TW200835465A (en) | 2007-02-26 | 2008-09-01 | Zu-Wang Shen | Biological certification with cardiovascular health management function and apparatus for detecting death-causing type arrhythmia and method thereof |
US20170023542A1 (en) | 2015-07-26 | 2017-01-26 | Naishu Wang | Smartphone dock and diagnostic-test reader plus related methods |
BRPI0809174A2 (en) | 2007-04-02 | 2014-09-16 | Kamran Khan | "SYSTEM AND METHOD FOR PREDICTING THE TRANSMISSION OF AN INFECTIOUS AGENT THROUGH AIR TRAVEL" |
US8597190B2 (en) | 2007-05-18 | 2013-12-03 | Optiscan Biomedical Corporation | Monitoring systems and methods with fast initialization |
US20100255795A1 (en) | 2007-06-18 | 2010-10-07 | The Regents Of The University Of California | Cellular Phone Enabled Medical Imaging System |
DE08780145T1 (en) | 2007-07-11 | 2011-04-28 | Gr Intellectual Reserve, Llc | CONTINUOUS METHODS OF TREATING LIQUIDS AND PREPARING CERTAIN INGREDIENTS (eg, NANOPARTICLES) IN LIQUIDS, APPARATUS, AND NANOPARTICLE AND NANOPARTICLE / LIQUID SOLVENT THEREWITH |
US9186677B2 (en) | 2007-07-13 | 2015-11-17 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
CN101809577B (en) | 2007-07-23 | 2013-04-17 | Fio公司 | A method and system for collating, storing, analyzing and enabling access to collected and analyzed data associated with biological and environmental test subjects |
JP2009031887A (en) | 2007-07-25 | 2009-02-12 | Yokogawa Electric Corp | Infection information management system |
AU2008317533A1 (en) | 2007-10-22 | 2009-04-30 | Idoc24 Ab | Telemedicine care |
US20110090086A1 (en) | 2007-10-22 | 2011-04-21 | Kent Dicks | Systems for personal emergency intervention |
TWI377046B (en) | 2007-10-31 | 2012-11-21 | Netown Corp | A telemedicine device and system |
CN103033922A (en) | 2008-01-02 | 2013-04-10 | 加利福尼亚大学董事会 | High numerical aperture telemicroscopy apparatus |
CA2745107A1 (en) | 2008-01-08 | 2009-07-16 | Forwarding Software Limited | Mobile digital format |
US8881040B2 (en) | 2008-08-28 | 2014-11-04 | Georgetown University | System and method for detecting, collecting, analyzing, and communicating event-related information |
KR101573212B1 (en) | 2008-03-04 | 2015-12-02 | 삼성전자주식회사 | Remote medical diagnosis device including bio-mouse and bio-keyboard, and method using the same |
US8423385B2 (en) | 2008-04-14 | 2013-04-16 | Clipboardmd, Inc. | Electronic patient registration verification and payment system and method |
EP2291640B1 (en) | 2008-05-20 | 2018-12-26 | University Health Network | Device and method for fluorescence-based imaging and monitoring |
IL193440A (en) | 2008-08-13 | 2015-01-29 | Verint Systems Ltd | System and method for boarding area security |
KR100955002B1 (en) | 2008-10-14 | 2010-04-27 | 주식회사 솔라시아 | System of providing health management using smart card web server and method therof |
EP2382568A2 (en) | 2008-12-23 | 2011-11-02 | Roche Diagnostics GmbH | Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof |
US20100169220A1 (en) | 2008-12-31 | 2010-07-01 | Microsoft Corporation | Wearing health on your sleeve |
EP2387721A4 (en) | 2009-01-13 | 2014-05-14 | Fio Corp | A handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test |
JP2010190867A (en) | 2009-02-20 | 2010-09-02 | Chikafumi Teramoto | Remote diagnosis method |
US20100268057A1 (en) | 2009-03-10 | 2010-10-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods for health services planning and matching |
US9844333B2 (en) | 2009-03-24 | 2017-12-19 | International Business Machines Corporation | Remote delivery and monitoring of health care |
KR20100109383A (en) | 2009-03-30 | 2010-10-08 | 삼성전자주식회사 | Internet phone apparatus including biological analysis device, and a remote medical-service method using the same |
US8392917B2 (en) | 2009-03-30 | 2013-03-05 | Microsoft Corporation | Timer access from user mode through a shared memory page |
AU2010232407B2 (en) | 2009-04-03 | 2014-10-30 | Intrapace, Inc. | Feedback systems and methods to enhance obstructive and other obesity treatments |
WO2010118124A2 (en) | 2009-04-07 | 2010-10-14 | Reveal Sciences, Llc | Device, method, and apparatus for biological testing with a mobile device |
US20110172550A1 (en) | 2009-07-21 | 2011-07-14 | Michael Scott Martin | Uspa: systems and methods for ems device communication interface |
JP2011065540A (en) | 2009-09-18 | 2011-03-31 | Hitachi Solutions Ltd | Pandemic-responding health management system |
US20110084132A1 (en) | 2009-10-08 | 2011-04-14 | At&T Intellectual Property I, L.P. | Devices, Systems and Methods for Secure Remote Medical Diagnostics |
WO2011047200A2 (en) | 2009-10-14 | 2011-04-21 | Great Connection, Inc. | Systems and methods for converting and delivering medical images to mobile devices and remote communications systems |
MX2012004620A (en) | 2009-10-19 | 2012-06-25 | Theranos Inc | Integrated health data capture and analysis system. |
US9161716B2 (en) | 2009-10-27 | 2015-10-20 | N.E. Solutionz, Llc | Diagnostic imaging system for skin and affliction assessment |
WO2011060388A1 (en) | 2009-11-13 | 2011-05-19 | Zoll Medical Corporation | Community-based response system |
US9653002B2 (en) | 2009-11-19 | 2017-05-16 | The Cleveland Clinic Foundation | System and method for motor and cognitive analysis |
US20110137210A1 (en) | 2009-12-08 | 2011-06-09 | Johnson Marie A | Systems and methods for detecting cardiovascular disease |
US9974485B2 (en) | 2009-12-11 | 2018-05-22 | Verizon Patent And Licensing Inc. | Method and system for providing remote healthcare services |
US9558520B2 (en) | 2009-12-31 | 2017-01-31 | Hartford Fire Insurance Company | System and method for geocoded insurance processing using mobile devices |
US8821810B2 (en) | 2010-02-03 | 2014-09-02 | President And Fellows Of Harvard College | Devices and methods for multiplexed assays |
US8896715B2 (en) | 2010-02-11 | 2014-11-25 | Microsoft Corporation | Generic platform video image stabilization |
US8423435B1 (en) | 2010-02-26 | 2013-04-16 | Intuit Inc. | Payroll withholding for debt management |
CA2698078A1 (en) | 2010-03-26 | 2011-09-26 | Applied Technology Holdings, Inc. | Apparatus, systems and methods for gathering and processing biometric and biomechanical data |
WO2011140032A1 (en) | 2010-05-03 | 2011-11-10 | AMD Global Telemedicine, Inc. | Remote healthcare data-gathering and viewing system and method |
US20110301439A1 (en) | 2010-06-08 | 2011-12-08 | AliveUSA LLC | Wireless, ultrasonic personal health monitoring system |
JP2012002435A (en) | 2010-06-17 | 2012-01-05 | Panasonic Corp | Indoor unit of air conditioner |
US8527209B2 (en) | 2010-06-24 | 2013-09-03 | The Invention Science Fund I, Llc | Rejuvenation or preservation of germ cells |
CN102959569A (en) | 2010-06-30 | 2013-03-06 | 株式会社尼康 | Infection spread prevention support system, infection spread prevention support server, examination terminal, mobile terminal and program |
US10629311B2 (en) | 2010-07-30 | 2020-04-21 | Fawzi Shaya | System, method and apparatus for real-time access to networked radiology data |
US20120035279A1 (en) | 2010-08-06 | 2012-02-09 | Miller Jeffrey E | Protocol for screening travelers |
CN103026341A (en) | 2010-08-16 | 2013-04-03 | 西门子医疗保健诊断公司 | Method and device for optical alert recognition |
KR101164940B1 (en) | 2010-08-17 | 2012-07-12 | 어니컴 주식회사 | Medical caring system for pregnants and method of using the same |
GB2483482A (en) | 2010-09-09 | 2012-03-14 | Univ Dublin City | An optical testing system |
CN102539735A (en) | 2010-11-12 | 2012-07-04 | 美艾利尔圣地亚哥有限公司 | Test device and system with integrated quality assurance label |
CA2818171A1 (en) | 2010-11-24 | 2012-06-07 | Elan Pharmaceuticals, Inc. | Phagocytic activity as a marker of synucleinopathic disease |
US8651383B2 (en) | 2010-12-01 | 2014-02-18 | Lumidigm, Inc. | Data transmission to optical terminals |
WO2012081006A1 (en) | 2010-12-15 | 2012-06-21 | Michal Lev | System and method for analyzing and controlling epidemics |
CN102157023B (en) | 2011-01-13 | 2012-12-26 | 中华人民共和国深圳出入境检验检疫局 | Information system for self-help declaring and supervising of entry/exit passengers |
WO2012096749A2 (en) | 2011-01-14 | 2012-07-19 | Flash Seats, Llc | Mobile application bar code identification method and system |
US8798527B2 (en) | 2011-01-14 | 2014-08-05 | Covidien Lp | Wireless relay module for remote monitoring systems |
US9251685B2 (en) | 2011-02-17 | 2016-02-02 | International Business Machines Corporation | System and method for medical diagnosis using geospatial location data integrated with biomedical sensor information |
CA2829256C (en) | 2011-03-09 | 2022-05-03 | Humetrix.Com, Inc. | Mobile device-based system for automated, real time health record exchange |
US20140330579A1 (en) | 2011-03-31 | 2014-11-06 | Healthspot, Inc. | Medical Kiosk and Method of Use |
GB201105474D0 (en) | 2011-03-31 | 2011-05-18 | Albagaia Ltd | Testing apparatus |
US20120253847A1 (en) | 2011-03-31 | 2012-10-04 | General Electric Company | Health information telecommunications system and method |
US20120265702A1 (en) | 2011-04-13 | 2012-10-18 | GlobalVetLINK,LC | System And Method For Storing And Presenting Animal Certification Information |
US20120284046A1 (en) | 2011-05-06 | 2012-11-08 | Searete Llc | Computer program product for reporting a result of an evaluation of a sample after queuing the result for transmission |
US20120284047A1 (en) | 2011-05-06 | 2012-11-08 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for receiving a notification of a benefit after queuing the result of an evaluation of a sample for transmission |
EP2705373A4 (en) | 2011-05-06 | 2014-10-22 | Searete Llc | Sample evaluation result reporting after queuing the result for transmission |
US9907707B2 (en) | 2011-06-03 | 2018-03-06 | The Procter & Gamble Company | Sensor systems comprising auxiliary articles |
US10108783B2 (en) | 2011-07-05 | 2018-10-23 | Saudi Arabian Oil Company | Systems, computer medium and computer-implemented methods for monitoring health of employees using mobile devices |
US9526455B2 (en) | 2011-07-05 | 2016-12-27 | Saudi Arabian Oil Company | Systems, computer medium and computer-implemented methods for monitoring and improving health and productivity of employees |
WO2013004706A1 (en) | 2011-07-06 | 2013-01-10 | Quentiq AG | System and method for personal stress analysis |
WO2013010178A1 (en) | 2011-07-14 | 2013-01-17 | Brigham And Women's Hospital, Inc. | System and method for integration of mobile device imaging with microchip elisa |
US8737971B2 (en) | 2011-07-17 | 2014-05-27 | Pieter Van Rooyen | Universal personal diagnostics platform |
WO2013026999A1 (en) | 2011-08-19 | 2013-02-28 | Pulse Innovate Ltd | A wound management system |
US8899478B2 (en) | 2011-09-01 | 2014-12-02 | General Electric Company | System and method for medical data transfer |
US9715579B2 (en) | 2011-09-09 | 2017-07-25 | Alverix, Inc. | Distributed network of in-vitro diagnostic devices |
US9524372B2 (en) | 2011-09-09 | 2016-12-20 | Alverix, Inc. | In-vitro diagnostic device using external information in conjunction with test results |
US8889424B2 (en) | 2011-09-13 | 2014-11-18 | Joel R. L. Ehrenkranz | Device and method for performing a diagnostic test |
US8380541B1 (en) | 2011-09-25 | 2013-02-19 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US9485345B2 (en) | 2011-09-21 | 2016-11-01 | University Of North Texas | 911 services and vital sign measurement utilizing mobile phone sensors and applications |
US9076142B2 (en) | 2011-09-22 | 2015-07-07 | Marsiste ADOLPHE | Smart electronic wallet or smart e-wallet |
CN103946364B (en) | 2011-09-25 | 2018-04-24 | 赛拉诺斯知识产权有限责任公司 | System and method for multiple analysis |
US20140335505A1 (en) | 2011-09-25 | 2014-11-13 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US8485439B2 (en) | 2011-10-11 | 2013-07-16 | Solomon Systems, Inc. | System for providing identification and information, and for scheduling alerts |
US20140257058A1 (en) | 2011-10-19 | 2014-09-11 | Scanadu Incorporated | Automated personal medical diagnostic system, method, and arrangement |
KR20130047776A (en) | 2011-10-20 | 2013-05-09 | 이재천 | Stand alone domain each construction web site with auto maker and using it for the group system |
CN103091486B9 (en) | 2011-11-01 | 2017-08-04 | 成都领御生物技术有限公司 | Test strip detection system |
US20130116526A1 (en) | 2011-11-09 | 2013-05-09 | Telcare, Inc. | Handheld Blood Glucose Monitoring Device with Messaging Capability |
US20140295472A1 (en) | 2011-11-10 | 2014-10-02 | The Administrators Of The Tulane Educational Fund | Paper Based Diagnostic Test |
US8211715B1 (en) | 2011-11-15 | 2012-07-03 | Harrogate Holdings, Ltd. Co. | Consumer food testing device providing remote monitoring |
CN104303212B (en) | 2011-11-20 | 2016-08-24 | Fio公司 | Quality control pick-up method, system and equipment for biology/environment quick diagnosis test equipment |
US20200098461A1 (en) | 2011-11-23 | 2020-03-26 | Remedev, Inc. | Remotely-executed medical diagnosis and therapy including emergency automation |
SE536430C2 (en) | 2011-11-23 | 2013-10-29 | Calmark Sweden Ab | Test system arrangement and method of testing |
SG191435A1 (en) | 2011-12-13 | 2013-07-31 | Smart Communications Inc | System and method for transmitting partograph information and analysing the same |
GB2497750B (en) | 2011-12-19 | 2015-02-25 | Lumophore Ltd | Analysis of colorimetric or fluorometric test assays |
WO2013096745A2 (en) | 2011-12-21 | 2013-06-27 | Laboratory Corporation Of America Holdings | Systems, methods, and media for laboratory testing services |
US10586617B1 (en) | 2012-01-10 | 2020-03-10 | Cerner Innovation, Inc. | Decision support tool for managing autoimmune inflammatory disease |
WO2013112755A1 (en) | 2012-01-24 | 2013-08-01 | The Trustees Of Columbia University In The City Of New York | Field optimized assay devices, methods, and systems |
US9083546B2 (en) | 2012-01-31 | 2015-07-14 | Rajendra Padma Sadhu | System and method for communicating health parameters of an occupant in an automobile and a dynamic operation of the automobile and home automation |
WO2013119266A1 (en) | 2012-02-06 | 2013-08-15 | The Regents Of The University Of California | Portable rapid diagnostic test reader |
US10152702B2 (en) | 2012-02-07 | 2018-12-11 | Michael Ingber | Apparatus and methods for analyzing a medical condition |
US10394776B2 (en) | 2012-02-13 | 2019-08-27 | Bluedot Inc. | Warning system for infectious diseases and method therefor |
TWI556116B (en) | 2012-02-15 | 2016-11-01 | Hitachi Maxell | Skin condition analysis and analysis information management system, skin condition analysis and analysis information management method, and data management server |
TW201400813A (en) | 2012-02-17 | 2014-01-01 | Vitrum Diagnostics Inc | Informative diagnostic kit and device for immunochromatographic detection |
US8755580B2 (en) | 2012-03-17 | 2014-06-17 | Sony Corporation | Flourescent dot counting in digital pathology images |
DE102012102918A1 (en) | 2012-04-03 | 2013-10-10 | Eppendorf Ag | Laboratory device system and laboratory device for treating fluids and solids, and method for operating a laboratory device |
WO2013155002A1 (en) | 2012-04-09 | 2013-10-17 | Richard Franz | Wireless telemedicine system |
US20200340988A1 (en) | 2019-04-26 | 2020-10-29 | Joel R.L. Ehrenkranz | Device for performing an enzyme-based diagnostic test and methods for use thereof |
US10132802B2 (en) | 2012-04-17 | 2018-11-20 | i-calQ, LLC | Device for performing a diagnostic test and methods for use thereof |
US9041530B2 (en) | 2012-04-18 | 2015-05-26 | Qualcomm Incorporated | Biometric attribute anomaly detection system with adjusting notifications |
CN204428014U (en) | 2012-04-19 | 2015-07-01 | 尼尔·拉兹 | Be convenient to the medical examination apparatus carrying out long-range inspection |
EP2841938A4 (en) | 2012-04-25 | 2015-12-02 | Compliance Software Inc | Capturing and processing instant drug test results using a mobile device |
US9597016B2 (en) | 2012-04-27 | 2017-03-21 | The Curators Of The University Of Missouri | Activity analysis, fall detection and risk assessment systems and methods |
TWI591554B (en) | 2012-05-28 | 2017-07-11 | Chunghwa Telecom Co Ltd | Electronic ticket security system and method |
US20180358117A1 (en) | 2012-06-04 | 2018-12-13 | Pharmalto, Llc | System and Method for Personal Health Information Exchange |
CA2875364A1 (en) | 2012-06-05 | 2013-12-12 | Dairy Quality Inc. | Biological fluid analysis system and method |
US9766382B2 (en) | 2012-06-05 | 2017-09-19 | Hypermed Imaging, Inc. | Single-sensor hyperspectral imaging device |
US20140006051A1 (en) | 2012-06-27 | 2014-01-02 | Microsoft Corporation | Emergency medical profiles |
US9217706B2 (en) | 2012-06-28 | 2015-12-22 | Quick Llc | Mobile smart device infrared light measuring apparatus, πmethod, and system for analyzing substances |
US20150132835A1 (en) | 2012-07-02 | 2015-05-14 | 3Pdx, Llc | Devices, systems, and methods for diagnostic testing |
US20140012599A1 (en) | 2012-07-05 | 2014-01-09 | Sheldon G. Weiss | System and Method for Storing Health Information and Adjudicating Insurance Claims |
US20140012117A1 (en) | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
JP6004799B2 (en) | 2012-07-10 | 2016-10-12 | キヤノン株式会社 | Developer container and image forming apparatus |
US20140017643A1 (en) | 2012-07-16 | 2014-01-16 | Brian Sady | Software & cellphone use to analyze medical and psychological conditions |
EP2877838B1 (en) | 2012-07-24 | 2020-11-11 | Fio Corporation | Immunoassay rapid diagnostic test universal analysis device, system, method and computer readable medium |
US20160300021A1 (en) | 2012-07-26 | 2016-10-13 | Verlin L. Abbott | Secured mobile emergency personal medical information system |
AU2013296293A1 (en) | 2012-08-01 | 2015-03-05 | Yofimeter, Llc | User interface for analyte monitoring systems |
WO2014022717A1 (en) | 2012-08-01 | 2014-02-06 | The United States Of America As Represented By The Department Of Veterans Affairs | Methods for organizing the disinfection of one or more items contaminated with biological agents |
US9310300B2 (en) | 2012-08-03 | 2016-04-12 | Ingeneron Incorporated | Compact portable apparatus for optical assay |
US10276260B2 (en) | 2012-08-16 | 2019-04-30 | Ginger.io, Inc. | Method for providing therapy to an individual |
US9241663B2 (en) | 2012-09-05 | 2016-01-26 | Jana Care Inc. | Portable medical diagnostic systems and methods using a mobile device |
US8712020B2 (en) | 2012-09-06 | 2014-04-29 | Jeffrey J. Clawson | Pandemic protocol for emergency dispatch |
US9686395B2 (en) | 2012-09-11 | 2017-06-20 | Cornell University | Apparatus and method for point-of-collection measurement of a biomolecular reaction |
US9983197B2 (en) | 2012-09-14 | 2018-05-29 | University Of Manitoba | Low-cost portable microfluidic system for cell migration |
US9410827B2 (en) | 2012-10-09 | 2016-08-09 | Pixameter Corp. | Measurement using a calibration pattern |
CA2887492A1 (en) | 2012-10-23 | 2014-05-01 | Theranos, Inc. | Assisted medical and associated lifestyle decision making |
MX348392B (en) | 2012-10-26 | 2017-06-08 | Pixie Scient Llc | Health diagnostic systems and methods. |
CN104756093B (en) | 2012-10-27 | 2018-03-13 | 梁平 | For mobile or network equipment interchangeable wireless sensing device |
JP5844246B2 (en) | 2012-11-30 | 2016-01-13 | 富士フイルム株式会社 | Inspection result display device, its operating method, and control program |
US9436924B2 (en) | 2012-12-06 | 2016-09-06 | Ascensia Diabetes Care Holdings Ag | Automated analyte sensor ordering methods and apparatus |
CN104837404B (en) | 2012-12-10 | 2018-05-18 | 皇家飞利浦有限公司 | The medical supply or system of hemoglobin level are measured during accident using camera-projector system |
US10600516B2 (en) | 2012-12-12 | 2020-03-24 | Advanced Healthcare Systems, Inc. | Healthcare administration method for complex case and disease management |
WO2014100715A2 (en) | 2012-12-21 | 2014-06-26 | Ehrenkranz Joel R L | Supplements and monitoring systems for dosing of the supplements |
WO2014143276A2 (en) | 2012-12-31 | 2014-09-18 | Omni Medsci, Inc. | Short-wave infrared super-continuum lasers for natural gas leak detection, exploration, and other active remote sensing applications |
US8947656B2 (en) | 2013-01-04 | 2015-02-03 | The Board Of Trustees Of The University Of Illinois | Smartphone biosensor |
WO2014111828A1 (en) | 2013-01-17 | 2014-07-24 | Koninklijke Philips N.V. | System and method for intra-pulmonary percussive ventilation integrated with a ventilator |
US9693691B2 (en) | 2013-01-18 | 2017-07-04 | ZOLL Medical Corpoaration | Systems and methods for determining spatial locations of patient data gathering devices |
US9787815B2 (en) | 2013-01-21 | 2017-10-10 | Cornell University | Smartphone-based apparatus and method |
WO2014113770A1 (en) | 2013-01-21 | 2014-07-24 | Cornell University | Smartphone-based apparatus and method for obtaining repeatable, quantitative colorimetric measurement |
FI20135093L (en) | 2013-01-31 | 2014-08-01 | iStoc Oy | Mobile test reader device |
WO2014130592A1 (en) | 2013-02-20 | 2014-08-28 | Ddx: Digital Diagnostic Instruments, Llc | System, method, and apparatus for documenting and managing biopsy specimens and patient-specific information on-site |
US20170000359A1 (en) | 2013-02-22 | 2017-01-05 | Cloud Ds, Inc., a corporation of Delaware | Comprehensive body vital sign monitoring system |
WO2014178062A2 (en) | 2013-02-25 | 2014-11-06 | Biosense Technologies Private Ltd | Method and system for analysing body fluids |
US20150106118A1 (en) | 2013-02-27 | 2015-04-16 | Christopher A. Melo | Cloud-Based Storage and Retrieval of Medical Information Using Near Field Communication Devices |
US9500865B2 (en) | 2013-03-04 | 2016-11-22 | Alex C. Chen | Method and apparatus for recognizing behavior and providing information |
FI20135204L (en) | 2013-03-04 | 2014-09-25 | iStoc Oy | Test administration |
FI20135203L (en) | 2013-03-04 | 2014-09-05 | iStoc Oy | Test administration |
US9414776B2 (en) | 2013-03-06 | 2016-08-16 | Navigated Technologies, LLC | Patient permission-based mobile health-linked information collection and exchange systems and methods |
EP3540444B1 (en) | 2013-03-11 | 2022-10-26 | Cue Health Inc. | Systems and methods for detection and quantification of analytes |
US9481903B2 (en) | 2013-03-13 | 2016-11-01 | Roche Molecular Systems, Inc. | Systems and methods for detection of cells using engineered transduction particles |
EP3441976A1 (en) | 2013-03-14 | 2019-02-13 | M. Zubair Mirza | Internet based disease monitoring system (idms) |
US10303851B2 (en) | 2013-03-15 | 2019-05-28 | Md24 Patent Technology, Llc | Physician-centric health care delivery platform |
US9782075B2 (en) | 2013-03-15 | 2017-10-10 | I2Dx, Inc. | Electronic delivery of information in personalized medicine |
US9594878B2 (en) | 2013-03-15 | 2017-03-14 | Rush University Medical Center | Geographic utilization of artificial intelligence in real-time for disease identification and alert notification |
AU2013100344A4 (en) | 2013-03-21 | 2013-05-02 | Bui, Martin Duc MR | Patients' Real Time (PRT) is a patient information mobile software application that will potentially be used by medical staffs for access to patient information and investigation results (imaging or pathology) in real time as the results come to hand in electronic mobile form. The software application will be available on all forms of smart phones and tablets - modified for Apple's IOS phones and tablets, Google Android based phones and tablets, and Windows 7/8 based phones and tablets. The software will not be limited to mobile applications, but will be available for all personal computers. |
WO2014176556A1 (en) | 2013-04-26 | 2014-10-30 | Express Diagnostics International, Inc. | Portable testing system for detecting selected drugs or compounds in non-controlled environments |
CN103248681B (en) | 2013-04-27 | 2016-04-27 | 北京福乐云检测科技有限公司 | Based on the colloidal gold method detection cloud platform that mobile terminal reads |
JP6193659B2 (en) | 2013-06-03 | 2017-09-06 | 株式会社日本エンブレース | Medical / care support method, medical / care support system and medical / care support program |
US20150119652A1 (en) | 2013-10-31 | 2015-04-30 | Elwha LLC, a limited liability company of the State of Delaware | Telemedicine visual monitoring device with structured illumination |
US10641766B2 (en) | 2013-07-12 | 2020-05-05 | Nowdiagnostics, Inc. | Universal rapid diagnostic test reader with trans-visual sensitivity |
KR102230114B1 (en) | 2013-07-12 | 2021-03-18 | 나우다이아그노스틱스, 인코포레이티드 | A universal rapid diagnostic test reader with trans-visual sensitivity |
US9532699B2 (en) | 2013-07-15 | 2017-01-03 | Whirlpool Corporation | Dishwasher with sprayer |
GB201312998D0 (en) | 2013-07-19 | 2013-09-04 | Cambridge temperature concepts ltd | Acquiring reliable data |
US20150036131A1 (en) | 2013-08-05 | 2015-02-05 | Nanoscopia ( Cayman), Inc. | Handheld diagnostic system with chip-scale microscope and disposable sample holder having built-in reference features |
WO2015035260A1 (en) | 2013-09-06 | 2015-03-12 | Theranos, Inc. | Systems and methods for detecting infectious diseases |
US20150094606A1 (en) | 2013-10-02 | 2015-04-02 | Xerox Corporation | Breathing pattern identification for respiratory function assessment |
WO2015043639A1 (en) | 2013-09-26 | 2015-04-02 | Hewlett-Packard Indigo B.V. | Generating raised print data |
EP3052004B1 (en) | 2013-10-03 | 2022-03-30 | Neuroscience Research Australia (Neura) | Diagnosis of vision stability dysfunction |
US10276264B2 (en) | 2013-10-08 | 2019-04-30 | Mohan Kutty | Electronic health record system and method |
EP2863332A1 (en) | 2013-10-15 | 2015-04-22 | One Drop Diagnostics Sàrl | System and method for controlling access to analytical results of a diagnostic test assay |
WO2015061743A1 (en) | 2013-10-24 | 2015-04-30 | Theranos, Inc. | Systems and methods for ordering laboratory tests and providing results thereof |
CN103549961B (en) | 2013-10-31 | 2015-06-24 | 江苏贝泰福医疗科技有限公司 | Interactive hearing diagnosis and treatment system based on wireless mobile communication platform |
US10929509B2 (en) | 2013-11-07 | 2021-02-23 | Arjuna Raja | Accessing an interoperable medical code |
WO2015073878A1 (en) | 2013-11-15 | 2015-05-21 | Ur Diet, Llc | Real-time satiety biofeedback |
US20190038148A1 (en) | 2013-12-12 | 2019-02-07 | Alivecor, Inc. | Health with a mobile device |
US20150164323A1 (en) | 2013-12-16 | 2015-06-18 | Medtronic Minimed, Inc. | Secure communications between elements in a wireless network |
DE212014000241U1 (en) | 2013-12-23 | 2016-09-08 | Imerys Minerals Ltd. | cleaning structures |
US10012019B2 (en) | 2013-12-31 | 2018-07-03 | Guardian Glass, LLC | Vacuum insulating glass (VIG) unit with metallic peripheral edge seal and/or methods of making the same |
ES2879290T3 (en) | 2014-01-29 | 2021-11-22 | Becton Dickinson Co | System and method for confirming the collection and monitoring of samples at the clinical point of use |
AU2014100086A4 (en) | 2014-01-30 | 2014-02-27 | La Trobe University | Low-cost mobile ECL sensing system |
WO2015116540A1 (en) | 2014-01-31 | 2015-08-06 | Quick Release Lifescan, LLC | System and method for communicating protected health information |
WO2015127441A1 (en) | 2014-02-24 | 2015-08-27 | Brain Power, Llc | Systems, environment and methods for evaluation and management of autism spectrum disorder using a wearable data collection device |
CN203732539U (en) | 2014-02-28 | 2014-07-23 | 常州思康立生物科技有限公司 | Portable immunochromatography analyzer |
US11030708B2 (en) | 2014-02-28 | 2021-06-08 | Christine E. Akutagawa | Method of and device for implementing contagious illness analysis and tracking |
US9072425B1 (en) | 2014-03-04 | 2015-07-07 | Stuart Bogema | Method of providing a proper on-site evidence chain for a combined drug test/DNA preservation protocol |
JP2017516241A (en) | 2014-03-20 | 2017-06-15 | クイデル コーポレーション | Wireless system for monitoring disease in near real time |
WO2015145424A1 (en) | 2014-03-23 | 2015-10-01 | Doc@Home Ltd | A system for conducting a remote physical examination |
JP6377393B2 (en) | 2014-04-10 | 2018-08-22 | 三菱重工サーマルシステムズ株式会社 | Electric compressor control system and electric compressor for vehicle air conditioner equipped with the same |
WO2015159280A1 (en) | 2014-04-13 | 2015-10-22 | Spectrophon Ltd | Wireless colorimetric sensor |
WO2015161291A1 (en) | 2014-04-17 | 2015-10-22 | Church & Dwight Co., Inc. | Electronic test device data communication |
DE102014105937B4 (en) | 2014-04-28 | 2023-03-16 | Fujitsu Technology Solutions Gmbh | Monitoring system and monitoring procedures |
US9886750B2 (en) | 2014-05-08 | 2018-02-06 | LifeSaver Int'l Inc | Electronic device for reading diagnostic test results and collecting subject data for inclusion in a local chain of evidence database and for transferring and receiving data from remote databases |
US20150331995A1 (en) | 2014-05-14 | 2015-11-19 | Tiecheng Zhao | Evolving contextual clinical data engine for medical data processing |
EP3145585B1 (en) | 2014-05-20 | 2021-11-03 | electroCore, Inc. | Non-invasive nerve stimulation via mobile devices |
EP3151749B1 (en) | 2014-06-03 | 2023-11-29 | Smart Meter Corporation | System, apparatus and method for the wireless monitoring of medical test data |
WO2015191562A1 (en) | 2014-06-09 | 2015-12-17 | Revon Systems, Llc | Systems and methods for health tracking and management |
US9679113B2 (en) | 2014-06-11 | 2017-06-13 | Aic Innovations Group, Inc. | Medication adherence monitoring system and method |
US20150379206A1 (en) | 2014-06-26 | 2015-12-31 | Robert C. Villare | Universal medical access card system and process thereof |
WO2016005443A1 (en) | 2014-07-09 | 2016-01-14 | Arven Ilac Sanayi Ve Ticaret A.S. | A process for the preparation of formulations for inhalation |
US9601258B2 (en) | 2014-07-11 | 2017-03-21 | The Boeing Company | Symmetrical step-up and step-down autotransformer delta topology |
US10122010B2 (en) | 2014-07-11 | 2018-11-06 | Semiconductor Energy Laboratory Co., Ltd. | Secondary battery and electronic device including the same |
US11169670B2 (en) | 2014-07-31 | 2021-11-09 | William Sanford Krimsky | Remote medical evaluation heuristic |
US9658152B2 (en) | 2014-08-05 | 2017-05-23 | Siemens Healthcare Diagnostics Inc. | Optical interpretation of assay results |
US10758210B2 (en) | 2014-08-22 | 2020-09-01 | Oncura Partners Diagnostics, Llc | Ultrasound remote monitoring, operating and training system |
US20160063215A1 (en) | 2014-08-29 | 2016-03-03 | Ebay Inc. | Travel health management system |
CN106659484B (en) | 2014-09-01 | 2019-11-22 | 株式会社岛津制作所 | Optical measurement instrument |
US10448867B2 (en) | 2014-09-05 | 2019-10-22 | Vision Service Plan | Wearable gait monitoring apparatus, systems, and related methods |
CN107004237A (en) | 2014-09-05 | 2017-08-01 | 斯塔根有限公司 | The method that clinical examination data to clients are exported and inputted |
CN104198482A (en) | 2014-09-05 | 2014-12-10 | 北京智云达科技有限公司 | Test paper reading method and test paper reading device |
US20160071116A1 (en) | 2014-09-09 | 2016-03-10 | Sita Information Networking Computing Uk Limited | User profiling system and method therefor |
CA2961061A1 (en) | 2014-09-10 | 2016-03-17 | Ascensia Diabetes Care Holdings Ag | Smart logging for management of health-related issues |
CN110038652B (en) | 2014-09-11 | 2021-12-07 | 克忧健康公司 | Systems and methods for detecting and quantifying analytes |
US11728030B2 (en) | 2014-09-29 | 2023-08-15 | Apple Inc. | Methods of treatment and diagnosis using enhanced patient-physician communication |
US9973834B1 (en) | 2014-10-06 | 2018-05-15 | Allstate Insurance Company | Communication system and method for using human telematic data to provide a hazard alarm/notification message to a user in a static environment such as in or around buildings or other structures |
US20160103075A1 (en) | 2014-10-10 | 2016-04-14 | Detekt Biomedical LLC. | Wireless remote optical monitoring system |
US11587686B2 (en) | 2014-10-16 | 2023-02-21 | Cepheid | Biosecurity screening system and method |
US9854973B2 (en) | 2014-10-25 | 2018-01-02 | ARC Devices, Ltd | Hand-held medical-data capture-device interoperation with electronic medical record systems |
US11593842B2 (en) | 2014-10-28 | 2023-02-28 | Hygeia Health, Inc. | Systems, apparatuses, and methods for physiological data collection and providing targeted content |
EP3018470A1 (en) | 2014-11-04 | 2016-05-11 | Samsung Electronics Co., Ltd. | Method of and apparatus for measuring biometric information |
FR3028317A1 (en) | 2014-11-10 | 2016-05-13 | Ng Biotech | SYSTEM FOR EVALUATING AT LEAST ONE ANALYTE LIKELY TO BE CONTAINED IN A LIQUID SAMPLE DEPOSITED ON AN IMMUNOCHROMATOGRAPHIC DEVICE |
US10430557B2 (en) | 2014-11-17 | 2019-10-01 | Elwha Llc | Monitoring treatment compliance using patient activity patterns |
CA2967051C (en) | 2014-12-03 | 2022-12-06 | Magna International Inc. | Vehicle twist axle assembly |
CA2875578A1 (en) | 2014-12-24 | 2016-06-24 | Stephan HEATH | Systems, computer media, and methods for using electromagnetic frequency (emf) identification (id) devices for monitoring, collection, analysis, use and tracking of personal, medical, transaction, and location data for one or more individuals |
JP5984975B2 (en) | 2015-01-21 | 2016-09-06 | オリンパス株式会社 | Imaging apparatus, imaging method, and program |
US20180011973A1 (en) | 2015-01-28 | 2018-01-11 | Os - New Horizons Personal Computing Solutions Ltd. | An integrated mobile personal electronic device and a system to securely store, measure and manage users health data |
KR102323213B1 (en) | 2015-02-05 | 2021-11-08 | 삼성전자주식회사 | Apparatus and method for providing biometric information |
CA2884544A1 (en) | 2015-03-10 | 2016-09-10 | Scs Card Technology Inc. | Multi-application personal health record microprocessor card |
BR102015005444A2 (en) | 2015-03-11 | 2016-09-13 | Mirca Christina Da Silva Batista | wireless electromyograph equipment and its operating system |
KR102519764B1 (en) | 2015-03-31 | 2023-04-10 | 아지노모토 가부시키가이샤 | Evaluation method, evaluation device, evaluation program product, evaluation system, and terminal device |
CN104732468B (en) | 2015-04-08 | 2018-06-08 | 南京吉星兆健康信息咨询有限公司 | A kind of Telemedicine System based on mobile interchange |
RU2603494C2 (en) | 2015-04-22 | 2016-11-27 | Евгений Васильевич Халин | Worker electronic portfolio on occupational safety and preparation method thereof |
US10605816B1 (en) | 2015-08-11 | 2020-03-31 | Maxim Integrated Products, Inc. | H-field imager for assays |
US20160367194A1 (en) | 2015-05-14 | 2016-12-22 | Richard Murphy | Illumination system for mobile devices |
CN107690303B (en) | 2015-06-04 | 2021-11-05 | 惠普发展公司,有限责任合伙企业 | Computing device and method for generating three-dimensional model |
MX2017015926A (en) | 2015-06-08 | 2018-07-06 | Cj Healthcare Corp | Uses of benzimidazole derivative for nocturnal acid breakthrough. |
US20170055878A1 (en) | 2015-06-10 | 2017-03-02 | University Of Connecticut | Method and system for respiratory monitoring |
US20160365006A1 (en) | 2015-06-11 | 2016-12-15 | Paul Ash Minturn | Quantified Well-Being Evaluations, Improvement Programs and Scientific Wellness Video Games |
WO2016201595A1 (en) | 2015-06-15 | 2016-12-22 | 上海市浦东新区人民医院 | Rfid-based automatic treatment process system |
US20160367188A1 (en) | 2015-06-17 | 2016-12-22 | Bela Malik | Oral sensor alerting and communication system and developers' tool kit |
US11347000B2 (en) | 2015-06-19 | 2022-05-31 | The Regents Of The University Of California | Micro-plate reader for ELISA testing |
ES2718024T3 (en) | 2015-06-29 | 2019-06-27 | Cell Id Pte Ltd | Method and apparatus for collecting test data from the use of a disposable test kit |
WO2017002139A1 (en) | 2015-06-30 | 2017-01-05 | Preste Fausto | Electronic system for remote assistance of a person |
US9913583B2 (en) | 2015-07-01 | 2018-03-13 | Rememdia LC | Health monitoring system using outwardly manifested micro-physiological markers |
US20200118164A1 (en) | 2015-07-15 | 2020-04-16 | Edmond Defrank | Integrated mobile device management system |
KR101616473B1 (en) | 2015-07-16 | 2016-04-28 | 이병훈 | Smartphone with telemedical device |
CA2936876A1 (en) | 2015-07-22 | 2017-01-22 | Radicalogic Technologies, Inc. Dba Rl Solutions | Systems and methods for near-real or real-time contact tracing |
CN108139390B (en) | 2015-07-23 | 2021-06-04 | 中尺度技术有限责任公司 | Integrated consumable data management system and platform |
BR112018001352B1 (en) | 2015-07-24 | 2020-10-06 | Cepheid | DIAGNOSTIC TEST SYSTEM AND METHOD FOR OPERATING A DIAGNOSTIC TEST SYSTEM |
US20170020391A1 (en) | 2015-07-24 | 2017-01-26 | Johnson & Johnson Vision Care, Inc. | Biomedical devices for real time medical condition monitoring using biometric based information communication |
US10182770B2 (en) | 2015-07-28 | 2019-01-22 | Eins Technology Pte Ltd | Smart devices that capture images and sensed signals |
US10303843B2 (en) | 2015-08-06 | 2019-05-28 | Microsoft Technology Licensing, Llc | Computing system for identifying health risk regions |
RU2018107453A (en) | 2015-08-10 | 2019-09-12 | Эссенликс Корп. | DEVICES FOR ANALYSIS AND METHODS IN BIOLOGY / CHEMISTRY, PROVIDING SIMPLIFIED STAGES, SAMPLES OF SMALL VOLUME, INCREASED SPEED AND EASE OF APPLICATION |
JP6581290B2 (en) | 2015-08-14 | 2019-09-25 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Medical device data integration apparatus and method |
KR101773416B1 (en) | 2015-08-17 | 2017-09-01 | 원광대학교산학협력단 | A portable diagnosis system for detection of virus infection using a camera of device |
US20190054347A1 (en) | 2015-08-18 | 2019-02-21 | Michael Saigh | Wearable sports guidance communication system and developers tool kit |
JP6719123B2 (en) | 2015-08-31 | 2020-07-08 | エミット イメージング インコーポレイテッド | Fluorescent tissue tomography (FHT) system and FHT method |
US20170068785A1 (en) | 2015-09-09 | 2017-03-09 | Humetrix.Com, Inc. | Secure real-time health record exchange |
CN108633304B (en) | 2015-09-14 | 2020-08-14 | 艾森利克斯公司 | Device and system for collecting and analyzing steam condensate, in particular exhaled gas condensate, and method of use |
EP3341728A4 (en) | 2015-09-14 | 2019-04-17 | Essenlix Corp. | Device and system for analyzing a sample, particularly blood, as well as methods of using the same |
DE202015006405U1 (en) | 2015-09-17 | 2016-02-02 | Thomas Schury | International vaccination or prophylaxis certificate and vaccination certificate |
US10893989B2 (en) | 2015-09-23 | 2021-01-19 | Athena Gtx, Inc. | Autonomous critical care systems and integrated combat casualty care systems |
EP3356968B1 (en) | 2015-10-01 | 2020-08-05 | Dnanudge Limited | Method, apparatus and system for securely transferring biological information |
US10129450B2 (en) | 2015-10-02 | 2018-11-13 | Tareq Issam Nabhan | System and method for ophthalmological imaging adapted to a mobile processing device |
WO2017062941A1 (en) | 2015-10-08 | 2017-04-13 | The Penn State Research Foundation | Method for diagnosing lactation sufficiency |
US11024339B2 (en) | 2015-10-13 | 2021-06-01 | Richard A Rothschild | System and method for testing for COVID-19 |
US20170124263A1 (en) | 2015-10-30 | 2017-05-04 | Northrop Grumman Systems Corporation | Workflow and interface manager for a learning health system |
WO2017079849A1 (en) | 2015-11-13 | 2017-05-18 | Yes Biotechnology Inc. | Devices, systems and methods relating to in situ differentiation between viral and non-viral infections |
US20170140120A1 (en) | 2015-11-17 | 2017-05-18 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Mobile data hub for patient monitors |
US10325070B2 (en) | 2015-12-14 | 2019-06-18 | The Live Network Inc | Treatment intelligence and interactive presence portal for telehealth |
US20170177822A1 (en) | 2015-12-18 | 2017-06-22 | Pointright Inc. | Systems and methods for providing personalized prognostic profiles |
KR102469562B1 (en) | 2015-12-18 | 2022-11-22 | 삼성전자주식회사 | Apparatus and method for sharing personal electronic-health data |
CH711954A2 (en) | 2015-12-23 | 2017-06-30 | Ammann Dario | Noise sensor and system group for patient monitoring and alerting. |
US20170184506A1 (en) | 2015-12-29 | 2017-06-29 | Pritesh Arjunbhai Patel | Reagent test strips comprising reference regions for measurement with colorimetric test platform |
US10430552B2 (en) | 2015-12-31 | 2019-10-01 | Dan M. MIHAI | Distributed telemedicine system and method |
US20170188938A1 (en) | 2016-01-05 | 2017-07-06 | Huckleberry Labs, Inc. | System and method for monitoring sleep of a subject |
CN105675854A (en) | 2016-01-12 | 2016-06-15 | 王明敬 | Operating room multifunctional clinical examination and analysis device and method |
CN105740322A (en) | 2016-01-14 | 2016-07-06 | 深圳市检验检疫科学研究院 | Intelligent health quarantine big data analysis system for exit-entry epidemics |
WO2017124056A1 (en) | 2016-01-15 | 2017-07-20 | Collateral Opportunities, Llc | Location aware alerting and notification escalation system and method |
US10132743B2 (en) | 2016-01-25 | 2018-11-20 | General Electric Company | Fixed optics photo-thermal spectroscopy reader and method of use |
DE102016202428B4 (en) | 2016-02-17 | 2018-06-21 | Axagarius Gmbh & Co. Kg | Measuring system for colorimetric assays |
CN205404383U (en) | 2016-02-18 | 2016-07-27 | 常州罗盘星检测科技有限公司 | Portable water quality analyzer |
US11356554B2 (en) | 2016-02-25 | 2022-06-07 | Koninklijke Philips N.V. | Devices, system and methods for determining a priority level and/or conversation duration of a call |
TWM523925U (en) | 2016-02-25 | 2016-06-11 | 蕭如宣 | IoT integration platform |
US10732169B2 (en) | 2016-02-29 | 2020-08-04 | eNano Health Limited | Personalized healthcare P4 drug monitoring system and method |
US20170270253A1 (en) | 2016-03-15 | 2017-09-21 | Siemens Healthcare Gmbh | System, method and device for identifying an appropriate healthcare service provider and providing a healthcare referral |
US10923231B2 (en) | 2016-03-23 | 2021-02-16 | International Business Machines Corporation | Dynamic selection and sequencing of healthcare assessments for patients |
CN109416360A (en) | 2016-03-31 | 2019-03-01 | 迪森德克斯公司 | The generation and purposes of biomarker database |
US20170293730A1 (en) | 2016-04-08 | 2017-10-12 | 19Labs Inc. | Remote controlled medical assistance device |
US11322261B2 (en) | 2016-04-08 | 2022-05-03 | 19Labs Inc. | System and method for implementing augmented reality during telehealth sessions in a telehealth device |
CN105898217B (en) | 2016-04-14 | 2019-08-06 | 京东方科技集团股份有限公司 | Holography operation equipment and control equipment, holographic operating method and control method |
EP3442404B1 (en) | 2016-04-15 | 2022-07-27 | BR Invention Holding, LLC | Mobile medicine communication platform and methods and uses thereof |
CA3021761C (en) | 2016-04-22 | 2023-12-19 | Fitskin Inc. | Systems and method for skin analysis using electronic devices |
US10185906B2 (en) | 2016-04-26 | 2019-01-22 | Hand Held Products, Inc. | Indicia reading device and methods for decoding decodable indicia employing stereoscopic imaging |
US10936698B2 (en) | 2016-05-09 | 2021-03-02 | Global Tel*Link Corporation | System and method for integration of telemedicine into multimedia video visitation systems in correctional facilities |
US20170323441A1 (en) | 2016-05-09 | 2017-11-09 | University Of Washington | Filter-free devices and systems for measuring fluorescence of a microfluidic assay and associated methods of use |
JP2017204214A (en) | 2016-05-13 | 2017-11-16 | 株式会社リコー | Information processing device and program |
FR3051581B1 (en) | 2016-05-20 | 2018-10-05 | Paragon Id | DEVICE FOR GENERATING AND DYNAMIC SECURITY CODE DISPLAY |
WO2017205416A1 (en) | 2016-05-23 | 2017-11-30 | Vanderbilt University | Devices, kits, and methods for monitoring disease states |
CN106198538A (en) | 2016-06-24 | 2016-12-07 | 武汉山不厌高科技有限公司 | A kind of reagent paper read method and device |
JP6786906B2 (en) | 2016-06-27 | 2020-11-18 | 大日本印刷株式会社 | Health management system |
CN106250668A (en) | 2016-07-06 | 2016-12-21 | 无锡市疾病预防控制中心 | The Notifiable diseases such as hand-foot-mouth disease influenza are anti-fails to report management system and method |
DE102016008332A1 (en) | 2016-07-07 | 2018-01-11 | Fresenius Medical Care Deutschland Gmbh | Method for detecting symptoms of peritonitis |
CA3027424A1 (en) | 2016-07-15 | 2018-01-18 | Knox Spencer Associates Llc | Systems and methods for determining, tracking, and predicting common infectious illness outbreaks |
US10867700B2 (en) | 2016-07-18 | 2020-12-15 | Theresa R. Marshall | Electronic wellness check for establishing medical staff integrity and high functional efficiency |
US20180032757A1 (en) | 2016-08-01 | 2018-02-01 | Azeem Michael | Health Status Matching System and Method |
US11450432B2 (en) | 2016-08-02 | 2022-09-20 | Malecare, Inc. | Predictive and interactive diagnostic system |
US11154253B2 (en) | 2016-08-12 | 2021-10-26 | Dexcom, Inc. | Systems and methods for health data visualization and user support tools for continuous glucose monitoring |
WO2018035147A1 (en) | 2016-08-15 | 2018-02-22 | Valentine Edmund L | Drug and device combination products with improved safety and efficacy profiles |
WO2018039139A1 (en) | 2016-08-22 | 2018-03-01 | The Regents Of The University Of California | Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection |
CN106339857A (en) | 2016-08-24 | 2017-01-18 | 广东广信通信服务有限公司 | Security verification method of intelligent office system based on mobile Internet |
WO2018044894A1 (en) | 2016-08-29 | 2018-03-08 | Chen James C | Connected systems, devices, and methods for monitoring clinical treatments |
GB2553512A (en) | 2016-08-30 | 2018-03-14 | Irene Comlan Arcadius Ahouansou Mydjoegbedoh | Reusable, affordable and sustainable pregnancy, ovalation and gestational age test kit |
US10561317B2 (en) | 2016-09-16 | 2020-02-18 | Meghana Kambham | Device for comprehensive health monitoring |
US11522692B2 (en) * | 2016-09-23 | 2022-12-06 | Becton, Dickinson And Company | Encryption system for medical devices |
DE202016105331U1 (en) | 2016-09-23 | 2016-11-14 | DOC@HOME Ltd. | System for carrying out a physical remote examination |
JP2018054695A (en) | 2016-09-26 | 2018-04-05 | 富士ゼロックス株式会社 | Electrophotographic photoreceptor, method of manufacturing electrophotographic photoreceptor, process cartridge, and image formation device |
US11133094B2 (en) | 2016-09-28 | 2021-09-28 | Flatiron Health, Inc. | Systems and methods for visualizing data |
CN106645116B (en) | 2016-09-29 | 2019-06-07 | 太原理工大学 | Biological rapid detection method based on smart phone two-dimensional code style |
WO2018063207A1 (en) | 2016-09-29 | 2018-04-05 | Intel Corporation | Resistive random access memory cell |
US10776772B2 (en) | 2016-09-30 | 2020-09-15 | Middleware, Inc. | Automated digital method and system of providing or sharing access |
US20180108430A1 (en) | 2016-09-30 | 2018-04-19 | Board Of Regents, The University Of Texas System | Method and system for population health management in a captivated healthcare system |
KR20180036150A (en) | 2016-09-30 | 2018-04-09 | 삼성전자주식회사 | Spectrometric sensing apparatus in electronic device and method thereof |
CN207457253U (en) | 2016-10-12 | 2018-06-05 | 姜海鹰 | A kind of hormone and metabolin half-quantitative detection system based on cell phone application |
US20190027250A1 (en) | 2016-10-17 | 2019-01-24 | Reliant Immune Diagnostics, Inc | System and method for transforming a biologic into a number |
US20190035491A1 (en) | 2016-10-17 | 2019-01-31 | Reliant Immune Diagnostics, Inc | System and method for remote mapping of agent-induced material swab |
US9857373B1 (en) | 2016-10-17 | 2018-01-02 | Reliant Immune Diagnostics, LLC | Pregnancy test to assess disease risk |
US20190096516A1 (en) | 2016-10-17 | 2019-03-28 | Reliant Immune Diagnostics, Inc | System and method for medical escalation and intervention that is a direct result of a remote diagnostic test |
US11107585B2 (en) | 2016-10-17 | 2021-08-31 | Reliant Immune Diagnostics, Inc | System and method for a digital consumer medical wallet and storehouse |
US11693002B2 (en) | 2016-10-17 | 2023-07-04 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type |
US20190027259A1 (en) | 2016-10-17 | 2019-01-24 | Reliant Immune Diagnostics, Inc | System and method for remote mapping of gold conjugates |
US9857372B1 (en) | 2016-10-17 | 2018-01-02 | Reliant Immune Diagnostics, LLC | Arbovirus indicative birth defect risk test |
US11651866B2 (en) | 2016-10-17 | 2023-05-16 | Reliant Immune Diagnostics, Inc. | System and method for real-time insurance quote in response to a self-diagnostic test |
US20190027258A1 (en) | 2016-10-17 | 2019-01-24 | Reliant Immune Diagnostics, Inc | System and method for mapping a diagnostic test to an individual user to create a unique profile on a remote database |
US10902951B2 (en) | 2016-10-17 | 2021-01-26 | Reliant Immune Diagnostics, Inc. | System and method for machine learning application for providing medical test results using visual indicia |
US20180107802A1 (en) | 2016-10-17 | 2018-04-19 | Sneez, Llc | Computer implemented method and system, and computer program product, for collecting and displaying health status information |
EP4241680A3 (en) | 2016-10-18 | 2023-11-15 | DexCom, Inc. | System and method for communication of analyte data |
WO2018076105A1 (en) | 2016-10-24 | 2018-05-03 | Surgiology Inc. | System, method and apparatus for managing surgical procedures |
US20180121625A1 (en) | 2016-11-03 | 2018-05-03 | Bret Alan Barker | Method and system for facilitating wound care management |
CN106526177A (en) | 2016-11-05 | 2017-03-22 | 深圳市前海安测信息技术有限公司 | Biomarker detection system and method based on colloidal gold test strip |
AU2017362505B2 (en) | 2016-11-18 | 2023-02-02 | Cepheid | Sample processing module array handling system and methods |
US20180150600A1 (en) | 2016-11-30 | 2018-05-31 | International Business Machines Corporation | Reducing contagious disease spread utilizing travel information |
KR102287872B1 (en) | 2016-12-09 | 2021-08-09 | 나우다이아그노스틱스, 인코포레이티드 | Diagnostic test assays with security and related devices and methods of using the same |
US10331924B2 (en) | 2016-12-14 | 2019-06-25 | Reliant Immune Diagnostics, Inc. | System and method for audiovisual response to retail diagnostic product |
US20180366230A1 (en) | 2016-12-14 | 2018-12-20 | Reliant Immune Diagnostics, LLC | System and method for epidemic tracking on mobile device |
US11594337B2 (en) | 2016-12-14 | 2023-02-28 | Reliant Immune Diagnostics, Inc. | System and method for advertising in response to diagnostic test results |
US11125746B2 (en) | 2016-12-14 | 2021-09-21 | Reliant Immune Diagnostics, Inc. | Two-sided flow-through immunoassay |
US20180165417A1 (en) | 2016-12-14 | 2018-06-14 | David R. Hall | Bathroom Telemedicine Station |
US11295859B2 (en) | 2016-12-14 | 2022-04-05 | Reliant Immune Diagnostics, Inc. | System and method for handing diagnostic test results to telemedicine provider |
MX2019006981A (en) | 2016-12-14 | 2020-09-07 | Novetechnologies Llc | Livestock biosecurity system and method of use. |
US10527555B2 (en) | 2016-12-14 | 2020-01-07 | Reliant Immune Disgnostics, Inc. | System and method for visual trigger to perform diagnostic test |
US11164680B2 (en) | 2016-12-14 | 2021-11-02 | Reliant Immune Diagnostics, Inc. | System and method for initiating telemedicine conference using self-diagnostic test |
US11170877B2 (en) | 2016-12-14 | 2021-11-09 | Reliant Immune Diagnostics, LLC | System and method for correlating retail testing product to medical diagnostic code |
KR102486814B1 (en) | 2016-12-15 | 2023-01-10 | 삼성전자주식회사 | Server, user terminal apparatus, erectronic apparatus, and contrl method thereof |
US10847259B2 (en) | 2016-12-15 | 2020-11-24 | Compete Safe, Inc. | System and methods for managing health-related information for a population |
US11928201B2 (en) | 2016-12-22 | 2024-03-12 | Hid Global Cid Sas | Mobile credential with online/offline delivery |
WO2018115492A1 (en) | 2016-12-22 | 2018-06-28 | Koninklijke Philips N.V. | Medical viewing certificates for mobile devices |
WO2018115317A1 (en) | 2016-12-23 | 2018-06-28 | Sanofi-Aventis Deutschland Gmbh | Data management unit for supporting health control |
JP6123041B1 (en) | 2017-01-04 | 2017-04-26 | 株式会社日立製作所 | Magnetic resonance imaging apparatus, cryosystem control apparatus, and cryosystem control method |
CN106771286A (en) | 2017-01-16 | 2017-05-31 | 成都恩普生医疗科技有限公司 | A kind of Intelligent urine analysis system and its operating method |
US10884454B2 (en) | 2017-01-18 | 2021-01-05 | Blue Storm Media Inc | Line-of-sight device housing a first device and configured for display of content from a second device |
US11423755B2 (en) | 2017-05-17 | 2022-08-23 | Blue Storm Media, Inc. | System and method for a digital proof of vaccine |
US10783546B2 (en) | 2017-05-17 | 2020-09-22 | Blue Storm Media, Inc. | Color and symbol coded display on a digital badge for communicating permission to approach and activate further digital content interaction |
US20180218124A1 (en) * | 2017-01-31 | 2018-08-02 | Joseph G. Gorelick | Method and System for Entry, Transfer, Storage, Transmission and Retrieval of Medical, Health and Healthcare Related Data |
US10772552B2 (en) | 2017-02-03 | 2020-09-15 | Alfred H. Bedell, JR. | Digital health system for the continuous quantification of physiological biomarkers, biological regulators, and analytes in real-time |
CN111465882B (en) | 2017-02-08 | 2023-05-26 | Essenlix公司 | Optical device, apparatus and system for assay |
WO2018148609A2 (en) | 2017-02-09 | 2018-08-16 | Essenlix Corporation | Colorimetric assays |
KR101798818B1 (en) | 2017-02-09 | 2017-11-16 | 노드정보기술(주) | Remote medical examination system using portable wireless security motion medical apparatus |
WO2018156667A1 (en) | 2017-02-21 | 2018-08-30 | Mark Jacobs | Patient monitoring system |
US20180256111A1 (en) | 2017-03-07 | 2018-09-13 | Primus Llc | Apparatus and method to record health care vitals and information on a stand-alone and mobile device. |
CN106909796A (en) | 2017-03-10 | 2017-06-30 | 广东省妇幼保健院 | Infectious disease actively monitoring early warning system in a kind of medical institutions |
FI3596232T3 (en) | 2017-03-12 | 2023-08-01 | Ilytica Llc | Digital molecular assays |
US20180277252A1 (en) | 2017-03-17 | 2018-09-27 | Getwellnetwork, Inc. | Person Engagement Index for Providing Automated Personalized Healthcare Functions |
US20180278691A1 (en) | 2017-03-22 | 2018-09-27 | Wilman Vergara, JR. | Method and system for facilitating management of wellness of users |
US20190346369A1 (en) | 2017-03-27 | 2019-11-14 | The Regents Of The University Of California | Mobile phone based fluorescent multi-well plate reader |
US11410155B2 (en) | 2017-03-27 | 2022-08-09 | Amazon Technologies, Inc. | Secure scannable code systems and methods |
CN106872538A (en) | 2017-03-28 | 2017-06-20 | 海南大学 | A kind of high-flux electric chemical analysis system based on smart mobile phone |
CN106872341A (en) | 2017-03-29 | 2017-06-20 | 海南大学 | A kind of instant microbe diagnosis instrument of movement based on smart mobile phone |
US10146909B2 (en) | 2017-04-06 | 2018-12-04 | Diassess Inc. | Image-based disease diagnostics using a mobile device |
CN106874632B (en) | 2017-04-06 | 2020-09-01 | 聂聪 | Intelligent monitoring system for chronic disease health index |
US11618928B2 (en) | 2017-04-12 | 2023-04-04 | The Broad Institute, Inc. | CRISPR effector system based diagnostics for malaria detection |
US20180308569A1 (en) | 2017-04-25 | 2018-10-25 | S Eric Luellen | System or method for engaging patients, coordinating care, pharmacovigilance, analysis or maximizing safety or clinical outcomes |
GB2561863A (en) | 2017-04-25 | 2018-10-31 | Sumitomo Chemical Co | Methods for colorimetric analysis |
CN107022650A (en) | 2017-04-27 | 2017-08-08 | 西南民族大学 | Pig Delta coronavirus detection kit and application based on constant temperature isolation type fluorescent PCR platform |
CN107121542B (en) | 2017-04-28 | 2018-08-31 | 厦门大学 | A kind of immunity-chromatography test strip quantitative detection system and method based on mobile phone |
CN107255712B (en) | 2017-05-03 | 2019-08-06 | 上海交通大学 | A kind of immunochromatography chip quantified system analysis based on smart phone |
CN107133901B (en) | 2017-05-05 | 2020-11-03 | 中国科学院深圳先进技术研究院 | Infectious disease prevention and control method and system |
CA3062585A1 (en) | 2017-05-08 | 2018-11-15 | Biological Dynamics, Inc. | Methods and systems for analyte information processing |
US20180317769A1 (en) | 2017-05-08 | 2018-11-08 | Sajid Khan | System and method for real time blood glucose monitoring and response |
CN110868916A (en) | 2017-05-09 | 2020-03-06 | 悦思生物科技股份有限公司 | Devices, systems and methods related to handheld communication devices for in situ discrimination between viral and non-viral infections |
JP2018190290A (en) | 2017-05-10 | 2018-11-29 | 本田技研工業株式会社 | Health management device for crew member, health management system for crew member, and health management method for crew member |
US20200350989A1 (en) | 2017-05-17 | 2020-11-05 | Blue Storm Media, Inc. | System and Method for Interactively Engaging Devices with a Matching Signal Display |
US10354166B2 (en) | 2017-05-22 | 2019-07-16 | Bio-Rad Laboratories (Israel) Inc. | Reading test cards using a mobile device |
CN107239655A (en) | 2017-05-26 | 2017-10-10 | 陈明福 | A kind of recognition methods of online health certificate file |
EP3410330B1 (en) | 2017-05-31 | 2021-07-21 | Mastercard International Incorporated | Improvements in biometric authentication |
CN206772947U (en) | 2017-06-06 | 2017-12-19 | 徐立刚 | Moveable physicochemical detection analysis experimental bench |
CN112218720A (en) | 2017-06-12 | 2021-01-12 | Essenlix公司 | Homogeneous assay |
WO2018227256A1 (en) | 2017-06-16 | 2018-12-20 | Soter Analytics Pty Ltd | Method and system for monitoring core body movements |
US10733730B2 (en) | 2017-06-19 | 2020-08-04 | Viz.ai Inc. | Method and system for computer-aided triage |
CN107330524A (en) | 2017-06-20 | 2017-11-07 | 北京市运输管理技术支持中心 | A kind of motor vehicle maintenance management service system |
WO2018237227A1 (en) | 2017-06-22 | 2018-12-27 | Massachusetts Institute Of Technology | Multiplexed immunoassay for detecting biomarkers of disease |
JP6788845B2 (en) | 2017-06-23 | 2020-11-25 | パナソニックIpマネジメント株式会社 | Remote communication methods, remote communication systems and autonomous mobile devices |
CN109243597A (en) | 2017-06-29 | 2019-01-18 | 京东方科技集团股份有限公司 | Remote medical facility, information acquisition apparatus and Telemedicine System and method |
US20190014996A1 (en) | 2017-07-14 | 2019-01-17 | Hai Rong Qian | Smart medical diagnosis system |
US11328806B2 (en) | 2017-07-17 | 2022-05-10 | Avkn Patient-Driven Care, Inc | System for tracking patient recovery following an orthopedic procedure |
US10768185B2 (en) | 2017-07-20 | 2020-09-08 | Trustees Of Boston University | Tenofovir detection assay |
US20190035499A1 (en) | 2017-07-25 | 2019-01-31 | Daya Medicals, Inc. (Canada) | Intelligent monitoring, interactive, and wireless internet connected medication adherence, analytics, and database solution |
KR101789208B1 (en) | 2017-07-27 | 2017-10-23 | 주식회사 지아이에스21 | The apparatus and method of management platform for ground utilities and underground utilities with exploration and measurement |
WO2019020477A1 (en) | 2017-07-28 | 2019-01-31 | Koninklijke Philips N.V. | Monitoring direct and indirect transmission of infections in a healthcare facility using a real-time locating system |
US11935634B2 (en) | 2017-07-28 | 2024-03-19 | Google Llc | System and method for predicting and summarizing medical events from electronic health records |
US20190031145A1 (en) | 2017-07-28 | 2019-01-31 | Alclear, Llc | Biometric identification system connected vehicle |
CN112204373A (en) | 2017-08-01 | 2021-01-08 | Essenlix公司 | Device and method for platelet determination |
CN111107935A (en) | 2017-08-03 | 2020-05-05 | 菲帛罗缇埃克斯有限公司 | Lateral flow assay device for skin care applications |
WO2019032824A1 (en) | 2017-08-09 | 2019-02-14 | Arizona Board Of Regents On Behalf Of Arizona State University | Dark-field microscope apparatus utilizing portable electronic communication device |
US10602987B2 (en) | 2017-08-10 | 2020-03-31 | Arc Devices Limited | Multi-vital-sign smartphone system in an electronic medical records system |
EP3669377A1 (en) | 2017-08-14 | 2020-06-24 | Psomagen, Inc. | Disease-associated microbiome characterization process |
CN107610745A (en) | 2017-08-22 | 2018-01-19 | 浙江大学医学院附属第医院 | The central pharmacy management method and system of trial drug |
KR101837081B1 (en) | 2017-08-24 | 2018-03-09 | 주식회사 제트바이오텍 | Disease states real-time monitoring system |
CA2977384A1 (en) | 2017-08-28 | 2019-02-28 | John Moses | Portable health monitor |
KR102460573B1 (en) | 2017-08-31 | 2022-10-28 | 주식회사 케이티 | System and method for infectious disease diffusion prevention |
US20190080789A1 (en) | 2017-09-12 | 2019-03-14 | Esteban Martin Kloosterman | System for live monitoring of vitals for patients and physicians |
EP3454341A1 (en) | 2017-09-12 | 2019-03-13 | Siemens Healthcare GmbH | Automated processing of patient data for health care |
JP6958158B2 (en) | 2017-09-15 | 2021-11-02 | 宇部興産株式会社 | Exhaust gas treatment equipment and exhaust gas treatment method |
US20190088373A1 (en) | 2017-09-15 | 2019-03-21 | Alberto Sarmentero | Automated Assistant For Remote Patient Tracking, Diagnosing, Alerting, And Prevention Of Heart Diseases, Cardio Warning Service/System |
CN107655889A (en) | 2017-09-22 | 2018-02-02 | 暨南大学 | Colorimetric chromatograph test strip based on smart mobile phone reads detection means and application |
US10861600B2 (en) | 2017-09-28 | 2020-12-08 | General Electric Company | Method and system for user-verifiable certification of software for medical devices |
AU2018342607A1 (en) | 2017-09-29 | 2020-04-23 | Sippa Solutions, Llc | Method for enhancing patient compliance with a medical therapy plan and mobile device therefor |
US10658076B2 (en) | 2017-10-09 | 2020-05-19 | Peter Gulati | System and method for increasing efficiency of medical laboratory data interpretation, real time clinical decision support, and patient communications |
WO2019075432A1 (en) | 2017-10-12 | 2019-04-18 | Moon Jorlin | Systems and methods for measuring, quantifying, displaying and/or otherwise handling/reporting health status data and/or risks via self-directed health screening, information, and processing information regarding associated professional advice |
US11393561B2 (en) | 2017-10-13 | 2022-07-19 | Essenlix Corporation | Devices and methods for authenticating a medical test and use of the same |
CN207408411U (en) | 2017-10-16 | 2018-05-25 | 常州思康立生物科技有限公司 | Hand-held immunochromatographiassays assays instrument with heating function |
AU2018355173A1 (en) | 2017-10-24 | 2020-05-28 | Adventia Technology, LLC | Systems, methods, and devices for aggregated health data processing and treatment recommendation generation platforms |
ES2943012T3 (en) | 2017-10-25 | 2023-06-08 | Hoffmann La Roche | Procedures and devices for performing an analytical measurement |
US11237113B2 (en) | 2017-10-26 | 2022-02-01 | Essenlix Corporation | Rapid pH measurement |
US20190170734A1 (en) | 2017-10-26 | 2019-06-06 | Essenlix Corporation | Compact Illuminator, Imaging and Systems and the Use of the Same |
KR102034352B1 (en) | 2017-10-31 | 2019-10-18 | 전자부품연구원 | In-vitro diagnostic system comprising attaching type-optical device using mobile device |
US10930381B2 (en) | 2017-11-10 | 2021-02-23 | Reliant Immune Diagnostics, Inc. | Microfluidic testing system for mobile veterinary applications |
US11529104B2 (en) | 2017-11-13 | 2022-12-20 | Ai Care Corporation | Method of blood pressure estimation using trend analysis |
BR112020008334A2 (en) | 2017-11-17 | 2020-10-20 | Essity Hygiene And Health Aktiebolag | method for associating a monitoring device, hygiene monitoring device and hygiene monitoring system |
HUP1700468A2 (en) | 2017-11-17 | 2019-05-28 | Gyoergy Zoltan Kozmann | Method and equipment for monitoring effectiveness of physical in paricular sport activities |
CN111630604A (en) | 2017-11-20 | 2020-09-04 | 纳诺全球公司 | Data collection and analysis based on detection of biological cells or biological substances |
US11195610B2 (en) | 2017-11-22 | 2021-12-07 | Takuya Shimomura | Priority alerts based on medical information |
DE102017129476B4 (en) | 2017-12-11 | 2024-04-18 | Bundesrepublik Deutschland, vertreten durch die Bundesministerin für Wirtschaft und Energie, diese vertreten durch den Präsidenten der Bundesanstalt für Materialforschung und-prüfung (BAM) | Label-free optical detection in capture zones immobilized on strips for lateral flow assays |
WO2019118936A2 (en) | 2017-12-14 | 2019-06-20 | Essenlix Corporation | Devices, systems, and methods for monitoring hair |
WO2019117563A1 (en) | 2017-12-15 | 2019-06-20 | 삼성전자 주식회사 | Integrated predictive analysis apparatus for interactive telehealth and operating method therefor |
GB2569803B (en) | 2017-12-22 | 2021-11-24 | Novarum Dx Ltd | Analysis of a captured image to determine a test outcome |
CN108053134A (en) | 2017-12-26 | 2018-05-18 | 广州纬仪信息科技有限公司 | A kind of safe verification method based on mobile Internet smart office system |
WO2019130494A1 (en) | 2017-12-27 | 2019-07-04 | 株式会社オプティム | Computer system, alert method, and program |
CN108562741A (en) | 2018-01-04 | 2018-09-21 | 南京农业大学 | A kind of imidaclothiz bioluminescence sidestream immune chromatography method |
BR112020012916A2 (en) | 2018-01-09 | 2020-12-08 | Idexx Laboratories, Inc. | METHODS FOR MEASURING ANALYTICAL AND / OR PROTEIN IN BIOLOGICAL SAMPLES |
WO2019140334A1 (en) | 2018-01-11 | 2019-07-18 | Essenlix Corporation | Homogeneous assay (ii) |
WO2019143330A1 (en) | 2018-01-17 | 2019-07-25 | Hall David R | Remote healthcare-monitoring system with user enabled diagnostic capabilities |
KR20200112922A (en) | 2018-01-22 | 2020-10-05 | 파디아 에이비 | How to reconcile analysis results |
US11532398B2 (en) | 2018-01-29 | 2022-12-20 | Laboratory Corporation Of America Holdings | Learning filter for the detection of indicators in healthcare data |
CN111918797B (en) | 2018-02-01 | 2022-04-26 | 斯特拉泰克安全公司 | Method and system for providing bluetooth-based Passive Entry and Passive Start (PEPS) for a vehicle |
JP2019130494A (en) | 2018-02-01 | 2019-08-08 | トヨタ自動車株式会社 | Coating jig |
JP7090429B2 (en) | 2018-02-07 | 2022-06-24 | 株式会社堀場製作所 | Inspection order processing device, computer program for it, and inspection system |
SG11202008914WA (en) | 2018-02-15 | 2020-10-29 | Caretech Services Pty Ltd | A platform and system for use in therapeutic procedures |
KR20200123796A (en) | 2018-02-16 | 2020-10-30 | 노오쓰웨스턴 유니버시티 | Wireless medical sensor and method |
EP3527972A1 (en) | 2018-02-19 | 2019-08-21 | Roche Diabetes Care GmbH | Method and devices for performing an analytical measurement |
CN108461158A (en) | 2018-03-05 | 2018-08-28 | 浙江健智元生物科技有限公司 | A kind of remote ischemic pre-adaptation health training system and method |
WO2019178140A1 (en) | 2018-03-12 | 2019-09-19 | Laboratory Corporation Of America Holdings | Data management for genetic laboratory testing |
WO2019175660A1 (en) | 2018-03-14 | 2019-09-19 | Menicon Co. Ltd. | Method for detecting a health condition with biomarkers |
US20200066415A1 (en) | 2018-04-10 | 2020-02-27 | Hill-Rom Services, Inc. | Interfaces displaying patient data |
WO2019200148A1 (en) | 2018-04-11 | 2019-10-17 | Siren Care, Inc. | Systems and methods for registration and activation of temperature-sensing garments |
JP6570691B1 (en) | 2018-04-13 | 2019-09-04 | 株式会社デジメット | Personal medical information collection system |
US20190320900A1 (en) | 2018-04-18 | 2019-10-24 | CureCompanion Inc. | Telemedicine system |
CA3098779A1 (en) | 2018-05-07 | 2019-11-14 | Immundiagnostik Ag | System for analysing quantitative lateral flow chromatography |
US10835122B2 (en) | 2018-05-14 | 2020-11-17 | Reliant Immune Diagnostics, Inc. | System and method for image processing of medical test results using generalized curve field transform |
CN108615214A (en) | 2018-05-17 | 2018-10-02 | 邵春芝 | Entry and exit port passenger's health quarantine system and operating method |
US10847258B2 (en) | 2018-05-17 | 2020-11-24 | 4DA Inc. | System, methods, and apparatuses for medication records tracking |
US11081232B2 (en) | 2018-05-23 | 2021-08-03 | Roche Diabetes Care, Inc. | Medical device data management configuration systems and methods of use |
KR20190134314A (en) | 2018-05-25 | 2019-12-04 | 주식회사 더한 | Remote medical Diagnostic System |
US10706302B2 (en) | 2018-06-01 | 2020-07-07 | Volvo Car Corporation | Real time vehicle occupant emergency health data systems and methods |
US10935561B2 (en) | 2018-06-01 | 2021-03-02 | Genmark Diagnostics, Inc. | Integrated diagnostic instrument |
US10636527B2 (en) | 2018-06-06 | 2020-04-28 | Reliant Immune Diagnostics, Inc. | System and method for quantifying, ensuring, and triggering the prescriptive authority for a telemedicine session |
US11232872B2 (en) * | 2018-06-06 | 2022-01-25 | Reliant Immune Diagnostics, Inc. | Code trigger telemedicine session |
US11125749B2 (en) | 2018-06-06 | 2021-09-21 | Reliant Immune Diagnostics, Inc. | System and method for remote colorimetry and ratiometric comparison and quantification in analysis of medical test results |
CN110580953A (en) | 2018-06-08 | 2019-12-17 | 上海交迅智能科技有限公司 | Disease diagnosis system and method adopting artificial intelligence |
US11112406B2 (en) | 2018-06-15 | 2021-09-07 | Reliant Immune Diagnostics, Inc. | System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results |
US20200345316A1 (en) | 2018-06-27 | 2020-11-05 | Ronald Allen Noel | Method To Communicate The Status OF Predetermined Conditions Without The Need For Any Manual Intervention |
CN108844951B (en) | 2018-06-28 | 2021-07-13 | 中国农业大学 | Mercury ion detection product and method and smartphone imaging analysis system |
EP3818545A1 (en) | 2018-07-02 | 2021-05-12 | Baxter International Inc. | Graph database for outbreak tracking and management |
GB201810897D0 (en) | 2018-07-03 | 2018-08-15 | Chronomics Ltd | Phenotype prediction |
WO2020009900A1 (en) | 2018-07-04 | 2020-01-09 | Mores, Inc. | System for remote noninvasive contactless assessment and prediction of body organ health |
CA3106183A1 (en) | 2018-07-13 | 2020-01-16 | Plaqless Ltd | An apparatus for detecting oral diseases and hazards |
CN108614100A (en) | 2018-07-19 | 2018-10-02 | 苏州芯海智能科技有限公司 | A kind of quickly and easily detection device |
GB201811927D0 (en) | 2018-07-20 | 2018-09-05 | Experiment X Ltd | Lateral flow test strip immunoassay in vitro diagnostic device |
WO2020023865A1 (en) | 2018-07-26 | 2020-01-30 | Luminent Health, LLC | Apparatus and method for providing improved health care |
KR102152030B1 (en) | 2018-08-01 | 2020-09-04 | 한양대학교 산학협력단 | Method and apparatus for processing personal information based on information distribution in aid and emergency situation |
WO2020028837A1 (en) | 2018-08-03 | 2020-02-06 | Wellmetrix, Llc | Systems and methods for monitoring an individual's health |
JP7422308B2 (en) | 2018-08-08 | 2024-01-26 | パナソニックIpマネジメント株式会社 | Information provision method, server, voice recognition device, and information provision program |
US11443855B2 (en) | 2018-08-21 | 2022-09-13 | Patientmd, Inc. | Secure dispersed network for improved communications between healthcare industry participants |
CN109147916B (en) | 2018-08-22 | 2023-05-26 | 江苏超敏科技有限公司 | Medical waste online supervision device and method |
CN112638241A (en) | 2018-08-23 | 2021-04-09 | 三和生物科技有限公司 | Portable diagnostic apparatus and method thereof |
IL261679A (en) | 2018-09-06 | 2018-10-31 | Acuant Inc | System and method for management of digital id |
JP7282323B2 (en) | 2018-09-13 | 2023-05-29 | 株式会社産業予防医業機構 | Infectious disease test result information sharing system, infectious disease test result information sharing method |
WO2020061066A1 (en) | 2018-09-17 | 2020-03-26 | Computer World Services Corp. dba LabSavvy | Systems and methods for automated reporting and education for laboratory test results |
US11369318B2 (en) | 2019-05-31 | 2022-06-28 | Light Ai, Inc. | Image processing of streptococcal infection in pharyngitis subjects |
KR20200041458A (en) | 2018-10-12 | 2020-04-22 | 센시(주) | An entrance and exit gate capable of diagnosising health status of passengers |
US20200125965A1 (en) | 2018-10-21 | 2020-04-23 | Anuthep Benja-Athon | Abiotic Intelligence-Rendered Thinking Faculty |
JP2020067939A (en) | 2018-10-26 | 2020-04-30 | パナソニックIpマネジメント株式会社 | Infection risk identification system, information terminal, and infection risk identification method |
FR3087918A1 (en) | 2018-10-29 | 2020-05-01 | Matthieu Pelissier | SOLUTION TO AUTOMATE COLLECTION, DATA PROCESSING AND INTERPRETATION IN THE CONTEXT OF PROPHYLAXIS OPERATIONS FOR THE SCREENING OF BOVINE TUBERCULOSIS. |
KR102167995B1 (en) | 2018-10-31 | 2020-10-20 | (주)위비즈테크 | System and method for certifying trading related companies |
CN111161812A (en) | 2018-11-08 | 2020-05-15 | 珠海横琴盛达兆业科技投资有限公司 | Management method for realizing store employee health record based on Internet platform |
US11055575B2 (en) | 2018-11-13 | 2021-07-06 | CurieAI, Inc. | Intelligent health monitoring |
JP7165892B2 (en) | 2018-11-14 | 2022-11-07 | パナソニックIpマネジメント株式会社 | Pathogen information management system, pathogen information management method and information terminal |
EP3654338A1 (en) | 2018-11-15 | 2020-05-20 | F. Hoffmann-La Roche AG | Method and devices for exchanging health data |
US20200167871A1 (en) | 2018-11-26 | 2020-05-28 | MedXoom, Inc. | Platform as a service serving the healthcare marketplace |
US10290101B1 (en) | 2018-12-07 | 2019-05-14 | Sonavista, Inc. | Heat map based medical image diagnostic mechanism |
CN109658303A (en) | 2018-12-13 | 2019-04-19 | 湖南德雅曼达科技有限公司 | A kind of system and method that nosocomial infection prevention and control are learnt for medical worker |
CN109587337A (en) | 2018-12-14 | 2019-04-05 | 江苏科技大学 | A kind of method and smart phone of quick detection mycotoxin |
FI20186112A1 (en) | 2018-12-19 | 2020-06-20 | Actim Oy | System and method for analysing a point-of-care test result |
US20200204377A1 (en) | 2018-12-19 | 2020-06-25 | Alclear, Llc | Digital notarization station that uses a biometric identification service |
US11159321B2 (en) | 2018-12-19 | 2021-10-26 | Alclear, Llc | Digital notarization using a biometric identification service |
CN111354443A (en) | 2018-12-20 | 2020-06-30 | 广州华银医学检验中心有限公司 | Remote pathological diagnosis section digital image processing and transmission technology |
KR20200082445A (en) | 2018-12-28 | 2020-07-08 | (주)블루와이즈 | Health and life safety management system using position information |
CN209678887U (en) | 2018-12-29 | 2019-11-26 | 南方医科大学南方医院 | Integral first-aid POCT test box and the mobile inspection management system of the first aid POCT being made of it |
US20200209214A1 (en) | 2019-01-02 | 2020-07-02 | Healthy.Io Ltd. | Urinalysis testing kit with encoded data |
US20220065795A1 (en) | 2019-01-15 | 2022-03-03 | Quidel Corporation | System and methods for remote assessment of a sample assay for disease diagnostics |
KR102242704B1 (en) | 2019-01-31 | 2021-04-21 | 한국과학기술원 | System for Assaying Pathogens Integrated with Smart Devices |
KR102604352B1 (en) | 2019-02-19 | 2023-11-21 | 삼성전자 주식회사 | Arrangement of electronic device including the same |
US11264130B2 (en) | 2019-02-28 | 2022-03-01 | Fujifilm Business Innovation Corp. | System and method for estimating pathogen transfer from mobile interaction in clinical environments and a warning system and method for reducing cross-contamination risks |
EP3702988A1 (en) | 2019-02-28 | 2020-09-02 | Caldr | Computer-implemented system and method for scheduling healthcare appointments |
US20200279631A1 (en) | 2019-03-01 | 2020-09-03 | Alclear, Llc | Biometric secured medical check in |
CN111667902A (en) | 2019-03-08 | 2020-09-15 | 震一科技(天津)有限公司 | Clinical operation management system |
US20210058736A1 (en) | 2019-03-10 | 2021-02-25 | Ottogee, Inc | Proximity alert and contact tracing device, method and system |
WO2020186231A2 (en) | 2019-03-14 | 2020-09-17 | The Broad Institute, Inc. | Crispr effector system based multiplex diagnostics |
WO2020198511A1 (en) | 2019-03-27 | 2020-10-01 | Juno Diagnostics, Inc. | Digital health ecosystem |
US20200312428A1 (en) | 2019-03-29 | 2020-10-01 | GE Precision Healthcare LLC | SmartLabs Processor |
US20200321090A1 (en) | 2019-04-03 | 2020-10-08 | Portable EMR Solutions, Inc. | Portable Electronic Medical Record Card and Associated Systems and Methods |
CN110045106A (en) | 2019-04-18 | 2019-07-23 | 桂林理工大学 | One kind exempting from instrument enzyme-linked immunosorbent assay for measuring |
CN210199118U (en) | 2019-04-22 | 2020-03-27 | 广西埃韦迪生物科技有限公司 | Medical hand-held type colloidal gold immunoassay appearance |
CN109900893A (en) | 2019-04-22 | 2019-06-18 | 广西埃韦迪生物科技有限公司 | A kind of hospital handheld formula colloid gold immune analyzer |
CN210071666U (en) | 2019-04-28 | 2020-02-14 | 深圳市赛泰诺生物技术有限公司 | Pathogenic microorganism detection device and smart phone |
CN110021415A (en) | 2019-04-29 | 2019-07-16 | 千讯股份有限公司 | Medical and health organization practitioner history information management system |
US20200350079A1 (en) | 2019-05-01 | 2020-11-05 | James Thomas | Epidemic Alert System |
TW202042137A (en) | 2019-05-02 | 2020-11-16 | 歐生全科技股份有限公司 | Intelligent wallet apparatus and method for operating the same |
US20200357497A1 (en) | 2019-05-09 | 2020-11-12 | Deirdre Kamber Todd | Secure systems, devices and methods for storing and accessing personal identification, medical, and veterinary information |
US20200357526A1 (en) | 2019-05-10 | 2020-11-12 | Hygea Precision Medicine, Inc. | Systems and methods for clinical guidance of genetic testing for patients via a mobile application |
CN110189823B (en) | 2019-05-29 | 2021-09-28 | 深圳市国联健康数据科技有限责任公司 | Intelligent homologous health medical treatment and prevention system |
AU2020303972A1 (en) | 2019-06-22 | 2022-02-10 | Cerus Corporation | Systems and methods for implementing treatment of biological fluids |
CN110444296B (en) | 2019-07-02 | 2022-07-29 | 中国科学院计算技术研究所 | Three-dimensional color block obstacle testing system, storage medium, device and implementation method |
CN110349641A (en) | 2019-07-05 | 2019-10-18 | 中国人民解放军总医院 | A kind of health and fitness information inquiry unit convenient for operation |
CN111863168A (en) | 2019-07-11 | 2020-10-30 | 中国医学科学院阜外医院 | Hardware system with exchange protocol |
CN111835762A (en) | 2019-07-11 | 2020-10-27 | 中国医学科学院阜外医院 | Hardware system based on asymmetric key algorithm |
US20210050116A1 (en) | 2019-07-23 | 2021-02-18 | The Broad Institute, Inc. | Health data aggregation and outbreak modeling |
US20210043326A1 (en) | 2019-08-05 | 2021-02-11 | GE Precision Healthcare LLC | Methods and systems for telemetry monitoring protocol management |
CN211883765U (en) | 2019-08-20 | 2020-11-10 | 河北时代电子有限公司 | Wisdom medical treatment basic data acquisition device |
US11545271B2 (en) | 2019-08-20 | 2023-01-03 | GE Precision Healthcare LLC | Systems and methods for public and private communication threads |
US20210056639A1 (en) | 2019-08-22 | 2021-02-25 | Azova, Inc. | Telemedicine practitioner onboarding with on-demand per encounter malpractice liability coverage |
CN110570918A (en) | 2019-09-10 | 2019-12-13 | 中国人民解放军陆军军医大学第一附属医院 | medical information remote sharing system and method based on big data |
CN211674200U (en) | 2019-10-16 | 2020-10-16 | 河北大学 | Intelligent health monitoring system for daily care of old people |
CN110796422A (en) | 2019-11-07 | 2020-02-14 | 唐山启奥科技股份有限公司 | Information blood collecting and supplying method |
CN110827997A (en) | 2019-11-14 | 2020-02-21 | 青岛大学附属医院 | Intensive care system based on artificial intelligence |
CN111220801B (en) | 2019-12-25 | 2023-05-09 | 华南农业大学 | High-throughput multichannel immunochromatographic analysis method and system based on smart phone |
CN110957032A (en) | 2019-12-31 | 2020-04-03 | 重庆亚德科技股份有限公司 | Remote medical diagnosis system for traditional Chinese medicine |
CN211015833U (en) | 2020-01-14 | 2020-07-14 | 中科海微(北京)科技有限公司 | Rescue system capable of automatically identifying and alarming |
CN111564209A (en) | 2020-01-19 | 2020-08-21 | 郑莫非 | Wearable device, terminal device, health management method and health management system |
CA3168681A1 (en) | 2020-01-27 | 2021-08-05 | Cubic Corporation | Tracking transportation for hands-free gate |
CN211787265U (en) | 2020-02-18 | 2020-10-27 | 安居慧云(厦门)科技有限公司 | A intelligent temperature measurement entrance guard that is used for novel body temperature screening of coronavirus epidemic prevention |
CN111354119A (en) | 2020-02-21 | 2020-06-30 | 成都超有范儿科技有限公司 | Intelligent passing platform for community residents in epidemic prevention and control period |
CN111340442A (en) | 2020-02-21 | 2020-06-26 | 成都超有范儿科技有限公司 | Novel community pass application and use method based on epidemic disease prevention |
KR102159722B1 (en) | 2020-02-21 | 2020-09-24 | (주) 티나쓰리디 | Method for warning risk of virus infection, program that performs the method and apparatus on which the program is installed using confirmer information of infectious virus |
CN211776141U (en) | 2020-02-25 | 2020-10-27 | 马宗义 | Self-service medical service kiosk |
CN111261302B (en) | 2020-02-26 | 2024-04-19 | 汤一平 | Epidemic virus field visualization method and system based on space-time trajectory data |
CN211787238U (en) | 2020-03-03 | 2020-10-27 | 安居慧云(厦门)科技有限公司 | Intelligent entrance guard for novel coronavirus epidemic prevention grid management |
CN111370136A (en) | 2020-03-03 | 2020-07-03 | 绵竹市疾病预防控制中心 | Epidemic prevention and control information system for emergency public health event |
CN111311018A (en) | 2020-03-04 | 2020-06-19 | 苏州远征魂车船技术有限公司 | Accurate management and control system of epidemic situation |
CN111403045A (en) | 2020-03-04 | 2020-07-10 | 苏州远征魂车船技术有限公司 | Diversified and accurate management and control system for infectious epidemic situation |
CN111370135A (en) | 2020-03-04 | 2020-07-03 | 苏州远征魂车船技术有限公司 | Accurate management and control system of epidemic situation |
CN111210886A (en) | 2020-03-05 | 2020-05-29 | 宁波一川交通科技有限公司 | System and method for collecting human health data in real time |
CN111027525B (en) | 2020-03-09 | 2020-06-30 | 中国民用航空总局第二研究所 | Method, device and system for tracking potential infected persons in public places during epidemic situation |
US20210286864A1 (en) | 2020-03-13 | 2021-09-16 | NextGen Monetization Trust | Dual-mode biometric configuration for user validation and user health check to determine access to products and/or services |
US11437127B2 (en) | 2020-03-13 | 2022-09-06 | NextGen Monetization Trust | Trusted third-party computerized platform for AI-based health wallet |
CN111312406B (en) | 2020-03-15 | 2020-11-13 | 薪得付信息技术(山东)有限公司 | Epidemic situation label data processing method and system |
CN211454690U (en) | 2020-03-17 | 2020-09-08 | 苏州雷格特智能设备股份有限公司 | Intelligent epidemic prevention gate system |
CN111243150A (en) | 2020-03-17 | 2020-06-05 | 苏州雷格特智能设备股份有限公司 | Intelligent epidemic prevention gate system |
CN111276257A (en) | 2020-03-17 | 2020-06-12 | 胡远超 | Novel coronavirus pneumonia screening and evaluating system based on APP |
CN211454692U (en) | 2020-03-17 | 2020-09-08 | 苏州雷格特智能设备股份有限公司 | Intelligent stereoscopic vision temperature measurement ticket checking system |
CN111354473A (en) | 2020-03-20 | 2020-06-30 | 天津绿州能源装备有限公司 | Application system for searching new coronary pneumonia infected person based on navigation map and mobile phone positioning |
CN111444444A (en) | 2020-03-24 | 2020-07-24 | 数字广东网络建设有限公司 | Epidemic prevention health information acquisition method and device |
AU2020100481A4 (en) | 2020-03-29 | 2020-05-14 | Liu, Xiang MR | Provide a solution to estimate the person infected risk and the surrounding risks. The solution provides flexible policy configurations for giving individual instructions according to his infected risks. Therefore, it provides a solution to allow society to tuned to gain the balance of Economy and Health for different situations |
KR102399702B1 (en) | 2020-03-30 | 2022-05-19 | 주식회사 올라운드 | Trace system for Infectious people and trace method using it |
US10887104B1 (en) | 2020-04-01 | 2021-01-05 | Onu Technology Inc. | Methods and systems for cryptographically secured decentralized testing |
US20200291490A1 (en) | 2020-04-05 | 2020-09-17 | Sensiva Health Llc | Risk Stratification for Contagious Disease |
CN111554404B (en) | 2020-04-13 | 2023-09-08 | 吾征智能技术(北京)有限公司 | Disease prediction system and method based on indoor environment |
CN111513691A (en) | 2020-04-13 | 2020-08-11 | 深圳市爱深盈通信息技术有限公司 | Epidemic situation prevention and control method, server and system |
CN111461272A (en) | 2020-04-13 | 2020-07-28 | 福建汇博物联科技有限公司 | Epidemic situation isolation management and control system and method |
WO2021211155A1 (en) | 2020-04-14 | 2021-10-21 | Unityband, LLC | System and method to manage safe physical distancing between entities |
KR102216148B1 (en) | 2020-04-16 | 2021-02-16 | 선유기술 주식회사 | Infectious disease management method and apparatus |
CN111643121A (en) | 2020-04-16 | 2020-09-11 | 柳州市工人医院 | Automatic infectious virus inspection and diagnosis system and inspection and diagnosis method thereof |
CN111582660A (en) | 2020-04-17 | 2020-08-25 | 阿坝师范学院 | Resident health index evaluation method |
US20210326474A1 (en) * | 2020-04-17 | 2021-10-21 | Vacmobile Corporation | Systems and methods for storing, authenticating and transmitting digital health information and records |
CN111540476B (en) | 2020-04-20 | 2020-12-01 | 中国科学院地理科学与资源研究所 | Respiratory infectious disease infectious tree reconstruction method based on mobile phone signaling data |
CN111540477B (en) | 2020-04-20 | 2021-04-30 | 中国科学院地理科学与资源研究所 | Respiratory infectious disease close contact person identification method based on mobile phone data |
EP4139938A4 (en) | 2020-04-21 | 2023-12-20 | OpenClear, Inc. | Method and apparatus for personal pathogen status verification at point of entry into an area of congregation |
CN111598134B (en) | 2020-04-24 | 2022-04-15 | 山东体育学院 | Test analysis method for gymnastics movement data monitoring |
CN111582097A (en) | 2020-04-28 | 2020-08-25 | 百色市人民医院 | Epidemic situation monitoring system |
CN111552000B (en) | 2020-04-29 | 2024-01-16 | 利智华(北京)智能科技有限公司 | Airport passenger security check information management system, method, equipment and storage medium |
US10777325B1 (en) | 2020-04-29 | 2020-09-15 | Zhaoyang Li | Self-governed individual social safe determination and confirmation method and system |
CN211858162U (en) | 2020-04-30 | 2020-11-03 | 广西海宝医疗科技有限公司 | Multifunctional mobile telemedicine device |
AU2020101208A4 (en) | 2020-05-01 | 2020-08-06 | Health Beacon Limited | System And Method For Vaccine Administration Verification |
US11263850B2 (en) | 2020-05-01 | 2022-03-01 | Aaj Computer Services, Inc. | Systems and methods for managing infectious disease dissemination |
CN111462460B (en) | 2020-05-01 | 2021-05-14 | 江阴市徐霞客中学 | Home-school linkage type new coronavirus warning protection method |
CN111651216A (en) | 2020-05-07 | 2020-09-11 | 小米数字科技有限公司 | NFC card processing method and device and storage medium |
CN111540427A (en) | 2020-05-09 | 2020-08-14 | 柳州市工人医院 | Remote ward round system based on Internet of things |
CN111430023A (en) | 2020-05-11 | 2020-07-17 | 周建 | Remote intelligent cunguan chi pulse diagnosis device |
CN111640513A (en) | 2020-05-13 | 2020-09-08 | 无锡市疾病预防控制中心 | Cloud platform-based epidemiological investigation and management method and system for new acute respiratory infectious disease |
US20210358068A1 (en) * | 2020-05-14 | 2021-11-18 | Bbl Healthcare Solutions Ltd | Method for issuing a verified health pass, use thereof for entering a venue and contact tracing method |
CN111550880A (en) | 2020-05-18 | 2020-08-18 | 大连彼姆科技有限公司 | Epidemic prevention treatment method and system |
CN111693694B (en) | 2020-05-19 | 2023-02-17 | 江苏大学 | Multi-virus immunodetection device and method based on smart phone and micro-fluidic chip |
KR102190873B1 (en) | 2020-05-28 | 2020-12-14 | 강원도 | The method of controllingthe spread of infections managing entertainment spot entrance event |
KR102190872B1 (en) | 2020-05-28 | 2020-12-14 | 강원도 | The method of controllingthe spread of infections and managing entering islands or boarding ships using touch stamp on smartphone |
CN112530600A (en) | 2020-05-26 | 2021-03-19 | 第四范式(北京)技术有限公司 | Infectious disease tracing method and device, electronic equipment and storage medium |
CN111935203B (en) | 2020-05-26 | 2022-06-10 | 成都中科大旗软件股份有限公司 | Time-sharing reservation electronic ticketing system and device supporting health codes |
CN212061244U (en) | 2020-05-26 | 2020-12-01 | 成都中科大旗软件股份有限公司 | Electronic ticketing device supporting health codes |
CN111369721B (en) | 2020-05-26 | 2021-02-19 | 浙江宇视科技有限公司 | Quarantine method, gate unit and gate system |
DE202020002331U1 (en) | 2020-05-27 | 2020-07-10 | Bernhard Lösing | Badge to demonstrate immunity to specific infections. |
JP6765777B1 (en) | 2020-05-27 | 2020-10-07 | 順一 月舘 | Mobile control system |
CN111652104A (en) | 2020-05-28 | 2020-09-11 | 苏州盈迪信康科技股份有限公司 | Non-contact infrared body temperature screening integrated reception platform based on face recognition technology |
CN111629334A (en) | 2020-05-28 | 2020-09-04 | 南京科技职业学院 | Method for supporting epidemic prevention and control in mobile communication |
CN111667390A (en) | 2020-05-29 | 2020-09-15 | 软通动力信息技术有限公司 | Epidemic prevention and control management system and method |
CN111640228A (en) | 2020-05-29 | 2020-09-08 | 四川亨通网智科技有限公司 | Scenic spot entering park access control system |
CN111484929A (en) | 2020-05-29 | 2020-08-04 | 上海思路迪生物医学科技有限公司 | Movable pathogen nucleic acid detection laboratory system supporting rapid deployment |
CN111627565B (en) | 2020-05-29 | 2023-12-29 | 黑龙江文图测绘地理信息有限责任公司 | Early warning system and method for infectious epidemic danger source |
CN111654825B (en) | 2020-06-02 | 2022-03-25 | Tcl通讯(宁波)有限公司 | Checkpoint passing management method, device and storage medium |
CN111403006B (en) | 2020-06-03 | 2020-09-25 | 成都逸视通生物科技有限责任公司 | Microorganism detection system and device |
CN211906967U (en) | 2020-06-04 | 2020-11-10 | 郭文军 | Terminal medical equipment data acquisition unit |
US10841737B2 (en) | 2020-06-05 | 2020-11-17 | Innovet, Llc | Apparatus and method for minimizing direct and indirect cross-contamination of pathogens between personnel within a workplace |
CN111639272A (en) | 2020-06-09 | 2020-09-08 | 四川隧唐科技股份有限公司 | Personnel health monitoring method, device and system |
CN111681727A (en) | 2020-06-09 | 2020-09-18 | 中南大学 | COVID-19 data acquisition and analysis system |
US11335441B2 (en) | 2020-06-12 | 2022-05-17 | Tensorx, Inc. | Health safety system, service, and method |
US10923216B1 (en) | 2020-06-12 | 2021-02-16 | Tensorx, Inc. | Health status system, platform, and method |
CN111710401A (en) | 2020-06-17 | 2020-09-25 | 刘付荣 | Method and system for determining time of seeing doctor by combining big data with medical insurance card |
US20210407689A1 (en) | 2020-06-28 | 2021-12-30 | Robert George Coghlan | Unified process for transmissible viral pathogens radial proximity real-time virtual global positioning plotting and social distancing computerized advanced advisory registry driven platform medical service |
US10888283B1 (en) | 2020-06-30 | 2021-01-12 | Boonsieng Benjauthrit | COVID-19 symptoms alert machine (CSAM) scanners |
CN111882164A (en) | 2020-06-30 | 2020-11-03 | 河海大学 | Village group epidemic prevention integrated platform based on internet of things architecture |
CN111755124B (en) | 2020-07-01 | 2024-01-26 | 电子科技大学 | Student back school management method for epidemic situation period |
CN111798970A (en) | 2020-07-05 | 2020-10-20 | 成都吱吖科技有限公司 | Cardiovascular disease data monitoring and triage platform and monitoring and triage method |
CN111798951A (en) | 2020-07-07 | 2020-10-20 | 徐延华 | Self-help medical guide system for infectious diseases |
CN111798607A (en) | 2020-07-08 | 2020-10-20 | 李雨泽 | Internet-based identification management system for patient registration and exit hospital outpatient service barrier gate |
CN111785393B (en) | 2020-07-08 | 2022-02-01 | 蒋芳 | Epidemic disease investigation method and system based on public place positioning sensor |
AU2020101336A4 (en) | 2020-07-12 | 2020-08-20 | D, Saisanthiya Mrs | An efficient machine learning technique to track the covid patients along with secondary contacts |
DE202020104079U1 (en) | 2020-07-15 | 2020-07-22 | Oxti Corporation | Epidemic prevention device that can be used with electronic equipment |
US10991190B1 (en) | 2020-07-20 | 2021-04-27 | Abbott Laboratories | Digital pass verification systems and methods |
US20210012869A1 (en) | 2020-07-22 | 2021-01-14 | Biosafety Diagnostics, Inc. | Systems and Methods for Real-Time Health Certification Using Point-of-Care Data |
US10931643B1 (en) | 2020-07-27 | 2021-02-23 | Kpn Innovations, Llc. | Methods and systems of telemedicine diagnostics through remote sensing |
CN111798982A (en) | 2020-07-28 | 2020-10-20 | 重庆警察学院 | Police health management system and health management method |
CN111863223B (en) | 2020-07-28 | 2021-08-20 | 卫宁健康科技集团股份有限公司 | Recommendation method and system for medical and health services, electronic device and storage medium |
CN111863224A (en) | 2020-08-03 | 2020-10-30 | 派凡科技(上海)有限公司 | Multifunctional intelligent hand hygiene monitoring system and method |
CN111879769A (en) | 2020-08-05 | 2020-11-03 | 安徽师范大学 | Device for reading medical detection kit |
AU2020101728A4 (en) | 2020-08-08 | 2020-09-17 | Balusamy, Balamurugan PROF | Smart COVID Scanner: Portable and Affordable Scanner to Detect COVID-19 Virus |
CN111968730A (en) | 2020-08-18 | 2020-11-20 | 重庆叁伊云科技有限公司 | Online electronic accompanying certificate application and use method |
AU2020102044A4 (en) | 2020-08-28 | 2020-10-08 | A, Chandrashekhar Dr | A smart and automated patient monitoring bed for covid patients |
CN112017342A (en) | 2020-09-07 | 2020-12-01 | 福清市冠恒电子科技有限公司 | Security check door to epidemic situation prevention and control |
DE202020004020U1 (en) | 2020-09-23 | 2020-10-21 | Till Keesmann | Mobile measuring, storage and communication device |
CN112102945B (en) | 2020-11-09 | 2021-02-05 | 电子科技大学 | Device for predicting severe condition of COVID-19 patient |
CA3203143A1 (en) | 2020-11-25 | 2022-06-02 | Binx Health Limited | Systems and methods for diagnostic testing |
AU2020103842A4 (en) | 2020-12-02 | 2021-02-11 | Bimal Kumar Mishra | A system and a method for analyzing and forecasting transmission of virus |
-
2020
- 2020-10-12 US US17/068,608 patent/US10991190B1/en active Active
- 2020-10-12 US US17/068,601 patent/US20220020481A1/en not_active Abandoned
- 2020-10-12 US US17/068,599 patent/US10991185B1/en active Active
-
2021
- 2021-03-22 US US17/208,754 patent/US11514737B2/en active Active
- 2021-04-26 US US17/240,644 patent/US11514738B2/en active Active
- 2021-09-15 US US17/476,223 patent/US11574514B2/en active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11514737B2 (en) | 2020-07-20 | 2022-11-29 | Abbott Laboratories | Digital pass verification systems and methods |
US11514738B2 (en) | 2020-07-20 | 2022-11-29 | Abbott Laboratories | Digital pass verification systems and methods |
US11574514B2 (en) | 2020-07-20 | 2023-02-07 | Abbott Laboratories | Digital pass verification systems and methods |
US20220176970A1 (en) * | 2020-12-08 | 2022-06-09 | Endera Corporation | Vehicle-based wellness diagnostic platform |
US11894137B2 (en) | 2021-01-12 | 2024-02-06 | Emed Labs, Llc | Health testing and diagnostics platform |
US11942218B2 (en) | 2021-01-12 | 2024-03-26 | Emed Labs, Llc | Health testing and diagnostics platform |
US20230057531A1 (en) * | 2021-08-17 | 2023-02-23 | Emed Labs, Llc | Mobile device stands for at-home diagnostics and healthcare |
Also Published As
Publication number | Publication date |
---|---|
US11514737B2 (en) | 2022-11-29 |
US20220020236A1 (en) | 2022-01-20 |
US10991190B1 (en) | 2021-04-27 |
US10991185B1 (en) | 2021-04-27 |
US11574514B2 (en) | 2023-02-07 |
US20220020237A1 (en) | 2022-01-20 |
US11514738B2 (en) | 2022-11-29 |
US20220020239A1 (en) | 2022-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11514738B2 (en) | Digital pass verification systems and methods | |
US20210326474A1 (en) | Systems and methods for storing, authenticating and transmitting digital health information and records | |
US20230298416A1 (en) | Digital pass verification systems and methods | |
US10169607B1 (en) | Individual centric personal data management process and method | |
US20210327548A1 (en) | Storing, authenticating, and transmitting health data | |
US9208284B1 (en) | Medical professional application integration into electronic health record system | |
Johnston et al. | Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners | |
US10460078B2 (en) | Systems and methods for remote demand based data management of clinical locations | |
Siegler et al. | An electronic pre-exposure prophylaxis initiation and maintenance home care system for nonurban young men who have sex with men: protocol for a randomized controlled trial | |
CN111192674A (en) | Method and apparatus for exchanging health data | |
Reisner et al. | Longitudinal cohort study of gender affirmation and HIV-related health in transgender and gender diverse adults: the LEGACY project protocol | |
Park et al. | A worker-centered personal health record app for workplace health promotion using national health care data sets: design and development study | |
CA3175822A1 (en) | Storing, authenticating, and transmitting health data | |
EP4183155A1 (en) | Digital pass verification systems and methods | |
Dixon et al. | Public health informatics infrastructure | |
Drayton Jackson et al. | Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology | |
Chu et al. | Understanding the risks and benefits of a patient portal configured for HIV care: patient and healthcare professional perspectives | |
Crawford et al. | The new York state SARS-CoV-2 testing Consortium: regional communication in response to the COVID-19 pandemic | |
WO2017173187A1 (en) | Systems and methods for remote demand based data management of clinical locations | |
Doshi et al. | Fast and frictionless: A novel approach to radiology appointment scheduling using a mobile app and recommendation engine | |
Bhakta et al. | The Toronto Guidelines: a practical means for childhood cancer staging | |
Yoo et al. | Designing digital COVID-19 screening: Insights and deliberations | |
Kaiser | Counting what counts: Epidemiologic measurement and generating meaningful findings | |
Hopkins et al. | Informatics in disease prevention and epidemiology | |
Tan et al. | A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ABBOTT LABORATORIES, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUTHRA, NITESH;FRAYMAN, LEV F.;FINCH, TERRY;AND OTHERS;SIGNING DATES FROM 20201012 TO 20201102;REEL/FRAME:054304/0227 |
|
AS | Assignment |
Owner name: ABBOTT LABORATORIES, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WOOD, NICHOLAS ALEXANDER ROBERTSON;REEL/FRAME:056362/0894 Effective date: 20210518 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |